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ABSTRACT  
Introduction 
Mondia whitei commonly known as “White Ginger” is a highly acclaimed medicinal plant that is 
extensively used across Africa. M. whitei is used as treatment for sexual dysfunction and is 
considered to be an aphrodisiac by traditional medicine practitioners. Yet, scientific evidence to 
support these claims are minimal and those that are published possess ambiguity. To date, only one 
study reporting the in vitro effect of the aqueous rhizome extract of M. whitei on human sperm 
motility is available. Therefore, the aim of the study was to determine the in vitro effects of M. 
whitei in human sperm functions. 
Materials and Methods 
Roots of Mondia whitei obtained from the tropical Kakamega rain forest, located in the Western 
Province of Kenya, were cleaned and chopped into smaller segments. These pieces were oven-
dried at 250C for 3 days and milled to form a powdery substance which was infused with hot (about 
700C) distilled water for 1 hour. After cooling and filtration, the extract was frozen at -200C and 
subsequently freeze-dried. The dried extract was then stored at 40C in a closed container until 
experimentation. 
A total of 60 semen samples were collected: 28 of them represented healthy sperm donors and 32 
infertile patients. Among these subjects, oligozoospermic and asthenozoospermic semen samples 
were identified and analysed separately. Sperm were washed using human tubular fluid medium 
supplemented with bovine serum albumin (HTF-BSA) and incubated for 1 hour at 370C with 
different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml). A sample without 
M. whitei served as control. Sperm cell motility, vitality, reactive oxygen species (ROS) production, 
mitochondrial membrane potential (MMP), capacitation, acrosome reaction and DNA 
fragmentation were assessed. 
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Results 
Total motility and the percentage of sperm with intact MMP showed significant dose-dependent 
increases in both groups (patient and donor), while, the percentages of progressively motile sperm 
only revealed significant increases in the patient group. Besides, the percentage of ROS-positive 
spermatozoa showed significant trend towards higher concentrations in the patient group only. 
Conversely, a trend towards reduced sperm DNA-fragmentation could be observed in the patient, 
but not the donor group. Similar tendencies were noted in oligozoospermic and asthenozoospermic, 
but not for normozoospermic subjects. Yet, sperm vitality, capacitation, acrosome reaction and 
kinematic parameters were not affected.  
Conclusions 
Phytochemicals present in M. whitei root extract maintains spermatozoa total motility, progressive 
motility and intact-MMP and DNA integrity. However, at therapeutic concentration (<1.85 µg/ml) 
it does not trigger sperm intrinsic superoxide production nor increase ROS by causing oxidative 
stress, that leads to DNA fragmentation.  
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CHAPTER 1: INTRODUCTION 
 
1.1 General insight 
 
The great diversity and therapeutic potential of plants could be beneficial if substantial research 
into the traditional use of plants as medicine would be done. This study seeks to clarify the role of 
Mondia whitei in the traditional treatment of male infertility.  
Human male fertility is a vital aspect of reproduction based on the ability of spermatozoa to fertilize 
and activate the egg and support early embryonic life. However, it has been considered lower than 
most animals (Jørgensen et al., 2001), with increasing infertility rates in many countries affecting 
one in six couples (Sharpe et al., 2003; Kamel, 2010). The issue of male infertility is multi-factorial 
with some men suffering from low fertility in spite of having adequate numbers of sperm with 
normal morphology and motility. However, the lack of knowledge in regard to the multi-factorial 
causes of male infertility has proved challenging on the rational approach towards development of 
effective therapies (Wu et al., 1989). According to Agarwal and his colleagues (2014), about 
30,625,864 to 30,641,262 of the male population worldwide suffer from infertility based on the 
World Health Organisation (WHO) 2010 standards.  
One of the first people to alert the world on the possibilities of declining male fertility is said to be 
Professor Niels Skakkeback (Dindyal, 2004). The Danish scientists’ study showed that sperm count 
from healthy men had dropped by more than half in 50 years. This study was conducted at the 
Department of Growth and Development at Copenhagen University, between 1938 and 1992 and 
it involve 14,947 men (Carlsen et al., 1992). Despite the fact that Carsen’s and colleagues findings 
caused a lot of debate (Swan et al., 2000) subsequent studies have confirmed these outcomes. For 
instance, an investigation done in Paris which involved 1350 sperm donors found a decrease in 
sperm count by approximately 2% each year over the past 23 years (Sharpe et al., 1995). Dindyal 
et al., (2004) recorded a 25% decline in sperm count over 20 years with an average of 100 
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million/ml recorded in 1950. These figures went down in 1970 and 1990 to 75 million/ml and 50 
million/ml, respectively. 
Discovering the complexity of spermatogenic development has been the centre core of many 
researchers over the past decades, for a clear understanding of what factors are involved during this 
process. This will enable the development of strategic measures to address challenges posed in 
issues related to human male infertility (Ruwanpura et al., 2010).  On the other hand, medicinal 
plants have been extensively used, particularly in Third World and developing countries, in the 
treatment of male reproductive dysfunction despite the fact that little research has been done on 
them (Semwal et al., 2013).  This shortcoming can be addressed through advancement in research 
which has provided a corner stone for standard analysis of sperm function.  
This chapter outlines an understanding of the male reproductive system, endocrine regulations and 
formation of spermatozoa. It also focuses on the history of traditional herbalism in use of M. whitei 
to address issues of male infertility.  
 
1.2 Human male reproductive system 
1.2.1 An overview 
The male reproductive system is a linkage of internal and external organs whose function is to 
produce, maintain, conduct and deliver viable sperm to fertilize an ovum (Rhodes, 1969; Sherwood, 
2011; Scanlon and Sanders, 2014). This is made possible through spermatogenesis, endocrine and 
paracrine hormonal regulation of reproductive function i.e. (Gonadotrophin releasing hormone 
[GnRH], Follicle-stimulating hormone [FSH], Luteinizing hormone [LH], Inhibin and testosterone 
[androgen]) (Sofikitis et al., 2008; O'Shaughnessy, 2014) and deliverance of semen containing 
spermatozoa into the female reproductive tract through sexual intercourse. The organs of the male 
reproductive system include: testes (site for spermatogenesis and hormonal production); 
epididymis (storage of mature spermatozoa and site for maturation); vas deferens and accessory 
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glands (seminal vesicles, prostate, and bulbourethral gland) (Figure 1). The testis, accessory glands 
and epididymis are instrumental in the formation of the seminal fluid which serves as: a lubricant 
to the passage spermatozoa must progress through; media through which spermatozoa are 
transported; protecting agent of spermatozoa from the acidic environment of the female genital 
tract and source of energy for the sperm activities since it contains fructose (De Kretser et al., 1998). 
The external genitalia comprise of the scrotum (encloses the testes) and the penis (an erectile organ 
that houses the distal portion of the urethra) (Martini et al., 2015). 
Figure 1: The Male Reproductive system - Sagittal section of the male reproductive organs 
showing the testes (site for spermatogenesis and hormonal production); epididymis (site for 
maturation and storage of spermatozoa) and accessory glands (seminal vesicles, prostate and 
bulbourethral gland) (Martini et al., 2015). 
 
1.2.2 The testes 
The development of the gonad is a unique embryological condition which can either become an 
ovary or testes (Gilbert, 2000). Though, formation of the testes will then depend on early activation 
of a gene localized in the Y-chromosome known as TDF (testis determining factor) (Hadley et al., 
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1985). Basically, the testis determining Sry (Y-encoded gene) triggers the undifferentiated genital 
ridge also known as bio-potential gonad to develop into testes (Wilhelm et al., 2007).  
Sertoli cells are the first cells to differentiate, therefore setting a trend of testes differentiation 
(Mackay, 2000). Direct testicular activities, organisation and coordination are thought to be 
prompted via a signal from the Sertoli cells (Cortes et al., 1987). Though the mechanisms involving 
the differentiation are poorly understood (Sharpe, 2010). Hardley et al. (1985) supposed that Sertoli 
cells surround the germ cells which have migrated into the gonad, followed by attraction of 
peritubular myoid cells encircling the Sertoli-germ cell complex, resulting in the formation of the 
seminiferous cord (Wilhelm et al., 2007). The cord undergoes elongation as Sertoli and germ cells 
proliferate, after it anchors itself at both ends in the rete testis.  Concurrently, foetal Leydig cells 
differentiate and begin to produce testosterone (Quinn and Koopman, 2012). This differentiation 
takes place in the interstitial space between the seminiferous cords (Sharpe, 2010). 
Follicle stimulating hormone (FSH) induces Sertoli cell proliferation in neonate producing a final 
number of cells that differentiate terminally during puberty (Ross and Capel, 2005). Later, Sertoli 
cells lose their proliferation ability (Tan et al., 2005; Macedo, 2012). Testosterone produced within 
the Leydig cells in the developing testis act to stimulate the Sertoli cells proliferation (Quinn and 
Koopman, 2012). Besides, the number of sperm cells produced in adulthood is determined by the 
number of Sertoli cells within the testis (Orth et al., 2000; Sharpe et al., 2003). Thus, only a given 
number of germ cells through their development into sperm cells can be supported by each Sertoli 
cell (Orth et al., 1988).  Proliferation of Sertoli cells takes place during foetal life, post and neo-
natal period and just before puberty (Ross and Capel, 2005). According to Plant and Marshall 
(2001), the importance of Sertoli cell proliferation and factors that regulate this process during the 
different periods of development may differ: for instance, during foetal and neonatal period; 
testosterone seems to play an important role whilst, FSH is of more significance during puberty. 
Additionally, proliferation of Sertoli cell during this period may also be affected by lifestyle and 
environmental factors at any of those stages (Rebourcet et al., 2016). In his review Sharpe (2010) 
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stated that this impact could directly lessen the quality of sperm production which may directly 
affect sperm count. 
1.2.3 Testicular feature 
The testes located in the scrotal sac are two oval organ  (3 cm anterior to posterior, 2 cm wide and 
4 cm long each) (Figure 2) (Marieb and Hoehn, 2007). They possesses two major functions, 
gametogenic and endocrine, of which, the endocrine function entails synthesis of male sex 
hormones while the gametogenic function  involves production of hormone (Mortimer, 1994). Each 
testis is surrounded by two connective tissues, the outermost tissue found in the anterior lateral 
surfaces is the Tunica vaginalis, moving inwards is Tunica albuginea, which is a thick fibrous 
connective tissue that subdivides the testis into about 250 lobules. Each lobule contains 1 to 4 
seminiferous tubules and interstitial connective tissues (Sherwood, 2011). According to Marieb 
(2007), the seminiferous tubule is made up of complex stratified epithelium containing two basic 
cell population known as the Sertoli cells and spermatogenic cells.  Basically, Sertoli cells are 
physical support cells that do not undergo replication, while spermatogenic cells (stem cells) 
regularly replicate and differentiate into mature sperm as they migrate towards the lumen.  
The interstitial connective tissue contain Leydig cells, that function in-producing and releasing 
testosterone (Wistuba et al., 2007).  In the long run, the seminiferous tubules merge into larger set 
of tubules known as the rete testis. Ultimately, the rete testis drains into a larger tubule known as 
efferent ducts which in turn drains into the epididymis which is made up of head, body and tail. 
Lastly but not least, the tail dilates into ductus deferens (Figure 2) (Macedo, 2012; Martini et al., 
2015). The ductus deferens continues up the spermatic cord into the body through the inguinal 
canal. Right and left ductus deferens proceeds cranially over the ureters behind the urinary bladder. 
As the duct passes behind the bladder, it has attached to its gland called the seminal vesicles. 
However, prior to this attachment, the ductus enlarges into the ampulla (site of sperm storage before 
ejaculation) (Marieb and Hoehn, 2007). 
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Figure 2: The testis: sagittal section of the testis showing the two tunics connective tissue; 
Epididymis (connection between testis and ductus deferens); ductus deferens and accessory glands 
(Marieb et al., 2007). 
 
1.2.4 Spermatogenesis 
One of the most important functions in life is the production of spermatozoa through 
spermatogenesis, which takes place in the male gonad (testis). The process is complex and needs 
highly organised tissues that are potently regulated by hormonal interaction, cell to cell 
communication and differential gene expression (Steger et al., 1998). In summary, spermatogenesis 
is an essential, complex biological process, leading to the formation of highly specialized mature 
spermatozoa within the testis through an organised cascade of events (Macedo, 2012). 
During this process, spermatogenia undergo meiotic recombination, reduction of genome to 
haploid state and immense cellular modification that results in motile spermatozoa capable of 
crossing the female reproductive tract, enduring various biological assaults for viability and 
eventually fertilizing a mature oocyte to give rise to an embryo (Carrell, 2013). This process is a 
highly co-ordinated mechanism fundamental in ensuring constant sperm production, characterised 
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by mitotically inactive Sertoli and germ cells undergoing mitosis, meiosis and spermiogenesis 
(Steger et al., 1998; Hogarth and Griswold, 2010). The production of functional spermatozoa in the 
testes takes approximately 74 days and an additional 12 days for maturation of released sperm in 
the epididymis (Durairajanayagam et al., 2015), yielding about 100 million spermatozoa each day 
(Reijo et al., 1995). Spermatogenesis commences at puberty and continues until death (Clermont, 
1963; Clermont and Antar, 1973) and is characterised by a series of events that originate at the 
basal compartment and ends at the apical compartment of the seminiferous tubule 
(Durairajanayagam et al., 2015).  
1.2.4.1 Occurances in the basal compartment of the seminiferous tubule 
This compartment marks the origin of spermatogenesis with spermatogonial renewal and 
proliferation via mitosis and differentiation; cell cycle progression from type B spermatogonia to 
preleptotene spermatocytes (Figure 3) (Cheng and Mruk, 2012). Firstly, stem cells called 
spermatogonia divide by mitosis to produce two daughter cells. Type A spermatogonia divide into 
type Apale and type Adark, although it is debatable how this cells are involved in proliferation 
activities (Steger et al., 1998). Spermatogonia are referred to as Apale spermatogonia as soon as they 
enter the differential pathway (Hogarth and Griswold, 2010). Type Apale spermatogonia undergo 
self-renewal to generate the stem cell pool based on their chromatin structure. In time, type Apale 
spermatogonia will then develop into type B spermatogonia (precursor of sperm) and eventually 
proceed to preleptotene followed by leptotene primary spermatocytes (De Kretser et al., 1998; 
Hogarth and Griswold, 2010).  In the human, undifferentiated Adark spermatogenia have the 
capacity to become gametes but are not yet committed to the process. However, they do undergo 
mitosis to increase the testicular stem cell population and provide progenitor cells that undergo 
spermatogenesis (Meehan et al., 2000). 
1.2.4.2 Occurrences in the ad-luminal compartment of the seminiferous tubule 
A summary of activities in this compartment includes: cell cycle progression from zygotene and 
pachytene to diplotene spermatocytes, followed by meiosis I and II; development of round 
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spermatids to spermatozoa via spermiogenesis and spermiation (Figure 3) (Cheng and Mruk, 2012). 
Meiotic events that enable maturation of spermatocytes encompass chromatin condensation in the 
nucleus, whereby spermatogenia enter the first meiotic division (prophase) is subdivided into: 
Preleptotene and Leptotene stages during which the chromatin condenses into visible 
chromosomes, followed by Zygotene and Pachytene stages which is characterised by pairing of 
homologous chromosomes to become primary spermatocyte. This is followed by the Diplotene 
stage in which each cell undergoes chromosomal crossing over. Hence, the formation of duplicates, 
of which 22 pairs are autosomal chromosomes, 2 X-chromosomes and 2 Y-chromosomes (Cheng 
and Mruk, 2012), takes place. These cells then undergo meiosis II, which is characterised by 
separation of sister chromatids into individual cells. The division of every spermatid leads to the 
formation of four haploid gametes (23 chromosomes) termed as round spermatids (Hogarth and 
Griswold, 2010). 
1.2.4.3 Spermiogenesis: Spermiation and maturation in the epididymis 
Spermiogenesis is a process by which haploid spermatids become specialized spermatozoa by the 
process of elongation and differentiation. There are four phases involved in this process namely 
Golgi phase, cap phase, acrosome phase and maturation phase (Steinberger, 1971). Through the 
four processes each round spermatid becomes fully compacted and develops into an elongated 
spermatid that undergoes spermiogenesis to form spermatozoa (Figure 4) (Durairajanayagam et al., 
2015). 
Lastly, spermiation, which involves the release of mature spermatozoa from the lumen of 
seminiferous tubule takes place (Hogarth and Griswold, 2010; Durairajanayagam et al., 2015).  
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Figure 3: summary of 3 stages of spermatogenesis: spermatoginal phase taking place at the basal 
compartment of the seminiferous tubule. Spermatogenia proliferate by mitotic division to produce 
Adark (Ad) spermatogonium which proceed to form stem cells and Apale (Ap) spermatogonium which 
proceed through spermatogenesis to form primary spermatocytes: Spermatocyte and spermatid 
phase taking place at the adluminal compartment of the seminiferous tubule. Spermatocyte phase: 
primary spermatocyte enter meiosis I to form secondary spermatocyte which enters meiosis II and 
results in the formation of spermatids. Spermatid phase: spermatid becomes specialized and motile 
spermatozoa (Adopted from Pearson Edu, 2013). 
 
From the lumen, spermatozoa leave the testis to the epididymis through the rete deferens; owing to 
the fact that the peritubular Myoid cells are able to conduct peristalsis necessary to move, at this 
stage sluggishly motile elongated testicular spermatozoa in the direction of the efferent duct to the 
epididymis  (Wistuba et al., 2007). In the epididymis, spermatozoa released from the testis get 
subjected to additional physiological maturation to acquire motility and the potential to fertilize an 
oocyte (Figure4) (Hogarth and Griswold, 2010). This process involves several biological and 
morphological changes encompassing compacting of nuclear substances via, enzyme mediated 
oxidative cross-linking protamines (Fujii and Tsunoda, 2011), which are enabled by the epididymal 
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micro-environment that helps maintain osmolarity. Hence, stabilizes the sperm membrane 
(Mortimer, 1997). 
1.2.5 Endocrine regulation of spermatogenesis 
Normal function of the testes and reproductive functions are regulated by interaction of the highly 
complex endocrine hypothalamus-pituitary-gonadal axis. The onset of puberty in the human male 
is strongly characterised by the production of testosterone, which is influenced upon stimulation of 
luteinising hormone (LH) and Leydig cells (Wistuba et al., 2007; Knez, 2013). Endocrine 
regulation of spermatogenesis is then maintained through the relationship between gonado-
trophins, steroid and testicular somatic cells (Sertoli and Leydig cells). 
1.2.6 The male reproductive hormones 
The hormonal reproductive axis in male consist of three main components: the hypothalamus, the 
pituitary and the testis (Hall and Guyton, 2011). This axis usually functions in a tightly controlled 
manner to produce hormones necessary for normal sexual development, sexual function and 
fertility (Wistuba et al., 2007). Hormones produced by glands in this axis include: hypothalamic 
gonadotropin releasing hormone (GnRH), pituitary gonadotropins [follicle stimulating hormone 
(FSH) and lutenising hormone (LH)] and testicular steroids (Rizzo, 2015). These hormones 
function in an integrative way to ensure normal development and regulation of the male 
reproductive system (Wistuba et al., 2007). Dysfunction in either the hypothalamus, pituitary or 
the testes may results in widespread repercussion such as ambiguous genitalia, delayed puberty and 
infertility (Hall and Guyton, 2011). 
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Figure 4: Illustration of a round spermatid undergoing the different phases of spermiogenesis 
which involves appearance of acrosome vesicles and flagella, growth of acrosome and flagella, 
shedding of excess cytoplasm to become specialized spermatozoa.  (Pearson Edu, 2011) 
 
1.2.6.1 Function of gonado-tropin-releasing hormone (GnRH) 
GnRH is a neuro-hormone produced by specific neuro cells, whose main function is stimulation of 
the synthesis and secretion of LH and FSH by the anterior pituitary gland. The neuro cells are 
distributed throughout the hypothalamus and release hormones at its neuro-terminals (Meccariello 
et al., 2014).  The preoptic area of the hypothalamus contains most of the GnRH neurons. GnRH 
is pulsatile and periodically occurring every 1-2 hours (Rizzo, 2015). The GnRH-containing 
neurons project to the median eminence where they release GnRH from their axon terminals into 
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the hypophyseal portal system. In the portal capillary, the GnRH travels to the anterior pituitary 
gland to influence the production of LH and FSH (Meccariello et al., 2014). 
1.2.6.2 Function of gonado-tropins hormones (FSH and LH) 
Gonado-tropin (LH and FSH) hormones are hetero-dimer glycoprotein hormones secreted from the 
anterior pituitary gland by gonado-tropic cells under the stimulation of GnRH (Pernasetti et al., 
2001; Hall and Guyton, 2011).  LH and FSH exert their effects on their respective target cells 
located chiefly in the testes. They do so mainly by activating the cyclic adenosine monophosphate 
second messenger which activates specific enzymes in the respective target cells (Wistuba et al., 
2007). 
LH stimulates the interstitial (Leydig) cells in the testis to stimulate testosterone hormone release; 
the amount of testosterone produced in male is thought to be approximately directly proportional 
to LH (Achard et al., 2009). According to Wistuba (2007), the main function of LH is determining 
secondary sexual characteristics by stimulating the secretion of testosterone. Guyton and Hall 
(2011) give more insight by saying the production of mature male gametes is also dependant on 
LH, which is a gonadotrope glycoprotein. It stimulates Leydig cells to produce testosterone 
(Achard et al., 2009). LH is increased in the perinatal period for a short period (7-13 weeks) before 
its activity is decreased again and remains slow until puberty (Kuiri-Hänninen et al., 2014). The 
levels are then elevated again at the onset of puberty. As a results, Leydig cells get stimulated to 
produce androgens again. Afterwards, this relationship is maintained through a feedback loop 
during male adulthood (Meccariello et al., 2014).  
FSH in turn stimulates Sertoli cells in the seminiferous tubules of the testes to grow and secrete 
various spermatogenesis substances (Wistuba et al., 2007). At the same time, testosterone and 
dihydrotestosterone diffuse into the seminiferous tubule to act on spermatogenesis. In addition, 
evidence has shown that FSH is important in multiplication of spermatogonia supported by 
testosterone action for proliferation of the germ cell line and plays a major role for the renewal of 
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type-A spermatogonia (Simoni et al., 2008). Thus, both FSH and testosterone contribute to the final 
maturation of spermatozoa, and protect the germ cell line against apoptosis (Hall and Guyton, 
2011). 
1.2.6.3 Function of Inhibin B 
Inhibin B is a glycoprotein which is synthesized by Sertoli cell through stimulation from FSH 
(Wistuba et al., 2007). The regulation of inhibin B is strongly associated with gonadotropins whose 
level decreases in males as they age (Ramaswamy and Plant, 2001). The onset of puberty activates 
the production of inhibin B (Meccariello et al., 2014). In early postnatal testis development, an 
increase of inhibin B levels is seen leading to down-regulation of  the hypothalamic-pituitary-
gonado axis which results in the changes in testosterone, LH and FSH levels (Wistuba et al., 2007). 
FSH action and Sertoli cell proliferation are associated with inhibin B activity during pre-pubertal 
testis formation (Simoni et al., 2008). Afterwards, the level of inhibin B declines which mirrors 
Sertoli cell density (Wistuba et al., 2007).  
The major determinant of inhibin B in adulthood (after completion of spermatogenesis in puberty) 
is the germ cells (Ramaswamy and Plant, 2001). Rising androgen levels are thought to be the 
activating factor in germ cell proliferation which secondarily depends on FSH and has been 
associated with changes in Inhibin B levels (Meccariello et al., 2014). Thus, inhibin B levels are 
indicated in spermatogenic efficiency since the level directly correlates with sperm count (Wistuba 
et al., 2007).  
The two main functions of heterodimeric gonadotropin FSH (glycoprotein), a major contributing 
factor in the regulation of spermatogenesis, in adulthood are: Regulation of inhibin B and 
determination of Sertoli cell number in immature testis. FSH influences maturation of Leydig cells 
(Simoni et al., 2008).  All these processes are mediated via G-protein coupled transmembrane FSH 
receptors (Wistuba et al., 2007). 
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1.2.6.4 Function of Testosterone 
Testosterone is the principle male steroid hormone from the androgen group (Simoni et al., 2008). 
In the male, testosterone is mainly secreted in the testes by interstitial Leydig cells. Small amounts 
are also secreted by the adrenal glands (Rizzo, 2015). The major function of testosterone in the 
testes is the maintenance of spermatogenesis via stimulation of Sertoli cells; its actions, are 
mediated through intracellular androgen receptor which acts as a transcription factor (Simoni et al., 
2008).  Testosterone produced by Leydig cells, passes into the Sertoli cells and binds to receptors. 
The combination of testosterone with the receptors is required for the Sertoli cells to function 
normally. In addition, testosterone is converted to two other steroids in the Sertoli cells: estrogen 
and dihydrotestosterone (Hall and Guyton, 2011). 
The Sertoli cells also secrete a protein called androgen-binding protein into the seminiferous 
tubules (Rizzo, 2015). Testosterone and dihydrotestosterone bind to androgen-binding protein and 
are carried along with other secretions of the seminiferous tubules to the epididymis. Estradiol and 
dihydrotestosterone may be the active hormones that promote sperm cell formation (Hall and 
Guyton, 2011). According to Rizzo (2015), other functions of testosterone include: promotion of 
growth, differentiation, and function of accessory organs of reproduction; maintenance of normal 
reproductive function in the adult, stimulates transport and delivery of sperm and increases sexual 
drive (libido) in both men and women. 
1.2.7 The male reproductive cells 
1.2.7.1 Sertoli cells 
These cells were first described in 1865 by Enrico Sertoli hence, origin of the name. He suggested 
they provided a number of nutrients for the germ cells within the seminal epithelium. Thereafter, 
many studies have stipulated the role of Sertoli cells in spermatogenesis which include: provision 
of nutrition at the differentiating sperms, formation of the blood-testes-barrier tight junctions, 
involvement in selective permeability hindering pathogens that may harm sperm cells and allowing 
the passing through of beneficial substances like testosterone, secretion of adequate fluid into the 
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lumen of the seminiferous tubule, which helps in sperm maturation towards the epididymis tubule 
and synthesis and metabolism of steroids (Dym and Raj, 1977; Wistuba et al., 2007; Sherwood, 
2011). 
1.2.7.2 Leydig cells 
Leydig cells (interstitial endocrinocytes) are clusters of endocrine cells found between seminiferous 
tubules, whose function is derived from endocrine and paracrine inter-communication (Ge et al., 
2009). These cells mainly synthesize and secret male sex hormones (androgens), the most 
important of which is testosterone (Wistuba et al., 2007). Endocrine stimulation by LH induces 
Leydig cells to secret testosterone. In turn, testosterone diffuses into the seminiferous tubule and 
drives spermatogenesis together with FSH (Ge et al., 2009). Therefore, making Leydig cell 
significant in spermatogenesis (Hall and Guyton, 2011). 
1.2.8 Hypothalamus-pituitary-gonadal axis 
1.2.8.1 Hypothalamus-pituitary-gonado axis initial stimulation  
The hypothalamus-pituitary-gonadal axis has to be stimulated prior to the onset of puberty to 
initiate the sexual life (Wistuba et al., 2007). This process is initiated through the release of 
Kisspeptin from the arcuate nuleus of the brain by specialized neurons (kiss-1-neuron) to stimulate 
gonadotropin releasing hormone (GnRH). Hence, GnRH is released as a result of kiss-1-neuron 
stimulating GnRH neurons in the hypothalamus leading to expression of GPR54 receptors, which 
binds kiss-peptin via a G-protein cascade (Smith et al., 2006). In turn, the release of GnRH from 
the hypothalamus in pulsatile intervals of 60 to 120 minutes, initiates the release of FSH and LH. 
Receptors expressed by Sertoli cells bind FSH, thus acting to stimulate spermatogenesis whilst LH 
stimulates Leydig cells to produce testosterone in the testis (Wistuba et al., 2007; Sharpe, 2010).  
The initial release of Kiss-peptin initiates pubertal events in both male and female (Smith et al., 
2006).  
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1.2.8.2 Hypothalamus-pituitary-gonadal axis function 
Gonadotropin Releasing Hormone (GnRH) is released from the hypothalamus in pulse rate 
intervals every 90-120 minutes (Cheng and Mruk, 2012). The portal blood carries GnRH to the 
anterior pituitary glands, which contains the gonadotrope cells (receptors of GnRH) (George et al., 
2011). Subsequently, the activation of GnRH receptors that is, a beta seven transmembrane G-
protein-coupled receptor that stimulates the isoform of phosphoinositide phospholipase C, which 
goes on to mobilise protein kinase C takes place, resulting in activation of proteins involved the 
synthesis and secretion of LH and FSH (Wistuba et al., 2007).  As a result of the stimulation by 
gonadotropins, steroidal hormones such as testosterone, estrogen and progesterone are 
consequently stimulated and released at target organs (testes in males and ovaries in females). 
These hormones are important for male and female secondary characteristics which include 
maintaining, supporting and ensuring reproduction, bone density and muscle mass (Ge et al., 2009; 
Hall and Guyton, 2011; Cheng and Mruk, 2012). However, when the testosterone level is at an 
increase, inhibin (synthesis in the Sertoli cells due to FSH) suppresses the effects of FSH locally in 
the testis, as well as FSH in the pituitary (Wistuba et al., 2007), by inhibiting the hypothalamus in 
releasing GnRH in a negative feedback (Figure 5). Thus, the system is kept in equilibrium. 
 
 
 
 
 
 
 
 
 
17 
 
 
Figure 5:  Illustration of hormonal regulation of male reproductive function: hypothalamus 
regulates activity of anterior pituitary (adenohypophysis), adenohypophysis synthesizes hormones 
(LH and FSH) that modulate activities of Sertoli and Leydig cells, Luteinizing Hormone (LH): 
stimulates testosterone production by Leydig cells, Follicle Stimulating Hormone (FSH): 
stimulates production of sperm in conjunction with testosterone by regulating the activity of Sertoli 
cells (Pearson Edu, 2011) 
 
1.2.9 Sperm function parameters analysis 
1.2.9.1 Motility 
Sperm motility is an aspect of semen quality which is believed to be important in defining fertility 
in relation to achievement of pregnancy (Yanagimachi et al., 1976). In general, it gives a measure 
of integrity of the sperm axoneme and tail structure, metabolic machinery of the mitochondria and 
morphology  (Pacey, 2006). Sperm movement is generated from the flagellum (tail structure) (Paoli 
et al., 2011) providing the propulsion for swimming, which is critical for sperm motility (Coetzee 
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et al., 1989; Pacey, 2006). Furthermore, sperm with good kinematic motility parameter are able to 
penetrate cervical mucus better (Aitken et al., 1991).  
Studies have indicated sperm motility to be a predictive value for pregnancy rates, since reduced 
sperm motility may reduce the chances of fertilization of the ovum, an aspect common in infertile 
men (Coetzee et al., 1989; Henkel, 2005). Bartoov et al. (2002) found sperm motility to 
significantly correlate with fertilization in vitro and has been clinically used to predict pregnancy 
(Aboua et al., 2009). Likewise, studies have shown that motility can directly be correlated to 
mitochondrial membrane potential (Kasai et al., 2002), plasma membrane integrity (Aitken et al., 
1991) and morphology (Kruger et al., 1987).  
However, knowing the percentage of sperm motility could be convenient for standardizing 
experimental studies whose interest would be examining sperm movement in isolation (Hirano et 
al., 2001), but  might not be suitable when tests are being performed for clinical purposes (Mortimer 
et al., 1986). Guzick et al. (2001) strongly support the fact that sperm motility provides useful 
information for diagnosing male infertility, but not in isolation as diagnostics of infertility. Hirano 
et al. (2001) and Mortimer (1994) in conjunction with their co-workers, contribute by stating that 
more detailed evaluation on sperm motility is a potentially valuable contribution in infertility 
diagnostics.  
Determining sperm motility parameters has revolutionized over the years (Mortimer et al., 2015). 
These parameters have now been standardized with the aid of motion analysis systems. Currently, 
WHO (2010) guideline reference values have been adopted as a standard methodology for 
laboratories engaged in semen analysis. It recommends the use of motility grading system as 
follows (Hirano et al., 2001): 
 Total motility: total spermatozoa moving actively (moving linearly or in a large 
circle, not considering speed) and all other patterns of motility with an absence of 
progression. 
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 Progressive motility: spermatozoa moving actively forward in a straight pattern. 
 Curvilinear velocity (VCL): measurement of the speed of travel of the centroid of 
the sperm head over a given period of time, i.e. the local speed along the curvilinear 
path traced by the sperm head. 
 Straight line velocity (VSL): straight line distance between the first and last centroid 
positions for a given period of time rather than the sum of all intermediate distances. 
 Average path velocity (VAP): spatially averaged path that eliminates the wobble of 
the sperm head, while preserving the basic curvature of the path, i.e. average path 
velocity based on every 5th frame of VCL path. 
 Linearity of forward progression (LIN): ratio of VSL to VCL, values range from 0 
to 100 with a value of 100 representing cells swimming in a straight line pattern and 
expressed as percentage. 
 Straightness (STR): linearity of the spatial average path, expressed as ratio of VSL 
to VAP. 
 Beat cross frequency (BCF): timed average rate at which the curvilinear sperm 
trajectory crosses its average path trajectory. 
  Hyperactivation: calculated capacitation of mature spermatozoa of all humans and 
functionally associated with sperm acrosome reaction. 
1.2.9.2 Vitality 
This parameter is an estimate of membrane integrity of the sperm cell (WHO, 2010). Sperm vitality 
assay testing is used to determine if the non-motile sperm are alive or dead and is indicated when 
sperm motility is less than 5% to 10% (Vasan, 2011). This in turn gives a reflection of accuracy of 
living non-motile spermatozoa. Ideally, the percentage of dead spermatozoa should be slightly 
excided by percentage of live spermatozoa (Björndahl et al., 2003). Sperm viability testing was 
introduced in 1984 by Jeyendran and his colleagues, they suggested non-motile viable sperm may 
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be used for intracytoplasmic sperm injection (ICSI) (Hossain et al., 1998). Sperm viability 
contributes to sperm-oocyte activation and fertilization and further development steps during 
embryogenesis. Therefore, selection of mature viable sperm for injection into the ooplasm is very 
important (Sati et al., 2015).  
According to Anerao et al. (2010) the quality of sperm has been found to be more significant than 
the count. Poor motility has been associated with reduced viability of spermatozoa (Dhar et al., 
1968; Savita and Huma, 2010). Moreover, the percentage of viable sperm has been highly 
correlated with spermatozoa with optimal functional mitochondria (Magistrini et al., 1997; 
Papaioannou et al., 1997). In addition, a study by De Lamirande and Gagnon (1992) found that 
reactive oxygen species (ROS) caused 10% - 20% decline in viability of human spermatozoa. 
Baumber et al. (2000) also found ROS to have caused a similar percentage decrease in equine sperm 
viability. 
1.2.9.3 Reactive oxygen species (ROS) 
ROS are highly reactive oxidizing agents and diffusible molecules that belong to the class of free-
radicals and peroxides which are generated in cells as by-product of aerobic respiration and metabolism 
(Halliwell, 1996; Valko et al., 2007).  The most common ROS that have effected human reproductive 
biology are free radicals i.e. molecules with a single, impaired electron in the outer orbits such as 
superoxide anions (·O2
-), hydroxide radical (·OH), peroxyl radicals (·ROOH) and hypochlorite 
radical (·OHCl.) (Sharma and Agarwal, 1996; de Lamirande et al., 1997a; Henkel et al., 2003). 
These unpaired electrons are extremely reactive with a half-life range of a nano-second to milli-
second, hence, they practically react at the site of generation (Halliwell, 1989; Henkel, 2012).  
Resulting to oxidation of biomolecules such as unsaturated fatty acids, sulfhydryl proteins, nucleic 
acids and hyaluronic acid, and this oxidative damage is a key component of pathological processes 
such as inflammation, carcinogenesis and degenerative disease of ageing (Halliwell and Gutteridge, 
1999). On the other hand, the most common non- radicals ROS are hydrogen peroxide (H2O2) or 
hypochlorous acid (HOCl) which are either oxidizing agents or easily converted into free radicals 
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(Petersen et al., 1980; Hamada et al., 2012). H2O2, is more stable, uncharged, with a higher oxidant 
potential, and can cross plasma membranes unlike the ·O2
- anion and other free radicals (Halliwell, 
1989). Possibly, the most damaging quality of H2O2 is that, it has the potential of splitting into very 
dangerous ·OH radical when it accepts an electron from ferrous or cuprous ions in a reaction known 
as Fenton reaction (Nieschlag et al., 1997). Furthermore, H2O2 is the main secretory products of 
the leukocytes (Clark and Klebanoff, 1978), these cells are involved in fighting infection in the 
male genital tract (Aitken et al., 1994; Sharma and Agarwal, 1996; Moustafa et al., 2004; Henkel, 
2005).  
Therefore, ROS can either be produces extrinsically by leukocytes or intrinsically by the male germ 
cells (Barroso et al., 2000, Henkel, 2005, 2012). The location of the production plays a role in 
sperm function in that, high level of extrinsic ROS produced by leukocytes appear to rather impair 
sperm motility, while intrinsic ROS production seems to preferentially affect sperm DNA 
fragmentation (Henkel, 2005). In addition, Studies have also shown that supra-physiological 
production of ROS causes oxidative stress (imbalance between ROS production and scavenging 
activities of reactive oxygen species) which leads to sperm dysfunction (Figure 6) (Bansal and 
Bilaspuri, 2010) by causing damage to the plasma membrane (Alvarez et al., 1987; Iwasaki and 
Gagnon, 1992; Aitken et al., 1998), or damage to DNA through stimulation of strand break and 
other oxidative damage in human spermatozoa (Figure 6) (Hughes et al., 1996; Twigg et al., 1998a; 
Aitken and Baker, 2006). On the other hand, physiological production of ROS is essential for 
normal physiological function since it leads to the activation of the intracellular pathways 
responsible for sperm maturation, capacitation, hyperactivation, acrosome reaction, chemotactic 
process and fusion with female gamete (Vasan, 2011; Du Plessis et al., 2015). Antioxidants (ROS 
scavengers) such as superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and the 
glutathione peroxidase/ reductase system, maintain the scavenging activities in the gonads and 
seminal fluid (Alvarez et al., 1987; Halliwell, 1989). 
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Figure 6: Structure suggesting interacting mechanisms in the role of oxidative stress and 
antioxidants affecting sperm function and fertility (SOD: antioxidants superoxide dismutase, GSH: 
glutathione reductase, IL8: interleukin 8, GROα: growth regulated protein alpha) (Adopted from 
(Lector, 1996). 
 
1.2.9.4 DNA fragmentation 
High levels of compatible and complex chromosomes capable of decondensation are qualities of 
fertile spermatozoa. Any form of chromatin mutation or DNA fragmentation may affect 
reproductive outcome (Agarwal and Said, 2003). Therefore, accurate transmission of paternal 
genetic information is attributed to sperm DNA integrity (Agarwal and Said, 2003; Franken and 
Oehninger, 2012). DNA fragmentation is the breakage that occurs on single or double-strand 
structures of spermatozoa DNA either, prior to or post-ejaculation causing DNA destruction (Rappa 
et al., 2016). Various factors can induce DNA damage in spermatozoa including: strand breakage 
that might occur in the process of spermatogenesis, endogenous endonucleases induced DNA 
fragmentation, chromatin condensation, oxidative stress post testicular DNA fragmentation 
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prompted by passage through the male reproductive tract, incidence of apoptosis during the process 
of spermatogenesis and environmental factors such as air pollution and smoking. Nonetheless, 
several studies have linked ROS production to all causes of sperm DNA damage (Lopes et al., 
1998b; Sakkas et al., 1999; Agarwal and Said, 2003; Wang et al., 2003; Henkel, 2005).  
Furthermore, studies have shown negative effects of DNA fragmentation for instance, high levels 
of sperm DNA damage have been directly correlated to poor seminal parameters such as reduced 
sperm concentration, motility or abnormal morphology (Irvine et al., 2000; Saleh et al., 2002),  and 
reduced acrosome reaction (Ozmen et al., 2007). Additionally, more investigations have affirmed 
the correlation of DNA fragmentation with oxidative stress and impaired sperm function (Lopes et 
al., 1998a) which has  negative influence on in vitro fertilization rate (Aitken et al., 1998; Henkel 
et al., 2003), and intrauterine insemination (IUI) (Duran et al., 2002). 
Spermatozoa from fertile men have been found to have less DNA damage than those from fertile 
men (Zini and Libman, 2006). Besides, Barroso et al. (2000) reported that nuclear defects like 
abnormal chromatin structure, aneuploidy, chromosome microdeletion and DNA strand break have 
been observed in spermatozoa from infertile men. 
1.2.9.5 Mitochondrial membrane potential (MMP)  
The sperm cells vital biological function is the transfer of male genome to female oocyte, a 
process which requires energy necessary for supporting sperm motility and active protein 
modifications such as phosphorylation (Miki, 2006) and, mitochondria function to produce this 
energy in the form of adenosine triphosphate (ATP) (Donnelly et al., 2000). Through the 
formation of an electronic potential across the outer and inner mitochondrial membrane during 
oxidative phosphorylation. This is also necessary for the import of mitochondrial proteins, 
calcium homeostasis and metabolite transport (Bourgeron, 2000).  Therefore, the 
mitochondrial membrane potential (MMP) is the parameter that best indicates mitochondrial 
function and is a reflection of mitochondrial energy in form of ATP (Donnelly et al., 2000). 
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Abnormalities in the structure of the sperm mitochondria (mid-piece area) had been linked to 
decreased sperm motility (Mann and Lutwak-Mann, 1981) and male infertility (Miki, 2006), 
thus highlighting the importance of this functional component (Mann and Lutwak-Mann, 1981; 
Turner, 2005). According to Mundy et al. (1995), sperms from asthenozoospermic males 
(individuals producing sperm with less than 40% total motility) were found to have smaller 
mid-pieces and a lower number of mitochondrial gyres. Therefore, leading to the reduction in 
enzymatic activities of the electron transport chain linked to the reduced sperm motility in 
asthenozoospermic patients (Folgerø et al., 1993).  
In addition, MMP has been found to correlate with other sperm functions making its measurement 
a reliable indicator of sperm quality (Barroso et al., 2000; Donnelly et al., 2000; Marchetti et al., 
2002; Marchetti et al., 2004). Spermatozoa that portray a reduced MMP contain increased level of 
ROS (Wang et al., 2003)  and are associated with decreased in vitro fertilization rates (Marchetti 
et al., 2002). Similarly, spermatozoa that display intact MMP in most cases have intact acrosome 
function and great fertilization capacity. In addition they have normal morphology and motility 
(Grunewald et al., 2008).  
Once the MMP is compromised, permeable transition pores (multi-component protein that 
regulates oxidative phosphorylation) are formed (Chang et al., 2002). They then aggregate in the 
mitochondrial membrane and induce cell death as a result of turning into a non-specific channel 
(Grimm and Brdiczka, 2007). The second mechanism in which the MMP will be compromised is 
through the induction of membrane permeability through various coordination of Bcl-protein 
(Chipuk et al., 2006), a process associated with caspases activation (Miki, 2006). Agarwal et al. 
(2004) stated that several andrological pathologies like immunological infertility, reduced sperm 
fertilization capability and varicocele have been associated with caspase activities. In terms of 
ejaculated sperm, caspase activity has been associated with low concentration of sperm cells, 
reduced motility, low level of fertilization rates, phosphatidylserine externalization of plasma 
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membrane leading to disrupted functionality (Marchetti et al., 2002; Cayli et al., 2004; Said et al., 
2004; Grunewald et al., 2008). Nonetheless, compromised mitochondrial function leads to 
decreased mitochondrial membrane function which in turn affects the DNA integrity and is also 
accompanied by ROS production (Kim et al., 2013). 
1.2.9.6 Capacitation and acrosome reaction 
1.2.9.6.1 Capacitation 
Capacitation is described as the biochemical and structural changes that spermatozoa undergo in 
the female reproductive tract in order to be able to execute acrosome reaction and fertilize an oocyte 
(Yanagimachi et al., 1976; Vasan, 2011; Ickowicz et al., 2012). These changes are comparatively 
associated with hyperactivation and acrosome reaction (de Lamirande et al., 1997a). In the human, 
this process takes about 4-5 hours with a gradual increase of the calcium ion (Ca2+) concentration, 
while acrosome reaction takes place within minutes with a large influx of Ca2+ (Stock and Fraser, 
1989). Capacitation as stated by de Lamirande et al. (1997b) is triggered by the increase in cAMP 
level influenced by influx of Ca2+, which leads to increased membrane fluidity due to altered lipid 
composition (cholesterol loss) (Figure 7) (Go and Wolf, 1985) and changes in enzyme activities 
(phosphorylation of tyrosine residues in proteins) (Visconti et al., 1995), also changes in the 
patterns of spermatozoon motility to hyperactivated motility (Yanagimachi, 1970). There after 
spermatozoa can proceed to acrosome reaction (Go and Wolf, 1985).  
1.2.9.6.2 Acrosome reaction 
The acrosome is a cap-like membrane structure organelle that covers the anterior one-half to two 
thirds of the sperm head (Figure 8). The discharge of hydrolytic enzymes (hyaluronidase and 
acrosin) (Vigil et al., 2011) from the vesicle in the acrosome of a sperm cell during fusion between 
the outer acrosomal and sperm plasma membrane is termed as acrosome reaction (Riley-Vargas et 
al., 2005). During this fusion, small lipid cumuli are generated from both membranes, stabilising 
each other until they become independent units (Vigil et al., 2011). The membrane housing the 
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acrosome enzyme loses continuity and stability leading to the release of acrosome content to the 
external medium (Go and Wolf, 1985). 
Furthermore, Wassarman (1987) found that the zona pellucida (ZP) is composed of three 
glycoproteins namely ZP1, ZP2 and ZP3. Multiple subunits of ZP2 and ZP3, form filament that are 
bound together by ZP1. When sperm binds to ZP3 it causes a change in Ca2+  (Ickowicz et al., 2012) 
and Na+ (Wassarman, 1987) flux across the plasmalemma which results in the acrosome reaction 
(Meilzel, 1984). The binding of the ZP to the plasma membrane can take place through two 
different receptors (Ickowicz et al., 2012), either by Gi coupled receptors which leads to 
phospholipase C (PLC) βi activation or by tyrosine kinase (TK) receptor coupled by (PLC)γ 
(Huneau et al., 1994). 
In case ZP binds to Gi-coupled receptors, it leads to the regulation of adenylyl cyclase (AC) 
(Ickowicz et al., 2012), hence, elevation of increased cyclic monophosphate cAMP and activation 
of protein kinase (PKA) (Breitbart and Spungin, 1997). Subsequently, PKA will activate Ca2+-
channels leading to more calcium moving from the anterior of the acrosome to cytosol (Ickowicz 
et al., 2012). The rise in Ca2+ level triggers activation of protein-kinase-c (PKC), which will lead 
to further opening of Ca2+-channel, thus increased Ca2+ level (Huneau et al., 1994) (Figure 9). This 
leads to increased membrane fluidity (Lee et al., 1987), protein tyrosine phosphorylation (PTP) 
(Ickowicz et al., 2012), increased cAMP concentration (Huneau et al., 1994) with protein 
phosphorylation (Breitbart and Spungin, 1997). The Gi and TK can also activate NA+/H+ pump 
leading to alkalization of the cytosol (Ickowicz et al., 2012). According to Benoff et al. (1996), 
capacitation and acrosome reaction are key parameters for assessing sperm fertilization capacity. 
In support Schuffner et al. (2002) states sperm acrosome reaction and hyperactivation are 
prerequisites to fertilization. Though, only hyperactivated sperm that move along a curved tract 
have been found to have the ability of penetrating the zona pellucida as opposed to those that are 
moving in a rectilinear manner (Schuffner et al., 2002). 
 
 
 
 
27 
 
Figure 7: A model describing the biochemical cascade in sperm capacitation: intracellular  
bicarbonate (HCO3
-) activates soluble adenyl cyclase (sAC) to generate cyclic adenosine 
monophosphate (cAMP) leading to protein kinase A (PKA) activation and cholesterol efflux from 
the sperm plasma membrane which further stimulate the HCO3−/sAC/cAMP/PKA cascade. PKA 
activates Src tyrone kinases to phosphorylate/inactivate phosphotidyl-Inisitol-triphosphate (PIP2) 
bound gelsolin. PIP2 is a cofactor for phospholipase D (PLD) activation and this activation is 
stimulated by protein kinase C α (PKCα), leading to phosphatidylcholine hydrolysis and production 
of phosphatidic acid (PA) which mediates the conversion of G-actin to F-actin. Thus, activation of 
PLD and prevention of F-actin dispersion by inhibiting gelsolin, allows F-actin formation. F-actin 
in the head prevents immature acrosome reaction and in the tail F-actin regulates sperm motility 
including (hyperactivation) HA motility (Adopted from Ickowicz et al., 2012). 
 
Therefore, spermatozoa depicting the necessary motility parameters may achieve capacitation 
necessary to cross the oocyte barrier, bind to the zona pellucida and finally complete the acrosome 
reaction to initiate pregnancy (Bakalczuk et al., 2016). As a result, clarification of cellular 
mechanism inducing acrosome reaction is very significant to the clinical evaluation of sperm 
functionality (Benoff et al., 1997). Since, human spermatozoa which are incapable of undergoing 
acrosome reaction will not fertilize an oocyte following conventional insemination in vitro 
(Overstreet et al., 1980; Benoff et al., 1997).  
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Figure 8:  Representation of acrosome reaction of human spermatozoa. A-capacitated spermatozoa 
binds to zona pellucida and causes acrosome reaction, B-fusion of outer membrane with plasma 
membrane, releasing acrosomal contents (acrosin) and C-Inner acrosomal membrane exposed to 
form outer surface of sperm head (Riley-Vargas et al., 2005).  
 
1.3 Infertility 
Infertility is defined as the failure of a couple to become pregnant after one year of regular, 
unprotected sexual intercourse (Saxena and Rastogi, 2015). Worldwide, about 15-20% of couples 
are affected by infertility during their reproductive life, with approximately 7.5-10% of male of 
reproductive age group being infertile (Miyamoto et al., 2011; Belloc et al., 2014; Saxena and 
Rastogi, 2015). According to (Ollero et al., 2001), one in every six couples of reproductive age 
presents with infertility, with 50% of the causes being classified as idiopathic. Pei et al. (2005) also, 
states that approximately 50% of infertility is as a result of male infertility.  Approximately 4.8 
million couples worldwide are infertile with the highest rate reported in Eastern Europe and Africa 
(Figure 10) (Agarwal et al., 2015), although compiling absolute statistics on occurrences of male 
infertility in some countries is difficulty as a result of the stigmas associated with it due to cultural 
and religious differences (Said et al., 2004). 
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Figure 9: A model describing the biochemical cascade that leads to the acrosome reaction (AR): 
binding of capacitated spermatozoa to the oocyte zona pellucida causes a fast and elevated increase 
in intra-spermatozoal calcium ion (Ca2+) concentration. As a result, active phospholipase C (PLC) 
catalyses, phosphatidyl-Inositol-biophosphate (PIP2) hydrolysis to produce Inositol-triphosphate 
(IP3) and diacylglycerol (DAG) and the release of bound p-gelsolin. The p-gelsolin undergoes 
dephosphorylation/ activation by tyrosine phosphatase leading to conversion of F-actin to G-actin. 
IP3 activates Ca2+ channel in the outer acrosomal membrane which reduces intra-acrosomal Ca2+ 
leading to the activation of Ca2+- dependent-Ca2+channel in the plasma membrane which causes 
further increase in intracellular Ca2+ which together with DAG activate protein kinase C (PKC) 
which mediates the acrosome reaction. Also, PKA-dependent PI3K activation occurs towards the 
end of the capacitation process, involves in the mechanism leading to the AR (Adopted from 
Ickowicz et al 2012). 
 
For instance, in Africa and Middle East men do not undergo fertility tests in most cases because, 
female counterparts take the blame for being infertile in many occasions (Agarwal et al., 2015). 
The culture protects and retains the infertile mens’ masculine identity in the society by letting in a 
brother or relative of the infertile man to impregnate their wife (Agarwal et al., 2015).  This prevents 
them from ridicule from other community members. For instance, in Uganda amongst the 
Banyakore ethnic group a direct translation of terms used to describe an infertile man would be, “a 
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person without legs” or “one trampled by a goat” (Kamatenesi-Mugisha and Oryem-Origa, 2005). 
Other communities will refer to them as “worthless” (Agarwal et al., 2015). These men are not 
supposed to be given any position of responsibilities or leadership since they are regarded as 
abnormal. They are socially excluded from society and muted when they make a contribution, 
hence reducing their self-esteem (Kamatenesi-Mugisha and Oryem-Origa, 2005). Psychologically, 
infertile men will try to have affairs with other women to test the viability of their manhood which 
could put them at risk of getting sexually transmitted infections (Kamatenesi-Mugisha and Oryem-
Origa, 2005). 
Reproductive healthcare has been regarded as the second most prevalent core problem on the 
African continent (Kamatenesi-Mugisha and Oryem-Origa, 2005). A wide range of disorders can 
be associated with male factor infertility ranging from  genetic defects, endocrine disorders, 
abnormal spermatogenesis, azoospermia, oligozoospermia, idiopathic factors, asthenozoospermia, 
teratozoospermia, oligoasthenozoospermia, oligoasthenoteratozoospermia, varicocele, 
chromosome defects, systemic disorders affecting fertility (Kartageners syndrome, fanconi 
anaemia (FANCA), myotonic dystrophy, sickle cell anaemia and β-Thalassemia) and idiopathic 
causes. A great number of unresolved idiopathic infertility cases in human male might be attributed 
to the complexity of the spermatogenic process, which might result to mutation of different genes 
(Matzuk and Lamb, 2008; Benkhalifa et al., 2014). 
Technology advancement in the past two decades has seen the development of assisted 
reproductive technology (ART) (Ola, 2012) and intracytoplasmic sperm injection (ICSI) (Wang et 
al., 2003), as some of the approaches that can be used to address other causes of male infertility 
(Merchant et al., 2011). Despite the technology advancement, it has been challenging to address 
the poorly understood genetic, environmental and idiopathic causes of male infertility (Santi et al., 
2015). Medical treatments of unexplained male infertility have been proven not of much benefit 
(Dabaja and Schlegel, 2014), resulting to the seeking of alternative form of treatment like the use 
of ethno-medicinal plants like Mondia whitei (Watcho et al., 2007).   
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Figure 10: World map showing studied cases of male factor infertility percentage per area (Asia, 
Africa, America, Europe and Oceania) as illustrated by Agwaral et al. (2015). 
 
1.4 Botanical medicine 
Traditional medicine (TM) also known as complementary and alternative medicine (CAM) is 
classified as the oldest health care system (Abdullahi, 2011). According to the (WHO 2000), TM 
“is the sum total of skills, knowledge and practices based on theories, beliefs and experiences 
indigenous to different cultures, whether applicable or not, used in maintenance of health, as well 
as prevention, diagnosis and improvement or treatment of physical and mental illness”. In addition, 
the WHO (2000) stated that a traditional healer is, “a person who is recognized by the community 
where she or he lives as someone competent to provide health care by using, plants, animals and 
minerals substances and other methods based on social, cultural and religious practices”. 
Taking Sub-Saharan Africa into account, one traditional healer attends to approximately 500 
patients in the population. This shows that contemporary ethno-botanical medicine continues being 
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a centre core of thousands of South Africans and Africans at large, with an estimated 80% of the 
population in use of plant medicine (Ernst, 2000; WHO, 2002). Putting across the important role 
TM plays in the lives of African people and their potential to serve as a crucial component of 
comprehensive health care strategy, this was the main, if not the only, form of healthcare for 
millions of African people before the introduction of cosmopolitan medicine (Abdullahi, 2011). In 
countries like Ethiopia, 90% of the population use herbal remedies as primary health care 
(Mahomoodally, 2013) and 70-80% of Ugandans rely on traditional healers for basic healthcare, 
with a number of ailments ranging from erectile dysfunction and sexual importance being treated 
traditionally for ages (Kamatenesi-Mugisha and Oryem-Origa, 2005).  
Medicinal plants have been used for centuries in treatment of diseases and body system dysfunction 
and there contribution to the development of pharmaceuticals cannot be ignored since 25% of 
modern medicine is derived from plants (Nantia et al., 2009). According to Mahomoodally (2013) 
modern comprehensive medicine has its roots in TM with information on important cures passed 
from generation to generation through verbal communication.  
Increasing public interest and awareness in Natural Medicine has led pharmaceutical industries and 
researchers to pay more attention on medicinal plants (Benzie and Wachtel-Galor, 2011). The 
paradigm shift from Western to herbal medicine, may partly be due to the fact that synthetic drugs 
have always shown adverse reaction and other undesirable side effects, especially seen from 
incorrect use. Hence, the belief those natural products are safe because they are more harmonious 
with biological system (Rates, 2001; Erasto et al., 2005; Vandebroek and Balick, 2012).  
Plant medicine not only provides the body with nutrients but also improves body function. 
Researchers have been encouraged and urged by WHO to evaluate the use of medicinal plants as 
sources of treatment, since they are easily available, accessible and affordable (Nantia et al., 2009). 
According to (Erasto et al., 2005), the low income group and indigenous Africans living in the rural 
areas may not access modern medicine. On the other hand, African traditional medicine 
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(indigenous) herbs are easily accessible and cost effective (Erasto et al., 2005). In fact, cultural and 
economic reasons have been linked to the use of medicinal plants prompting the WHO to encourage 
African member states to promote and integrate traditional medicinal practices in the health care 
system (Muhammad and Awaisu, 2008). 
Van Wyk et al. (1997) states that South Africa has got a diverse and rich flora which forms part of 
the medicinal wealth that ensures the Primary health care and livelihood of millions of its citizen 
is addressed. Hence, the past decade has prompted increased interest and reorganisation of 
indigenous medicinal plants of South Africa. These plant species are regarded as precious and 
highly valued, considering the rate at which the vegetation is getting depleted in this part of the 
world. There is a need to document and verify the precious knowledge in regards to medicinal 
plants. This will then result in better health services being provided to South Africa and Africa at 
large and enable integration of valued indigenous knowledge in herbal medicine with modern 
knowledge and technology (Mander et al., 2007). In a laudable effort to make ethno-botanical 
medicine scientific, there is a paradigm shift to evidence based medicine that is why this study is 
focused on giving scientific investigation on the biological activities associated with Mondia whitei 
to validate the traditional use in treatment of male infertility.  
 
1.5 Mondia whitei 
1.5.1 Description 
The genus Mondia of the Apocynaceae family is a woody, robust and vigorous aromatic perennial 
plant that grows from a large tuberous root stock. It has large heart-shaped opposite leaves and 
produces reddish, purple flowers borne in branched inflorescences (Figure 11) (Iwu, 2014). The 
species that are distributed in the Southern part of Africa flower from October to March, while 
those in the Northern part of Africa flower from May to August (Aremu et al., 2011). The roots 
spread laterally beneath the soil surface which enables easy harvesting. They taste like ginger or 
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liquorice and have an aroma reminding one of vanilla.   Initially, the taste is bitter then becomes 
sweeter with time. The large oval follicle fruits (75–100 × 44 mm) are almost woody and contain 
approximately (180-320) seeds (Van Wyk, 2011). 
The name Mondia is derived from the Zulu name umondi/mundi, while the species name whitei 
was in honour of the collector Mr. A. S. Whitei (Hutchings et al., 1996; Aremu et al., 2011). The 
common name include: white ginger, tonic root (English); mudondo (Angola); mudondo, bondo, 
molo busio (Cissongo- Central African Republic); nbondo, kimbiolongwa, kumba (ngwaka- 
Democratic Rebuplic of Congo); ubasangbwandiya, gatimba (Lugware-Democratic Republic of 
Congo); lacadje (Fula-Guinea Bissau); mkobela (Luhya-Kenya); citambalo (Malawi); Umondi, 
mundi, mindi (Zulu-South Africa);  sedando omutano (Uganda) and Mungurawu (Shona-
Zimbabwe) (Gelfand et al., 1985; Crouch et al., 1998; Aremu et al., 2011; Watcho et al., 2013). 
1.5.2 Geographical location 
The plant is indigenous to South, Central, East and West Africa (Hutchings et al., 1996). In South 
Africa, the plant is found mostly on the coast and midlands in KwaZulu-Natal, Limpopo province, 
extending to Swaziland and Zimbabwe. The distribution stretches to North and Southern parts of 
Sudan and West as far as Senegal, favouring tropical and sub-tropical areas. The medicinal plant 
specific location in West Africa include: Nigeria, Guinea, and Ghana; Central Africa: Cameroon; 
East Africa: Kenya, Uganda and Tanzania; Southern Africa: Malawi, Zimbabwe, Angola, 
Mozambique, South Africa (Figure 12) (Aremu et al., 2011).  
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Figure 11: Mondia whitei: A- creeping climber with leafless basal portion of stem, the leaves 
appear in a canopy on top of a well-supporting iron bar; B-twining stems with large leaves (100-
300 x 50-150mm) opposite, with deeply notched heart shaped base and stalk (30-55mmlong); C-
young buds and fully opened branched inflorescences flowers with reddish purple corolla lobes 
about 14mm long with green margin; and-mature roots (Aremu et al., 2011). 
 
1.5.3 Phytochemistry of Mondia whitei 
To date, only a few studies exist on the isolation of bioactive compounds from M. whitei. The most 
common and well-known compound isolated from M. whitei is 2-hydroxy-4-methoxybenzaldehyde 
(Figure 13; no. 5), a potent tyrosinase inhibitor and an isomer of vanillin (Kubo and Kinst-Hori, 
1999b). This compound has also been isolated from M. whitei by earlier researchers (Koorbanally 
et al., 2000; Oketch-Rabah, 2012). In addition, Koorbanally et al. (2000) reported for the first time 
the isolation of isovanillin (Figure 13; no. 6) previously thought to be a synthetic compound found 
in M. whitei (Koorbanally et al., 2000). Subsequently, a study performed by Patnam et al. (2005) 
reported the isolation and structural elucidation of an unusual chlorinated coumarinolignan, 5-
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chloropropacin (Figure 13:, no. 3), along with eight known compounds including propacin (Figure 
13; no. 1) and its 5′-methoxylated analogue by means of NMR and mass spectral analysis (Patnam 
et al., 2005). This was the first report of the isolation of coumarins and coumarinolignan (Figure 
13; no.2) as well as chlorinated coumarinolignan from the genus Mondia.  
 
 
Figure 12: Illustrate the distribution areas of M. whitei, from West Africa (Guinea, Ghana and 
Nigeria), Central Africa (Cameroon, Gabon and DR. Congo), East Africa (Kenya, Uganda and 
Tanzania) and Southern Africa (South Africa, Malawi, Angola, Mozambique, and Zimbabwe) 
(Venter et al., 2009). 
 
Nutritional analysis indicated that Mondia is rich in minerals and vitamins. The yields of the 
different nutrients from roots and leaves, respectively, are as follows (mg/g): potassium (11.34, 
32.05); sodium (5.61, 24); magnesium (1.40, 2.83); calcium (3.08, 8.25); iron (0.20, 0.43); zinc 
(0.03, 0.07); copper (0.003, 0.06); manganese (0.64, 0.05); cadmium and lead (trace, trace); crude 
protein (4.35, 21.8); beta-carotene (0.004, 0.022); thiamine (0.78, 3.70); niacin (0.52, 8.15); 
 
 
 
 
37 
riboﬂavin (0.62, 2.45); fructose (0.008, 0.015); xylose (9.17, 18.70); and glucose (2.40, 9.0) (Iwu, 
2014). 
 
 
Figure 13: Chemical structures of various compounds isolated from M. whitei: 1: Propacin, 2: 
Coumarinolignan, 3: 5-Chloropropacin, 4: (-)-Loliolide, 5: 2-Hydroxy-4-methoxybenzaldehyde 6:  
Isovanillin (Aremu et al., 2011). 
 
 
The conduction of bioassays led to the isolation of a monoterpene lactone (Figure 13; no. 4) (-)-
loliolide which displayed affinity to a transporter, serotonin (5-Hydroxytryptamine) (SERT), in a 
binding assay (Neergaard et al., 2010). Qualitative phytochemical analysis of the ethanoic extract 
of M. whitei indicated the presence of reducing sugars and triterpenes. However, other essential 
phytochemical groups such as alkaloids, flavonoids, phenolic and saponins were not detected 
(Quasie et al., 2010). Subsequently, the presence of phenolic, flavonoids and tannins were detected 
in vivo. The authors also reported anti-oxidant activity by assessing the high hydroxyl radical 
scavenging activity (Bouba et al., 2010). Some scholars suggest that the presence of a wide range 
of plant secondary metabolites such as phenolic, flavonoids and tannins in plants have a direct 
correlation to the exhibited biological activities. An investigation by Moyo et al. (2010) attributed 
anti-oxidant bioactivity to the presence of phenolic compounds in the plant, to some of the observed 
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bioactivities due to the secondary metabolites detected in the extract (Moyo et al., 2010).           
Aremu et al. (2011) critically reviewed the phytochemical composition of M. whitei roots and 
leaves and found high levels of disparities in some parameters such as the values for calcium and 
magnesium which remains a major concern (Aremu et al., 2011). Thus, the attributing factors that 
play a vital role in the plant physiology and sensitivity of equipment used should be taken into 
account when investigating the effect of a phytochemical, such as the collection localities, seasonal 
variation and all factors that could influence the properties of the extract and investigation. 
1.5.4 Ethno-botanical use 
Historically, in folklore medicine across Africa, Mondia has been used in addressing several 
ailments (Quasie et al., 2010). Most ethnic groups use Mondia to treat gastrointestinal conditions 
such as mild laxative, appetite stimulation and for abdominal pains; alleviate nausea, treatment of 
fever, bilharzias’ fit in children and stress/ tension in adults and several sexual dysfunctions (Aremu 
et al., 2011). Documents show that the root decoction has been used to induce labour in Uganda, 
treat malaria infection in Nigeria and Benin (Gelfand et al., 1985), anthelmintic infections in 
Nigeria and male infertility in Cameroon (Iwu, 2014). In Kenya, Mondia is used for many ailments 
e.g. ringworms, skin diseases and tension (Aremu et al., 2011), while in Cameroon it is used to 
treat urinary tract infection, jaundice, headache, diarrhoea and impotence (Watcho et al., 2007). 
Furthermore, Ghana traditional practitioners have used Mondia in management of erectile 
dysfunction and low sperm count (Martey and He, 2010). Yet, the Bondeni use the roots for body 
pain as well as the Maasai, while in Zimbabwe the roots are generally used for abdominal pain, 
constipation, poor appetite, schistosomiasis and as an aphrodisiac. The Shambala use the 
unspecified parts for fits in children, heartburn and impotence. Additionally, the Haya use it for 
uterine stimulation during child birth (Gelfand et al., 1985). The roots were chewed by the Zulu to 
relieve flatulence, indigestion, stomach ache and stimulate appetite (Hilton-Taylor, 1996). 
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1.5.5 In vitro studies and in vivo studies done on M. whitei  
The roots of Mondia are often chewed by men as a tonic and aphrodisiac, and for treatment of 
sexual asthenia, erectile dysfunction and increase sperm production (Martey and He, 2010). Few 
studies carried out to investigate the effect of this plant extract on male reproductive functions have 
given conflicting results (Lampiao et al., 2008; Martey and He, 2010; Watcho et al., 2006; 2007; 
2013). The root extract of Mondia was found to have contraceptive properties as well as 
properties associated with enhancing male fertility. 
1.5.5.1 In vitro studies 
In vitro study  on the effect of aqueous extract of M. whitei on the motility and progressive motility 
of spermatozoa on a time dependant manner, showed no significant difference between the control 
and the treated group at 30, 60 and 90 minutes after incubation (Lampiao et al., 2008). A statistical 
difference was seen after 120 minutes of incubation with highest concentration being significantly 
higher than the control group.  
1.5.5.2 In vivo studies 
Watcho et al. (2001) conducted an in vivo study on the effect induced by long term admission of a 
hexane extract of dried root of M. whitei at doses of 500 and 1000mg/Kg on body organ weights, 
biochemical, haematological and physiological responses of vas deferens to norepinephrine 
parameters of rats treated for 30 days findings, gave evidence of reversible antispermatogenic 
effects of M. whitei. 
In 2006, Watcho et al. Conducted another study on the long term investigation of a hexane extract 
of Mondia on doses of 500 and 1000mg/Kg on body organ weight and found that the relative weight 
of caput epididymis, ventral prostate and seminal vesicle were increased (Watcho et al., 2006). In 
2004, he did more studies using both hexane extract of Mondia in spinal rat showed effect of fictive 
ejaculation, which appeared not to be mediated through dopamine pathway, hence justifying ethno-
medicinal use of the plant (Watcho et al., 2013). 
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1.6 Aim of the study 
M. whitei is a widely used medicinal plant across Africa in traditional medicine for treatment of 
sexual dysfunction yet very minimal scientific evidence to support the therapy exist. One the other 
hand, evidence from the existing studies possess ambiguity. To date, only one study (Lampiao et 
al., 2008) on effect of aqueous root extract of M. whitei on human sperm motility has been 
documented. However, it only focused on one sperm parameter (total motility and progressive 
motility) which only gives a fraction but not comprehensive information on sperm functionality. 
Secondly, none of the studies took into account the use of traditional therapeutic doses. Therefore, 
based on the traditional extraction methods, mode of application and therapeutic dosage, this study 
is aimed at investigating the effect of aqueous root extract of M. whitei on:  
 Ability to enhance human sperm function by looking at motility and kinematic parameters 
associated with motility, capacitation, acrosome reaction and mitochondrial membrane 
potential.  
 Human sperm cell cytotoxicity by assessing the vitality, DNA-damage and reactive 
oxygen species. 
 The optimum dosage form that boost human sperm functionality. 
 Provide clarity on the safety of in vitro use of Mondia in human sperm.  
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Chemicals and Equipment 
In this study, all chemicals used were of highest possible quality of analytical or in vitro culture 
standard, and were purchased from the following companies: 
Corning Incorporated, New York, USA, supplied: 
 Test tubes (15 ml and 50 ml) 
 Eppendorf vials (1.5 ml) 
 
Kimix Chemicals, Eppingdust, South Africa, supplied: 
 Calcium chloride dihydrate (CaCl2 * 2 H2O) 
 Disodiumphosphate (Na2HPO4) 
 Ethanol 
 Magnesium sulphate heptahydrate (MgSO4 * 7 H2O) 
 Potassium chloride (KCl) 
 Sodium bicarbonate (NaHCO3) 
 
Knittel Gläser, Braunschweig, Germany, supplied: 
 Superfrost slides 
 Microscope slides 
 
Lasec, Cape Town, South Africa, supplied: 
 Filter paper (Munk Tell) 
Merck, Wadeville Gauteng, South Africa, supplied: 
 Glucose (anhydrous) 
 Hydrochloric acid (HCl) 
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 Hydroxymethyl amino methane (TRIS) 
 Potassium monophosphate (KH2PO4) 
 Sodium chloride (NaCl) 
 Sodium hydroxide (NaOH) 
 
Millipore, Billerica, USA: 
 Millipore distilling machine 
 
Trevigen, Gaithersburg, USA, supplied: 
 DePsipher kit 
 
Whatman, Madestone, England: 
 Filter paper 1  
 
Centrifuges 
Labortechnik, Wehingen, Germany, supplied: 
 Hermle Z160M 
 Hermle Z200A 
 
Incubators 
Lasec, Cape Town, South Africa, supplied: 
 Series 2000 
Leja, Nieuw-Vennep, Netherlands. Supplied: 
 8 chambers Leja slides 
Freeze dryer  
Virtis, Prague, Czech Republic, supplied: 
 Sentry 2.0  
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Microscopes 
Nikon Instruments Inc., Tokyo, Japan: 
 Eclipse i50 
Zeiss, Oberkochen, Germany, supplied: 
 Epifluorescence 
Zeiss, Cape Town, South Africa, supplied: 
 Photomicroscope III 
Sperm Class Analyzer (SCA) 
Microptic S.L., Barcelona, Spain, supplied: 
 Version 4.1.0.1 
 Version 5.1 Evolution  
Osmometer  
Wescor, Inc, Logan, Utah, USA, supplied: 
 Model 5100C  
 
2.2 Study design 
This study was approved by the Research Committee of the Faculty of Science, University of 
Western Cape, and ethical clearance was obtained by relevant Institutional Review Boards. 
For this in-vitro study, different sperm parameters were investigated on samples either obtained 
from healthy donors or patients after incubation for 1 hour with different concentration of aqueous 
root extract of Mondia whitei. The following parameters were investigated: motility, vitality, DNA 
fragmentation, mitochondrial membrane potential, acrosome reaction, ROS production and 
capacitation. Subsequently, on WHO (2010) criteria; semen samples with concentration ≤ 
15million sperm/ml (oligoozospermia) or progressive motility < 32%/ or total motility < 40% 
sperm/ml motility (asthenozoospermia) from both donors and patient group were identified and the 
effect of the Mondia extract on the different parameters was investigated. 
 
 
 
 
44 
2.3 Media  
2.3.1 Medium used for spermatozoa 
Quinn et al. (1985) described the Human Tubular Fluid (HTF) medium as optimal for the 
preparation of spermatozoa as it resembles the ionic composition of human tubular fluid and 
therefore, delays cell death and allows optimum time to execute all testing parameter. Hence, HTF 
was the preferred medium for washing of spermatozoa in this study. The basic composition of the 
HTF medium consists of the following substances which mimics those found in the female 
fallopian tube: 101.60 mM NaCl, 4.69 mM KCl, 2.04 mM CaCl2 * 2 H2O, 0.02 mM MgSO4 * 7 
H2O, 0.37 mM KH2PO4, Phenol red (dye indicator), 25 mM NaHCO3, 2.78 mM Glucose 
(anhydrous), 0.33 mM Na-Pyruvate, 21.40 mM Na-Lactate (60% syrup), Penicillin, Streptomycin, 
20 mM HEPES and dissolved in distilled water. After the solution was fully dissolved, osmolarity 
was adjusted to 280 mOsmol/kg. Finally, 10 mg/ml bovine serum albumin (BSA) were added 
before working with the medium (HTF-BSA). The medium was sterilized by filtration through 0.22 
µm filter (Merck Millipore, Tullagreen Carrigtwohills, Ireland). 
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The experimental set up of the study was as follows: 
 
 
Figure 14: The study design analysed spermatozoa functionality, after incubation with different 
concentration of M.whitei (0.0, 0.0185, 0.185, 1.85, 18.5, and 185) µg/ml root extract displaying 
investigative parameters and testing procedures. CTC-chlortetracycline, SCA-Sperm Class 
Analyser, E+N-Eosin-Nigrosin, DHE-dihydroethidine, ROS-Reactive oxygen species, MMP- 
Mitochondrial membrane potential. 
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2.4 Plant material 
2.4.1 Collection and identification of plant material 
The roots of Mondia whitei were obtained from Kakamega rain forest located in the Western 
Province of Kenya on 23rd April, 2015. The plant was identified by Paul Ambani a local ethno-
botanist. WHO (2003) guidelines of good agricultural and collection practices (GACP) for 
medicinal plants were observed. The roots of Mondia were identified and harvested under the best 
possible conditions, ecological non-destructive methods of collection were employed. Only some 
of the lateral roots were located and collected. The root specimen were washed, dried and deposited 
at the University of Western Cape (UWC), Bellville, South Africa, Department of Medical 
Biosciences. In the laboratory, the roots were equally rewashed and cut into smaller pieces of 
approximately 1-2 centimetres and dried for a week at 330C. Afterwards, the roots were ground 
into fine uniform powder. 
2.4.2 Extract preparation  
To prepare a hot aqueous root of Mondia, 1000 ml of distilled water were heated to about 750C and 
100 grams of powdered extract were then infused into water and allowed to stand at room 
temperature for one hour before it got filtered. The filtrate was swirled in liquid nitrogen for about 
10 minutes to accelerate the freezing process. Alternatively, the extract was frozen at -200C for 20 
hours. To yield a water soluble extract, the frozen sample was freeze-dried for 4 days under the 
guidance of Mr. Lilburn Cyster, Department of Biodiversity and Conservation Biology (UWC), 
using a Vertis freeze drier. 
Traditional healers generally prescribed a handful of Mondia roots per daily intake. Based on this, 
an average of three handful of Mondia roots were weighed (54.5g). The average yield obtained 
after 50g of Mondia roots extract was dissolved in 1 litre of water was 15.58g that is 31% weight 
to weight (w/w) yield.  Subsequent calculations were based on the fact that the average man weighs 
about 80kg and would consume 14.8g of the extract per day.  
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Summary calculation of the average dosage a person should take per day: 
In order to obtain yield of 15.58g, 50g of Mondia was dissolved in 1000cm3 of water. Therefore, a 
handful (54.50g) of Mondia roots gave an equivalent of 14.8g.  
Equation 
 54.50 × 15.58 =    14.8 g intake per person in a day. 
    50 
             Extract concentration (g/L) = (14.8 ÷80,000) 
 
The standard ‘normal’ concentration in a person would then be 1.85 µg/ml of M. whitei root extract. 
A stock solution containing 185 µg/ml Mondia extract in HTF-BSA was prepared and serial 
dilutions with a final concentration range of (0.0185, 0.185, 1.85, 18.5, 185 µg/ml) were obtained 
to accommodate both supra and hypo-physiological ranges. HTF-BSA without Mondia root extract 
served as a control (0 µg/ml).  
 
2.5 In vitro investigation of spermatozoa 
2.5.1 Sample collection 
Human semen samples were obtained from 60 men: 28 of them were healthy volunteers taking part 
in a semen donor programme at the Andrology Research Laboratory in the Department of Medical 
Biosciences, University of the Western Cape. The other 32 samples were obtained from patients 
attending the Reproductive Biology Unit in the Department of Obstetrics and Gynaecology, 
University of Stellenbosch at the Tygerberg Academic Hospital, Tygerberg, South Africa, and 
Vincent Palloti Hospital, Pinelands, South Africa, for assisted reproductive treatment or fertility 
problems. Samples were collected by masturbation into sterile plastic containers following 3-5 days 
of sexual abstinence. The sample collection procedure was in accordance with ethical guidelines 
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of the University of Western Cape. The Helsinki Declaration governing research on humans was 
also adhered to (WHO, 2003).  
2.5.2 Preparation of spermatozoa in vitro 
2.5.2.1 Determination of sperm concentration 
Semen samples were incubated at 37ºC for 10-20 minutes to allow liquefaction within the first one 
hour of acquisition. Thereafter, 2µl of liquefied semen were placed in a pre-warmed (370C) 8 
chamber Leja slide (Leja, Nieuw-Vennep, Netherlands) and sperm concentration was determined 
using computer aided semen analysis (CASA).  
2.5.2.2 Washing of spermatozoa 
Based on the concentration of spermatozoa in the sample, calculations were done to ensure that a 
standard amount of spermatozoa was maintained throughout the study. Thereafter, the semen was 
diluted 1:5 with HTF-BSA and centrifuged for 10 minutes at 500xg. The supernatant was discarded 
and the pellet re-suspended in HTF-BSA. Suspensions of spermatozoa in HTF-BSA were 
subsequently incubated with the different concentrations of M. whitei aqueous root extract for 1 
hour at 37ºC. 
2.5.3 Determination of sperm vitality  
Several dye exclusion techniques have been developed to assess sperm vitality, but the 1-step eosin-
nigrosin (E&N) technique is recommended by the WHO (2010), and is established as the 
Andrology standard in assessing sperm cell vitality  (Cooper et al., 2002; Björndahl et al., 2004; 
WHO, 2010). The E&N test is used to determine if non-motile sperm are alive or dead and is 
indicated when sperm motility is less than 5% - 10%. The stain does not stain live sperm, therefore 
live sperm will not absorb the dye (Figure 15) (Vasan, 2011). 
The 1-step eosin-nigrosin staining technique was used to determine viability according to the WHO 
(2010). The staining solution was prepared by dissolving 0.67g of Eosin Y and 0.9g of NaCl in 100 
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ml of distilled water with gentle heating. Thereafter, 10g of nigrosin were added and brought to 
boil. The solution was filtered through filter paper in order to remove coarse and gelatinous 
precipitates. The filtered solution was stored in a dark glass bottle at room temperature until use. 
To stain, 50 μl of the sperm suspension (after 1 hour incubation with different concentration of M. 
whitei at 370C), were mixed with 50 μl of the Eosin-Nigrosin stain in an Eppendorf vial. A smear 
was then made on a glass slide and left to air dry. Slides were then viewed with a 100X oil 
immersion objective in the bright field using a light microscope. A total of 200 spermatozoa were 
counted and the percentage of live sperm was then calculated. Dead sperm appear red/purple and 
live sperm white. 
 
Figure 15: 1 – Step eosin-nigrosin stain of human spermatozoa. Dead spermatozoa stained pink 
(A) live spermatozoa appear white/unstained (B) (X1000 magnification)  
 
2.5.4 Determination of sperm motility  
Sperm cell motility was measured using the motility module of Sperm Class Analyzer 5.0 (SCA 
Evolution, MICROPTIC S.L Barcelona, Spain) (Figure 16). 8-chamber Leja slides were employed 
and filled with 2µl of each sperm suspension after 1 hour incubation with different concentrations 
of M. whitei at 370C. Motility of at least 360 spermatozoa was analysed at 37ºC according to the 
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criteria set by the WHO (2010) with a Nikon Microscope (Nikon Instruments Inc., Americas) at 
100X PH1. The following different kinematic parameters were analysed: total motility, progressive 
motility, velocity curve line (VCL), velocity straight line (VSL), velocity average path (VAP), 
linearity (LIN), straightness (STR), beat cross frequency (BCF), amplitude of lateral head 
displacement (ALH), wobble (WOB) and hyperactivation (Table 1) .  
                    
 
Figure 16:  Determination of sperm concentration and motility by means of Sperm Class Analyser® 
(SCA) 5.0 analysis. CASA system version 4.1.0.1 (Microscopic S.L. Barcelona, Spain). This 
Figure indicates motility: Red and green comprised progressive motile sperm, blue representing 
non-progressive motile sperm and yellow representing immotile sperm.  
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Table 1: Different sperm kinematic parameters measured by the SCA® system 
Parameter and units    Description of parameters Measurement of movements 
   
Total motility (%)   Progressive + non-progressive 
motile   
Spermatozoa showing  movement 
Progressive motile (%)     Rapid + slow progressive 
motile                 
Spermatozoa with moving actively: 
either linearly or in a circle 
regardless of speed                                                                                   
Immotile (%)              Static No movement 
LIN (%)                    Linearity Linearity of the curvilinear path =  
VSL/VCL                                                                                          
STR (%)                   Straightness     Linearity of the average path = 
VSL/VAP                                                                                     
ALH (μm)               Amplitude of lateral head 
displacement         
Magnitude of lateral displacement of 
a sperm head about its average path                                                                                      
BCF (Hz)                  Beat across frequency                                   Magnitude of lateral displacement of 
a sperm head about its average path                                                                                          
Hyperactivation (%)    Hyperactivation     Distinctive motility acquired by 
mature spermatozoa to enable 
fertilization of an intact ovum                                                                                                           
WOB (%)                 Wobble                                                          Measure of oscillation of the actual 
path about the average 
path=VAP/VCL 
VSL (μm/s)              Straight-line velocity                                Time-averaged velocity of a sperm 
head along the straight line between 
its first detected position and its last                                                                                                       
VAP (μm/s)              Average path velocity                                    Time-averaged velocity of a sperm 
head along its average path                                                                                        
VCL (μm/s)             Curvilinear velocity Time-averaged velocity of a sperm 
head along its actual curvilinear path                                                                                         
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2.5.5 Determination of production of reactive oxygen species (ROS) in spermatozoa  
ROS production was determined using dihydroethidine (DHE) as fluorescing probe according to 
Henkel et al. (2003). A stock solution was prepared by using 20 μM DHE in PBS; the pH was 
adjusted to 7.4. After incubation of sperm samples with M. whitei aqueous root extract at the 
different concentrations for 1hr at 37ºC, an aliquot of 100 μl of spermatozoa was centrifuged for 
10 min at 500xg. After the supernatant was discarded, samples were resuspended in 100 μl PBS 
and 20 μl DHE stock and then incubated for 15 min at 37°C. 
Following this incubation period, 10 μl of each sample were viewed on a slide covered by a cover 
slip under oil immersion using an epifluorescence microscope with 488 nm excitation and 590 
emission filters (Zeiss). Bright orange fluorescing sperm indicate excessive ROS production. The 
percentage of ROS-positive sperm was calculated from at least 200 spermatozoa (Figure 17). 
           
 
 
Figure 17: Human spermatozoa after staining with DHE. ROS positive spermatozoa 
fluorescing bright orange (A); ROS negative spermatozoa did not fluoresces (B) (X1000 
magnification) 
A 
B 
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2.5.6 Determination of sperm mitochondrial membrane potential (MMP)  
Intact mitochondrial membrane potential (MMP) in sperm was determined using a lipophilic 
cationic dye (DePsipher™, Trevigen, Minneapolis, USA). The following modification was 
implemented from the protocol provided by the manufacturer: The reaction buffer was diluted with 
pre-warmed distilled water (370C) 1:10 and 20 μl stabilizer were added per milliliter buffer with 1 
μl of DePsipher dye. Thereafter, the solution was added to 500 μl prepared reaction buffer, vortexed 
thoroughly and centrifuged for 1 min at 10,000xg.  Finally, the supernatant was transferred into a 
test tube ready to be used, immediately.  
After incubation with Mondia aqueous root extract for 1 hour at 370C, 100µl of each concentration 
were diluted with PBS (1:1) and subjected to centrifugation for 10 minutes at 300Xg. The pellets 
were then re-suspended with 50-200 μl of DePsipher™ and incubated at 37°C for 20 minutes 
protected from light. After incubation, the sperm suspensions were centrifuged and the pellet was 
re-suspended with a reaction buffer. Spermatozoa were then immediately observed using a 
fluorescence microscope with a 488 nm excitation filter (Zeiss) at ×400 magnification. Sperm 
showing intense red/orange fluorescence were considered healthy with intact MMP (590 nm 
emission filter). In sperm with disrupted MMP, the monomer dye fluoresced green (530 nm 
emission filter) and they were generally classified as dying cells (Figure 18). A total of 200 
spermatozoa were counted and the number with intact MMP, was recorded as a percentage of the 
total number of sperm counted. 
                 
 
B 
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2.5.7 Determination of DNA fragmentation in spermatozoa 
DNA fragmentation was measured by using the terminal deoxynucleotidyl transferase-mediated 
dUTP-biotin nick end labeling (TUNEL) assay (Henkel et al., 2003).  The TUNEL assay measures 
DNA damage directly by detection of single and double DNA strand breaks (Henkel, 2007). These 
DNA strand breaks are detected in an enzymatic reaction by labelling the free 3’-OH and the 
modified nucleotides with terminal deoxynucleotidyl transferase.  
After incubation with M. whitei aqueous root extract at different concentrations at 370C, 100 µl 
sperm suspension were added to 100 µl of phosphate buffered saline (PBS) (Oxoid Ltd., 
Hampshire, England) and subjected to centrifugation at 300Xg for 10 minutes. The resultant pellets 
were re-suspended, wet smears were made on a StarFrost™ slide (Knittel Gläser, Braunschweig, 
Germany) and left to air-dry at room temperature (RT). Slides were then fixed in 4% formaldehyde 
in PBS (pH 7.4) for 25 minutes at 4°C. After fixation, slides were washed in PBS for 5 minutes at 
RT and permeabilized in 0.2% Triton™ X-100 (Sigma) in PBS for 5 minutes at RT. Subsequently, 
slides were rinsed twice in PBS for 5 minutes at RT and 100 μL of equilibration buffer were added 
to each slide and allowed to equilibrate for 10 minutes. After this, 20 μl of TUNEL reagent 
(DeadEnd™, Promega, Madison, WI, USA) were added to each slide and cooled with a plastic 
B A 
Figure 18: Determination of MMP using DePsipher™. Spermatozoa with intact Δψm 
showing red fluorescence (A), while those with disrupted Δψm have a green fluorescence 
(B). (X1000 magnification) 
B 
B 
A 
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cover slip (Promega). Following incubation for 60 minutes at 37°C in a humidified chamber 
protected from light, the reaction was terminated by immersion in 2×SSC (Promega) for 15 
minutes. Slides were then washed in PBS three times and more than 200 randomly selected sperm 
were immediately analysed using a fluorescence microscope (Zeiss, Oberkochen, Germany), with 
a 488 nm excitation filter and a 510-530 nm emission filter at ×400 magnification with an oil 
immersion objective. Sperm with normal DNA only showed a slight background staining (TUNEL-
negative), while those with fragmented DNA exhibited a bright green fluorescence (TUNEL-
positive). At least 200 spermatozoa were counted and TUNEL-positive sperm were recorded as a 
percentage of the total number of sperm per field (Figure 19). 
 
              
            
 
 
Figure 19: Human sperm with nuclear DNA damage. TUNEL-positive sperm fluorescent bright 
green (A) after TUNEL assay. TUNEL-negative sperm (B) showed background staining only. 
(×1000) 
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2.5.8 Determination of capacitation and acrosome reaction in spermatozoa 
The chlorotetracyclin (CTC) fluorescence assay protocol as stipulated according to Green et al. 
(1996), was used in assessing the state of capacitation and acrosome reaction. Distilled water was 
used to make 100 mg/ml stock solution of Hoechst 33258, then it was stored at 4ºC for up to 1 
month. Before use, this stock solution was diluted 1:1000 in HTF and then further 1:100 with sperm 
suspensions in HTF-BSA. Thereafter, samples were incubated at room temperature for 2 minutes 
before being washed by centrifugation through 4 ml of 2% polyvinylpyrrolidone (PVP40) in HTF 
at 900xg for 5 minutes. 
The CTC solution (pH 7.8) was prepared on the day of use and contained 750 μM CTC in a buffer 
of 130 mM NaCl, 5 mM cysteine in 20 mM Tris-HCl. This solution was kept wrapped in foil at 
4oC until use. Hoechst-treated spermatozoa (45μl) were mixed with an equal volume of the CTC 
solution and 8 μl of 12.5% w/v paraformaldehyde in 0.5 M Tris-HCl (pH 7.4) were added. 
Subsequently, 10 μl of the this suspension were placed on a slide and one drop of 0.22 M 1.4 
diazabicyclo(2.2.2)octane (DABCO) dissolved in glycerol: PBS (9:1) was mixed in carefully to 
retard fading of the fluorescence. Slides were then viewed with a 100x oil immersion objective 
using fluorescent microscope (Zeiss). In each sample, 200 live cells (Hoechst-negative) cells were 
assessed for CTC staining patterns as follows: uniform fluorescence over the entire head 
(characteristic of non-capacitated), acrosome-intact cells); fluorescence-free band in the post-
acrosomal region (characteristic of capacitated, acrosome-intact cells); and dull or absent 
fluorescence over the sperm head (characteristic of capacitated, acrosome-reacted cells) (Figure 
20). At all three stages bright fluorescence on the mid-piece could be seen. 
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2.6 Statistical analysis 
The MedCalc® statistical software (version 15.8; MedCalc Software, Mariakerke, Belgium) was 
used for statistical analyses.  Normal distribution was tested by means of the D’Agostino-Pearson 
test (D’agostino and Pearson, 1973). Afterwards, either parametric (Pearson correlation, repeated 
measure ANOVA), or non-parametric (Spearman Rank correlation) tests were employed 
accordingly. Data were expressed as mean±SD or SEM. A P-value of less than (P<0.05) was 
regarded as significant. 
 
 
 
 
 
 
 
Figure 20: Chlortetracycline staining of human sperm. Uncapacitated acrosome intact sperm (A) 
entire sperm head shows a bright fluorescence with or without a brighter equatorial band; 
capacitated acrosome-intact sperm (B) part of the sperm head fluoresce brightly but the sperm head 
post-acrosome region does not; capacitated acrosome-reacted sperm (C) is non-fluorescent with or 
without a fluorescent, post-acrosomal region. (X1000). 
B 
A 
C 
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CHAPTER THREE: RESULTS 
3.1 Effect of aqueous root extract of M. whitei on human spermatozoa functionality in vitro 
Different concentrations of aqueous root extract of M. whitei (0 µg/ml, 0.0185 µg/ml, 0.185 µg/ml, 
1.85 µg/ml, 18.5 µg/ml, 185 µg/ml) were used for the treatment of washed human spermatozoa 
from 60 semen samples. Results were captured after 1 hour incubation with M. whitei root extract 
at the above concentrations to indicate the extract effects on different sperm parameters.  
3.1.1 Summary statistics of parameters measured in this study 
A total of 60 semen samples have been included in the study: 28 of them represented healthy sperm 
donors; the other 32 represented infertile patients attending the fertility clinics mentioned above. 
The summary of the findings are tabulated in tables 2 and 3. Furthermore, oligozoospermic and 
asthenozoospermic semen samples were identified and analysed separately. Samples from seven 
patients were excluded because they were azoospermic or only dead spermatozoa were detected. 
Four samples from healthy participants were classified as patient samples because of 
bacteriospermia and reduced sperm concentration.  The cut-off value defining male infertility were 
as follows: time for pregnancy of partner (≥ 1 year), oligozoospermia (concentration < 15 
million/ml) and asthenozoospermic (progressive motility < 32% or total motility < 40%) (WHO, 
2010; Marchetti et al., 2013; Simon et al., 2013).   
Following D’Agostino–Pearson reference values test for normality, sperm parameters were 
measured as either Mean±SD or Median±range. Moreover, as any other common biological 
phenomenon, data from most parameters showed a high standard deviation. 
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3.1.2 Summary of sperm kinematic parameters of donor, patient and combined (donors and 
patients) group 
Whereas most motion parameter values in the donor group remained higher than in the patient 
group after 1 hour incubation of spermatozoa with increasing concentration of the M. whitei root 
extract (Table 2 and 3), there were no significant differences (one-way ANOVA analysis) nor a 
trend (repeated measures ANOVA analysis) in all the groups (donors, patients and combined: 
donors and patients). 
More so, as expected the patients showed significantly lower values for VAP than the donors. 
However, there were no changes nor a trend between different concentrations in VAP in all groups 
(Figure 21). This is most obvious in the controls and at low concentrations of M. whitei root extract. 
In contrast, at the highest M. whitei concentrations, no statistical significance could be observed, 
although the patient and combined group follow the same pattern as in the other concentration 
groups (one way ANOVA: donors; P=0.699, patients; P=0.105, donors and patients; P=0.804). 
In addition, when compared to the control after 1 hour incubation, spermatozoa at the highest (185 
μg/ml) concentration of M. whitei roots extract showed an increase (P=0.0195) in VCL in the 
patient group, as well as, the combined (patient and donor) (P=0.0022) group (Figure 22). Though, 
no trend was observed in the donor and combined (donor and patient) group (repeated measure 
ANOVA: donor P=0.595 and combined P=1.000). Yet, there was a significant trend (repeated 
measure ANOVA P=0.024) in sperm VCL for the patient group.  
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Table 2: Summary statistics of sperm kinematic motility parameters, following incubation with increasing concentrations of M. whitei aqueous root 
extract for 1 hour.  
Kinematic Parameters Group Control 0.0185 µg /ml 0.185 µg /ml 1.85 µg /ml 18.5 µg /ml 185 µg  /ml 
VAP (µm s-1) Donors* 36.0 ±10.79 
36.95(20.7-89) 
38.47 ±11.16 
41.2(14.7-67.3) 
37.59±11.34 
39.7(16-61.4) 
37.44 ±10.28 
39.4(14-58.4) 
37.06 ±11.23 
38(10.4-68.2) 
35.16 ±9.11 
36.4(18.3-54) 
Patients 27.88 ±9.78 
25.1(14-48.8) 
28.93 ±7.57 
29.7(12.9-45) 
29.08 ±9.47 
28.3(16.1-57.1) 
28.20 ±10.47 
27.4(7-54.6) 
30.50 ±8.34 
30(15.4-45.0) 
31.63±10.81 
30(12.9-57.1) 
VCL (µm s-1) Donors* 66.09± 15.96 
66.9(37-94.7) 
71.33 ±13.11 
70.9(41-92.8) 
70.08 ±15.10 
69.3(42.1-96) 
70.25 ± 13.34 
72.3(39.6-91) 
70.26 ±14.79 
71(35.7-95.4) 
69.87± 12.05 
67(50-91.3) 
Patients 54.33 ±10.27 
54.9(34-76.2) 
56.85 ±8.22 
59(41.7-70.8) 
57.12 ±10.75 
57.2(37.4-81) 
53.60 ±13.29 
56(25.5-79.5) 
58.88 ±10.86 
58.8(32.2-82) 
60.66 ±10.43 
59.4(41-81.1) 
VSL (µm s-1) Donors 27.24± 10.95 
22.6(6.4-50.9) 
30.38 ±12.65 
24.8(6.7-61) 
29.26 ±14.30 
26.4(8.2-71.9) 
28.30 ±10.84 
27.5(6.5-53) 
28.30 ±12.02 
28.2(5.4-61.8) 
28.00± 12.9 
25.4(10-66.2) 
Patients* 20.62 ±9.25 
17.5(8-40.2) 
20.89 ±9.06 
19.6(6.7-41.7) 
17.37 ±6.31 
17.5(8.2-28.1) 
20.26 ±10.48 
18.5(4.8-49) 
21.98 ±9.69 
20.2(9.8-48) 
23.58 ±10.92 
22.1(6.7-49) 
ALH (µm) Donors* 2.26 ±0.46 
2.2(1-3.5) 
2.33 ±0.29 
2.3(1.4-2.9) 
2.34 ±0.32 
2.3(1.8-3.3) 
2.30 ±0.37 
2.3(1.2-2.9) 
2.4 ±0.39 
2.3(1.7-3.1) 
2.21 ±0.43 
2.1(1.1-3.1) 
 Patients 1.75 ± 0.67 
1.9(0-29) 
1.98 ± 0.74 
2.1(0.5-3.5) 
1.95± 0.67 
2.1(0-2.7) 
1.85 ± 0.71 
2(0-2.7) 
2.02±  0.4 
2.1(1.0-2.8) 
2.09 ± 0.53 
2(0.7-3.3) 
Data comprise of donors (n=28) and patients (n=32) which is expressed as mean±SD and median (range). An asterix (*) indicate data with normal 
distribution. VAP: velocity average path; VCL: velocity curvilinear; VSL: velocity straight line; ALH= average lateral head displacement; SD; standard 
deviation. 
Donors: ANOVA P-value (VAP: P= 0.941; VCL: P= 0.850; VSL: P= 0.954; ALH: P= 0.622) 
Patients: ANOVA P-value (VAP: P= 0.105; VCL: P= 0.213; VSL: P= 0.160, ALH: P= 0.364) 
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Table 3: Summary statistics of sperm kinematic motility parameters, following incubation with increasing concentration of M. whitei root extract for 1 
hour.  
Data comprise of donors (n=28) and patients (n=32) which is expressed as mean±SD and median (range). An asterix (*) indicate data with normal 
distribution. BCF; beat across frequency, LIN; linearity, STR; straightness, WOB; wobble, SD; standard deviation. 
Donors ANOVA P-value (Hyperactivation: P= 0.441; BCF: P= 0.937; LIN: P= 0.928; STR: P= 0.921; WOB: P= 0.990)  
Patients ANOVA P-value (Hyperactivation: P= 0.611; BCF: P=0.789; LIN: P= 0.611; STR: P= 0.636; WOB: P= 0.820
Kinematic Parameters Group Control 0.0185 µg /ml 0.185 µg /ml 1.85 µg /ml 18.5 µg /ml 185 µg  /ml 
Hyperactivation (%)  Donors 3.98 ±2.83 
30(2-11.4) 
4.79  ±2.93 
4.8(0-10.6) 
4.08  ±3.16 
3.1(0.3-11.7) 
4.32 ± 2.54 
3.9(0.8-10) 
4.37  ±3.24 
3.2(0.2-11.2) 
4.73  ±3.34 
4.9(0.6-13) 
Patients 1.35 ±1.28 
1.1(0.0-5.7) 
1.08 ±0.97 
1.1(0-4.7) 
1.55 ±1.71 
1.1(0-5.7) 
1.83 ±2.07 
1.3(0-7.0) 
2.14 ±3.57 
1.3(0.0-18.6) 
2.40 ±2.21 
1.5(0-9.1) 
LIN (%) Donors 37.71± 11.09 
36.3(16-60.7) 
37.06 ± 10.5 
36.6(19-67.3) 
35.69 ±11.75 
35.7(18.8-66) 
35.84 ± 10.79 
35.5(5-58.5) 
35.39 ±11.33 
33.5(17-60) 
35.11 ±10.67 
33.9(8.8-56) 
Patients* 35.51± 10.67 
34.9(20-57.4) 
34.79 ± 10.53 
33.1(11-61.3) 
33.57 ±10.45 
34.8(11-61.3) 
37.32 ± 12.22 
37.3(18.9-62) 
38.90 ±11.18 
37.8(16.6-61) 
37.47 ±13.84 
36.2(16-61.3) 
STR (%)  Donors 68.97 ±12.97 
12.9(20.7-80) 
69.16 ±12.09 
70.6(8.6-91.2) 
67.32 ±12.68 
66.4(25.7-67.3) 
68.08 ±12.93 
66.5(9.7-91) 
67.34 ±12.65 
68.5(28.1-90.6) 
66.28± 12.36 
68.6(26.8-84.6) 
Patients 68.10 ±10.14 
68.4(9.8-85.4) 
68.88 ±10.87 
71.3(48.8-85.5) 
68.08 ±12.63 
69.2(29-87.1) 
68.97 ±11.03 
68.1(49.8-85.1) 
72.09 ±10.31 
71.6(46.6-85.8) 
70.25 ±12.33 
72.3(47.4-85.8) 
WOB (%) Donors 51.37 ± 9.57 
51.2(21-68.3) 
50.91 ± 9.76 
51.6(19-71.8) 
50.90 ±10.22 
50.2(51.9-71.8) 
50.53  ±9.11 
50.3(25-67.8) 
49.91 ±10.56 
50.2(18.4-71) 
49.86  ±9.21 
49.2(22-67.5) 
Patients* 49.10 ±7.95 
48.6(32-66.7) 
50.09 ±8.15 
49.5(30.7-66.8) 
49.40 ±7.62 
49.8(36.5-70.4) 
49.83 ±9.50 
50.2(27.3-71) 
51.49 ±9.22 
51.9(30.7-71) 
51.72 ±11.15 
51.9(30.7-71) 
BCF (HZ) Donors 13.79 ±2.68 
36.3(16-60.7) 
13.70 ±2.28 
36.6(19-67.3) 
13.37 ±2.64 
35.69(18.8-66) 
13.99 ±3.08 
33.5(5.1-58) 
13.67 ±2.90 
33.5(17-60) 
13.35 ±2.57 
33.9(8.8-55) 
Patients 11.07 ±5.02 
12.2(0-5.7) 
11.81 ±5.15 
13(0-23.3) 
11.31 ±4.54 
12.2(0-18.8) 
10.39 ±4.77 
22.8(0-17.8) 
11.82 ±4.25 
13.3(1.9-17) 
11.94 ±4.01 
12.7(3.6-18) 
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Figure 21: Effect of different concentrations of M. whitei root extract (0.0185, 0.185, 1.85, 18.5 and 185 
μg/ml) on velocity average path (VAP) of washed spermatozoa in vitro. Yellow represents: Healthy donors 
(n=28); Blue: Patients (n=32) and Green: Combined group of healthy donors and patients (n=60). Values 
shown as mean±SEM. No significant difference; one-way ANOVA: (donors; P=0.699, patients; P=0.105, 
combined; P=0.804) nor trend can be seen in all groups: repeated measure ANOVA: (donors; P=0.966, 
patients; P=0.135, combined; P=0.398). 
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Figure 22: Effect of different concentrations of M. whitei root extract (0.0185, 0.185, 1.85, 18.5 and 185 
μg/ml) on velocity curvilinear (VCL) of washed spermatozoa in vitro. Yellow represents: healthy donors 
(n=28); Blue: patients (n=32) and Green: combined group of healthy donors and patients (n=60). Values 
shown as mean±SEM. An increase in VCL is seen between the control and the highest concentration in 
patient (P=0.0195) and combined (P=0.0022) group, with a significant trend (repeated measure ANOVA: 
P=0.024) seen on the patient group. Yet, no trend is observed in the donor and the combined group: 
repeated measure ANOVA (donors; P=0.595, donors and patients; P=1.000). No significant change was 
seen in all groups: one-way ANOVA (donors; P=0.850, patients; P=0.213, combined; P=0.531) 
 
Apart from the combined (donor and patient) group which portrayed a noticeable significant (P=0.0375) 
increase on VSL at 185 μg/ml when compared to the control (Figure 23), there was no significant difference 
between different concentrations of M. whitei root extract nor trend on VSL across all groups. This is more 
apparent in the controls and at lower concentrations. Besides, at highest concentrations of M. whitei, no 
statistical differences could be seen in all groups: one-way ANOVA analysis: (donor; P=0.936, patients; 
P=0.160, donor and patient; P=0.535). 
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Figure 23: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185) μg/ml on 
velocity straight line (VSL) of washed spermatozoa in vitro. Yellow represents: healthy donors (n=30); 
Blue: patients (n=30) and Green: combined group of healthy donors and patients (n=60). Values shown as 
mean±SEM. No changes were found at all concentrations: One-way ANOVA analysis (donor; P=0.936, 
patients; P=0.160, donor and patient; P=0.535). 
  
Following 1 hour incubation of spermatozoa with different concentrations of M. whitei root extract, a 
marginal significant (P=0.0438) increase in ALH was observed when the controls in the patient group were 
compared with the highest concentration (185 μg/ml) (Figure 24). However, there were no changes between 
different concentrations of M.whitei nor a trend in ALH across all groups, especially in the control and at 
low concentration. In contrast, no changes could be observed at the highest concentration of M. whitei too. 
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Figure 24: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
average lateral head displacement (ALH) of washed spermatozoa in vitro. Yellow represents: healthy 
donors (n=28); Blue: patients (n=32) and Green: Combined group of healthy donors and patients (n=60).  
Values shown as mean±SEM. No statistical significant differences nor trend is seen: one-way ANOVA 
(donors P=0.483; patients P=0.478; combined P=0.391) and repeated measure ANOVA (donors P=0.777; 
patients P=0.118; combined P=0.440). However, a significant (P=0.0438) increase of ALH from the control 
to the highest (185 μg/ml) concentration is seen on the patients group.  
 
As expected, the donors showed significantly higher values of hyperactivated spermatozoa than the 
patients. Nonetheless, there was a significant (P=0.0301) increase in the percentage of hyperactiavated 
spermatozoa observed in the combined (donor and patient) group at 185 µg/ml when compared to the 
control, while no significant increase was reflected in the patient group as well as the donor group (Figure 
25).  Further analysis by one-way ANOVA (donor: P=0.824; patient: P=0.314, combined: P=0.666) and 
repeated measure ANOVA (donor: P=0.762, patient: P=0.059, combined: P=0.130) showed no changes 
nor trend in all groups. 
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Figure 25: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185μg/ml) on 
hyperactivated washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); Blue: patients 
(n=32) and Green: combined group of healthy donors and patients (n=60). Values shown as mean±SEM. 
A significant (P=0.0301) increase in the percentage of hyperactiavated spermatozoa for the combined 
(donor and patient) group is observed at 185 µg/ml when compared to the control. No changes nor trend 
can be seen in all the groups. 
 
 
On the other hand, there were no changes in the linearity of sperm movement between different 
concentrations of M. whitei root extract for all the groups (Figure 26). This is apparent in the controls and 
at low concentrations, more so the highest concentrations of M. whitei showed no changes too. (One-way 
ANOVA: donor: P=0.917, patient: P=0.611, combined: P=0.697) nor trend (repeated measure ANOVA: 
donors: P=0.291, patients: P=0.204, donors and patients: P=0.808) for all groups.
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Figure 26: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
linearity (LIN) of washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); Blue: patients 
(n=32) and Green: combined group of healthy donors and patients (n=60). Values shown as mean±SEM. 
No significant difference was found at all concentrations. 
 
 
Percentage straightness remained the same in all groups with increasing concentration of M.whitei. Hence, 
no significant changes (one-way ANOVA: donor: P=0.925, patient: P=0.636, donor and patient: P=0.824) 
could be observed (Figure 27). 
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Figure 27: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
percentage straightness (STR) of washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); 
Blue: patients (n=32) and Green: combined group of healthy donors and patients (n=60). Values shown as 
mean±SEM. No significant difference was found at all concentrations. 
 
 
Figure 28 displays the results for the treatment of spermatozoa with increasing concentrations of M. whitei, 
whereby there were no changes in the percentage of BCF at different concentrations across all groups in 
comparison to the control. Besides, further analysis with the use of one-way ANOVA: (donors: P=0.936, 
patients: P=0.636, donors and patients: P= 0.860) revealed no significant change in all the groups. 
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Figure 28: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
beat across frequency (BCF) of washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); 
Blue: patients (n=32) and Green: combined group of healthy donors and patients (n = 60). Values shown 
as mean±SEM. No changes nor trend was found at all concentrations. 
 
 
The percentage wobble remained the same with increasing concentration of M. whitei root extract. Hence 
no changes nor trend were seen (one-way ANOVA: donors P=0.989, patients P=0.820, donors and patients 
P=0.960) (Figure 29). 
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Figure 29: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
wobble of washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); Blue: patients (n=32) 
and Green: combined group of healthy donors and patients (n=60). Values shown as mean±SEM. No 
significant difference was found at all concentrations. 
 
3.1.3 Effect of M. whitei aqueous root extract in sperm motility 
Figures 30 and 31 display total motility and progressive motility for the three groups (donors, patients and 
combined group: donors and patients) respectively, after one hour of incubation at different concentrations 
of M. whitei extract. Despite the fact that there was a highly significant increase in total motility for the 
three groups: donor (P=0.0064), patient (P=0.0001) and the combined (donor and patient) (P<0.0001) 
group; no trend (repeated measure ANOVA: P=0.144) could be observed over all concentrations in the 
donor group. On the contrary, a highly significant (one-way ANOVA: P=0.0001) dose-dependent increase 
in motility to as low as 0.185 µg/ml extract (P=0.0392) was seen in the patient group (Figure 30). In 
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addition, the combined (donor and patient) group portrayed a highly significant trend (one-way ANOVA: 
P=0.0009; repeated measure ANOVA: P=0.0003) in percentage of total motile spermatozoa.  
 
Figure 30: Effect of different concentrations of M. whitei root extract (0.0185, 0.185, 1.85, 18.5 and 185 
μg/ml) on total motility of washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); Blue: 
patients (n=32) and Green: combined group of healthy donors and patients (n=60).Values are shown as 
mean±SEM. No significant difference can be seen nor any trend in the donors group. A significant 
(repeated measure ANOVA: P=0.0001) dose-dependent increase to as low as the concentrations of 
0.185µg/ml (P=0.0392) is seen on the patient group, whilst, the combined group shows an increase in 
percentage of motile sperm (P<0.0001) at 185 µg/ml when compared to the control with significant trend 
(repeated measure ANOVA: P = 0.0009). 
 
 
 
 
Nonetheless, there was no trend for progressive motility in the donor (repeated measure ANOVA: 
P=0.3618) as well as the combined group (repeated measure ANOVA: P=0.0624); even so, the combined 
group portrayed a highly significant (P=0.0008) increase in progressive motility when the highest 
 
 
 
 
72 
concentration (185 µg/ml) was compared to the control, whereas the donor group showed no statistical 
(P=0.2252) difference. The patient group showed a highly significant (one-way ANOVA P=0.0002) dose-
dependent increase on progressive motility when the highest (185 μg/ml) concentration was compared to 
the control (Figure 31). Similarly, further analysis using the repeated measures ANOVA revealed a highly 
significant (P=0.0068) positive trend between control and the highest concentration (185 μg/ml). 
 
Figure 31: Effect of different concentrations of M. whitei root extract (0.0185, 0.185, 1.85, 18.5 and 185 
μg/ml) on progressive motility of washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); 
Blue: patients (n=32) and Green: combined group of healthy donors and patients (n=60). Values are shown 
as mean±SEM. No significant difference can be seen nor any trend in the donors group. A strong significant 
(one-way ANOVA P=0.0002) dose-dependent increase and trend (repeated measure ANOVA: P=0.0068) 
is seen on the patient group. An increase (P=0.0008) in percentage of total motile sperm is observed at 185 
μg/ml when compared to the control with no significant trend (repeated measure ANOVA: P=0.0624) on 
the combined group. 
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3.1.4 Effect of M. whitei aqueous root extract on sperm vitality 
Following the exposure of different concentrations of M. whitei root extract to washed spermatozoa, 
patients’ sperm showed generally lower vitality as compared to the donors (Figure 32). However, the donor 
group (P=0.1102), the patient group (P=0.2579) and the combined (donor and patient) group (P=0.0684) 
showed no change in sperm vitality when various concentrations were compared to the control. 
Nevertheless, the results acquired after one-way ANOVA analysis were not significant in any group.  
Further analysis with repeated measure ANOVA revealed a marginal significant (P=0.0401) trend for the 
donor group. Yet, there was no trend for the patient (P=0.319) and the combined (P=0.187) group. 
3.1.5 Effect of M. whitei aqueous root extract on sperm mitochondrial membrane potential (MMP) 
Treatment of washed spermatozoa with increasing concentrations of M. whitei root extract depicted a 
highly significant dose-dependent increase in the percentage of spermatozoa with intact MMP across all 
groups: one-way ANOVA (patient; P<0.0001, combined (donor and patient); P<0.0001 and donor; 
P=0.0007) (Figure 33). More so, comparison between the control and the highest concentration (185µg/ml) 
also showed a significantly higher increase in percentage of spermatozoa with intact mitochondrial 
membrane potential in all groups: patient group (P<0.0001); donors and patient group (P<0.0001) and 
donor group (P=0.0001). Equally, a highly significant positive trend was seen across all groups: repeated 
measure ANOVA (donors: P=0.0001, patients: P<0.0001, combined (donors and patients: P<0.0001). 
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Figure 32: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
vitality of washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); Blue: patients (n=32) 
and Green: combined group of healthy donors and patients (n=60).  Values shown as mean±SEM. No 
significant difference: one-way ANOVA (donors; P=0.797, patients P=0.914, donors & patients; P=0.853) 
nor trend can be seen in patients and combined group: repeated measure ANOVA (patients: P=0.3188, 
combined: P=0.1868), however, a significant positive trend is seen in the donors group (P=0.0401). 
 
 
3.1.6 Effect of M. whitei aqueous root extract in sperm DNA fragmentation 
In the patient group, a dose-dependent declining (repeated measure ANOVA P=0.004) trend for the 
percentage of spermatozoa with DNA fragmentation was observed at higher concentrations. The direct 
comparison showed a significantly (P=0.0245) lower value at 18.5 µg/ml, along with a further marked, 
significantly (P=0.0112) reduced value at the highest concentration of 185 µg/ml as compared to the control 
(Figure 34). On the other hand, the donor group showed no change (P=0.6858) when the control was 
compared to the highest concentration (185 µg/ml). Furthermore, one-way ANOVA revealed no significant 
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change in all groups [one-way ANOVA: donor P=0.764, patient P=0.058 and combined (patients and 
donors) P=0.223]. 
 
 
Figure 33: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of sperm with intact mitochondrial membrane potential in vitro. Yellow represents: healthy 
donors (n=28); Blue: patients (n=32) and Green: combined group of healthy donors and patients (n=60). 
Values shown as mean±SEM. A highly significant dose-dependent percentage increase in MMP positive 
spermatozoa is seen across all groups: One-way ANOVA (donors; P=0.0007, patients; P<0.0001, 
combined; P<0.0001). Similarly, a highly significant positive trend of MMP positive spermatozoa 
percentage is seen across all groups: repeated measure ANOVA (donor: P=0.0001, patient: P<0.0001, 
combined: P<0.0001). 
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Figure 34: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
DNA fragmentation in vitro. Yellow represents: healthy donors (n=28); Blue: patients (n=32) and Green: 
combined group of healthy donors and patients (n=60).Values shown as mean±SEM. Sperm showing a 
significant (P=0.0112) decrease in percentage of DNA fragmented sperm in the patient group, as well as 
the combined group (P=0.0085) when the control is compared to the highest (185 μg/ml) concentrations. 
No significant difference (one-way ANOVA: donors P=0.0764, patients P=0.058, combined P=0.223) nor 
trend (repeated measure ANOVA: donors P=0.661) is seen on the mentioned group. However a significant 
trend is seen on the patient and combined group (repeated measure ANOVA: patients P=0.004 and 
combined P=0.019). 
 
3.1.7 Effect of M. whitei aqueous root extract in reactive oxygen species 
Incubation with increasing concentration of M. whitei root extract showed a significant trend (ANOVA 
trend analysis: patients: P=0.0005, combined: P=0.0005) towards increase percentage of ROS-positive 
spermatozoa (Figure 35). In fact, concentrations as low as 0.185 μg/ml showed a significant (P=0.0076) 
increase in the percentage of ROS-positive spermatozoa in comparison to the control in the patient group. 
However, no change, nor trend was observed in the donor group (one-way ANOVA: P=0.1782 and 
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repeated measures ANOVA: P=0.661), even though there was a significant difference between the control 
and the highest concentration (P = 0.0009).   
Figure 35: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage ROS-positive washed spermatozoa in vitro. Yellow represents: healthy donors (n=28); Blue: 
patients (n=32) and Green: combined group of healthy donors and patients (n=60). Values shown as 
mean±SEM. A significant trend (repeated measure ANOVA: patients: P=0.0005, combined: P=0.0005) 
towards increases percentage of ROS-positive spermatozoa is seen in both groups. Essentially, an increase 
in the percentage ROS-positive spermatozoa is seen: (donors P=0.0009, patient P=0.0004, combined 
P<0.0001) when the control of each group is compared to the respective highest concentration (185 μg/ml). 
 
3.1.8 Effect of aqueous extract of M. whitei at different concentration on capacitation and acrosome 
reaction of human sperm samples. 
The chlortetracycline fluorescence (CTC) assay (Table 4) shows no change in the percentage of capacitated 
and acrosome-reacted sperm across all groups (donors, patients, donors and patients).  
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As expected, the values for capacitated spermatozoa were significantly higher in the donor group than the 
patient and the combined (patient and donor) group (Figure 36). Further analysis using one-way ANOVA 
showed no effect across all groups: (one-way ANOVA: donors P= 0.432, patients P=0.452 and combined 
[donors and patients] P=0.832). The same applied to repeated measure ANOVA whereby no trend was 
seen across all groups: (repeated measure ANOVA: donors P=0.370, patients P=0.084 and combined 
P=0.204). 
The CTC assay revealed no changes in the percentage of acrosome-reacted sperm (Figure 37) in all groups: 
(one-way ANOVA: donors P=0.9578, patients P=0.9068, combined [donors and patients] P=0.9384), 
similarly no trend was seen in all the groups: repeated measure ANOVA (donors P=0.735, patients P=0.917 
and combined P=0.822).  
 
Table 4: Summary statistics of the percentage of capacitated and capacitated acrosome-reacted 
spermatozoa as detected by chlortetracycline fluorescence (CTC) assay after 1 hour incubation with 
increasing concentrations of M. whitei root extract. 
Concentration 
(µg/ml) 
Capacitated (%) Capacitated acrosome reacted sperm 
(%) 
Donors Patients Donors + 
patients 
Donors Patients Donors + 
patients 
Control 76.77±8.87 41.83±15.69 59.30±21.68 24.50±8.39 12.43±7.14 18.47±9.8 
0.0185 76.50±10.43 45.80±15.01 61.15±20.10 27.03±9.56 13.70±8.87 20.37±11.35 
0.185 73.83±10.19 48.30±16.06 61.06±18.54 23.50±7.74 13.63±6.60 18.57±8.68 
1.85 75.97±10.98 49.46±16.97 62.72±19.48 23.30±9.19 13.58±7.40 18.43±9.62 
18.5 76.37±10.97 47.50±17.09 61.93±20.26 24.93±7.76 12.77±5.80 18.85±9.16 
185 78.80±11.90 49.93±19.7 64.37±21.73 24.23±7.39 12.83±7.27 18.53±9.26 
One-way 
ANOVA P-
value 
0.641 0.452 0.832 0.568 0.974 0.877 
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Figure 36: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of capacitated spermatozoa in vitro. Yellow represents: healthy donors (n=28); Blue: patients 
(n=32) and Green: combined group of healthy donors and patients (n=60). Values shown as mean±SEM. 
No significant difference nor trend is seen in all groups: one-way ANOVA (donors; P= 0.432, patients; 
P=0.452 and combined [donors and patients] P=0.832) and repeated measure ANOVA (donors; P=0.370, 
patients; P=0.084 and combined P=0.204). 
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Figure 37: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of capacitated, acrosome-reacted spermatozoa in vitro. Yellow represents: healthy donors 
(n=28); Blue: patients (n=32) and Green: combined group of healthy donors and patients (n=60). Values 
shown as mean±SEM. No significant change nor trend can be seen: one-way ANOVA: (donors P=0.9578, 
patients P=0.9068, combined P=0.9384) and repeated measure ANOVA: (donors P=0.735, patients 
P=0.917 and combined P=0.822). 
 
 
3.1.9 Correlations of various sperm parameters within the donor, patient and combined (donor and 
patient) groups 
As illustrated in Table 5, a strong positive relationship of the percentage of total motile spermatozoa with 
progressively motile spermatozoa in the donors group (r=0.6760; P<0.0001), patients group (r=0.7715; 
P<0.0001) and the combined (donors and patients) group (r=0.8049; P<0.0001) were observed. Similarly, 
hyperactivated spermatozoa from the donors group (r=0.4607; P<0.0001), patients group (r=0.6268; 
P<0.0001) and combined (donors and patients) group (r=0.6407; P<0.0001) were significantly, positively 
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correlated with total motility. Moreover, the percentages of capacitated, acrosome-reacted sperm from the 
patients group (r=0.3312; P<0.0001) and percentages with intact-MMP (r=0.2425; P=0.0009) also 
portrayed a significant, weak positive correlation; however, the donors and the combined group showed no 
significant relationship. 
 
Table 5:  Correlation of total motility with sperm functional parameters.  
 
 
 
Table 6 portrays the correlations between the percentage of ROS-positive spermoatozoa and the following 
sperm functional parameters: Intact mitochondrial membrane potential (MMP), DNA-fragmentation 
(TUNEL) and capacitated acrosome-reacted spermatozoa. Interestingly, the percentage of DNA-
fragmented spermatozoa (r=-0.3096; P<0.0001) in the patient group was significantly, negatively 
correlated with the percentage of ROS-positive spermatozoa as opposed to the donor group (r=0.2023; 
P=0.0063). In the combined group, no (r=0.0641; P=0.2529) correlation was seen. Regardless of there 
being no significant correlation between the percentage of ROS-positive and the percentage of sperm with 
intact-MMP in the patient group (r=0.7886; P=0.2926), there was a significant weak negative correlation 
with the combined (donors and patients) group (r=-0.1622; P=0.0020) as well as, a weak significant 
positive correlation on the donors group (r=0.1696; P=0.0023).  The percentage of ROS-positive 
spermatozoa did not relate to the percentage of capacitated acrosome-reacted spermatozoa in all groups: 
donor (r=0.0285; P=0.7092), patients (r=0.0787; P=0.2975) and donors and patients (r= - 0.0831; 
P=0.1152). 
PARAMETER Donors Patients Patients + Donors 
r P r P r P 
Intact-MMP (%) -0.0726 <  0.3327 0.2452 0.0009 0.1927 0.0002 
Hyperactivation (%) 0.4606 < 0.0001 0.6268 < 0.0001 0.6407 < 0.0001 
Progressive-motility 
(%) 
0.6760 < 0.0001 0.7715 < 0.0001 0.8049 < 0.0001 
Capacitated, 
acrosome-reacted (%) 
0.1095 0.1435 -0.1308 0.0800 0.3317 < 0.0001 
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Table 6: Correlation of the percentage of ROS-positive sperm with sperm functional parameters  
PARAMETERS Donors Patients Patients + Donors 
r P r P r P 
Intact-MMP (%) 0.1696 0.0023 0.7886 0.2926 -0.1622 0.0020 
TUNEL (%) 0.2023 0.0063 -0.3096 < 0.0001 0.0641 0.2529 
Capacitated, 
acrosome-reacted (%) 
0.0285 0.7092 0.0787 0.2975 - 0.0831 0.1152 
 
 
The relationships between the percentage of hyperactivated, ROS-positive and capacitated acrosome-
reacted spermatozoa as shown in Table 7 revealed no significant relationship in the donor group and the 
combined group for the percentage of ROS-positive spermatozoa and capacitated, acrosome-reacted 
spermatozoa. However, the patients group showed a significant positive correlation (r=0.2664, P<0.0001) 
for the percentage of capacitated, acrosome-reacted sperm. Same tendency was reflected for the percentage 
of ROS-positive, only the patients group had a weak correlation (r=0.152, P=0.0421) with hyperactivated 
spermatozoa. 
 
Table 7: Correlation of the percentage of hyperactivated sperm with sperm functional parameters  
PARAMETERS Donors Patients Patients + Donors 
r P r P r P 
ROS-positive sperm (%) 0.105 0.1602 0.152 0.0421 -0.002 0.9667 
Capacitated, acrosome-
reacted (%) 
- 0.0952 0.2026 0.2664 < 0.0001 - 0.0543 0.4730 
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3.2.1 Effect of aqueous root extract of M. whitei on total and progressive motility in 
oligozoospermic and normozoospermic sperm samples 
Exposure of ejaculated washed spermatozoa to the root extract of M. whitei caused a highly significant 
(P=0.0013), dose-dependent increase in total motility in the oligozoospermic (one-way ANOVA: P=0.012) 
group (Figure 38). On the other hand, a significant (P=0.0064) increase in total motility was also observed 
when the control was compared to the highest concentration (185 µg/ml) but no significant effect (one-way 
ANOVA P=0.144) was seen in the normozoospermic group. In addition, repeated measure ANOVA 
showed a trend in both groups: repeated measure ANOVA (oligozoospermia P=0.002; normozoospermia 
P=0.0111) with a higher increase in the oligozoospermic group. Clearly, the difference between both 
groups at the highest concentration used (185µg/ml) was insignificant (p=0.2364) whereas, the difference 
was significant (P=0.0023) in the control. 
After 1 hour treatment of washed spermatozoa with increasing concentration of M. whitei, no change nor 
trend was observed for progressive motility in both groups: One-way ANOVA (oligozoospermia 
P=0.3178; normozoospermia P=0.869) and repeated measure ANOVA (oligozoospermia P=0.055; 
normozoospermia P=0.3618) (Figure 39). 
 
3.2.2 Effect of aqueous root extract of M. whitei on sperm kinematic parameters of oligozoospermic 
and normozoospermic group. 
As expected, the mean values of the kinematic parameters in the normozoospermic group were higher than 
the olizoospermic group (Table 8). However, no change was seen in all the kinematic parameters from both 
groups.  
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Figure 38: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of total motility of washed spermatozoa in vitro. Yellow represents: oligozoospermic 
(concentration <15 million/ml) group (n=19); Blue: normozoospermic (concentration >15 million/ml) 
group (n=28).Values shown as mean±SEM. A significant dose-dependent increase in sperm percentage 
total motility is seen in the oligozoospermia group (one-way ANOVA: P=0.012) but not on the 
normozoospermia group (one-way ANOVA: P=0.144). Virtually, an increase in (oligozoospermic: 
P=0.0013 and normozoospermic: P= 0.0064) is seen at highest concentration (185 μg/ml) when compared 
to the control in both groups. Repeated measure ANOVA is significant (oligozoospermic P=0.002, 
normozoospermic P=0.0111).  
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Figure 39: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185μg/ml) on the 
percentage of progressive motility of washed spermatozoa in vitro. Yellow represents: oligozoospermic 
(concentration <15 million/ml) group (n=19); Blue: normozoospermic (concentration >15 million/ml) 
group (n=28). Values shown as mean±SEM. One-way ANOVA is not significant (oligozoospermic 
P=0.3178, normozoospermic P=0.869), as well as, repeated measure ANOVA (oligozoospermic P=0.055; 
normozoospermic P=0.361) in both group. 
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Table 8: Summary statistics of sperm kinematic motility parameters, following incubation with increasing concentrations of M. whitei root extract for 1 
hour.  
Kinematic Parameters Group Control 0.0185 µg /ml 0.185 µg /ml 1.85 µg /ml 18.5 µg /ml 185 µg  /ml 
VAP (µm s-1) Oligozoospermic 22.81±7.34 31.0±6.55 27.34±5.41 25.14±9.25 30.04±8.56 29.95±7.54 
Normozoospermic 36.57±10.79 38.47±11.16 37.59±11.34 37.44±10.28 37.06±11.23 36.16±9.11 
VCL (µm s-1) Oligozoospermic 53.9±9.88 58.5±8.36 43.37±17.39 51.28±13.38 57.3±10.48 59.55±8.87 
Normozoospermic 66.09±15.96 71.33±13.11 70.08±15.10 70.25±13.34 70.26±14.79 69.87±12.05 
VSL (µm s-1) Oligozoospermic 18.03±6.79 22.03±7.54 19.89±20.7 17.18±8.23 22.16±8.87 21.88±8.36 
Normozoospermic 27.24±10.95 30.38±12.65 29.26±14.30 28.30±10.84 28.3±12.30 28.20±12.87 
ALH (µm) Oligozoospermic 1.69±0.69 2.06±0.67 1.89±0.72 1.88±0.73 1.99±0.33 2.01±0.54 
Normozoospermic 2.26±0.46 2.3±0.29 2.40±0.32 2.27±0.37 2.40±0.39 2.17±0.43 
Hyperactivation  
(%) 
Oligozoospermic 1.44±1.14 1.79±2.06 1.97±2.39 1.97±2.39 1.4±1.63 2.33±2.1 
Normozoospermic 4.30±2.92 4.7±2.98 4.1±3.26 4.2±2.57 4.4±3.3 4.7±3.50 
LIN (%) Oligozoospermic 32.59±8.37 36.08±10.38 33.95±8.86 40.2±12.3 40.2±12.3 36.02±12.63 
Normozoospermic 38.18±11.35 37.6±10.6 36.1±12.0 36.2±11.10 365.6±11.57 35.5±10.3 
STR (%) Oligozoospermic 66.52±8.24 67.72±10.82 69.92±12.33 66.86±9.19 47.36±8.05 68.4±12.71 
Normozoospermic 69.20±13.40 70.10±12.4 67.3±13.1 68.01±13.4 67.3±13.0 66.5±12.70 
WOB (%) Oligozoospermic 48.80±6.64 50.18±6.8 49.87±5.81 47.15±8.42 53.96±8.42 51.22±9.77 
Normozoospermic 51.70±9.80 51.22±10.00 50.48±10.52 50.80±9.40 50.10±10.90 50.1±9.50 
BCF (HZ) Oligozoospermic 10.16±5.25 12.12±5.28 11.46±4.37 9.57±4.42 12.01±4.34 11.68±4.10 
Normozoospermic 13.70±02.80 13.70±2.40 13.40±2.70 14.10±3.10 13.60±09.00 13.40±2.60 
Data comprises of oligozoospermic (concentration<15 million/ml) group (n=19) and normozoospermic (concentration>15 million/ml) group (n=28) and 
is expressed as mean±SD. VAP: velocity average path; VCL: velocity curvilinear; VSL: velocity straight line; ALH: average lateral head displacement; 
hyperactivation; BCF: beat across frequency; LIN: linearity; STR: straightness; WOB: wobble; SD: standard deviation. 
Oligozoospermic ANOVA P-value (VAP: P=0.053; VCL: P= 0.058; VSL: P=0.181; ALH: P=0.585; hyperactivation: P=0.763; BCF: P=0.320;    
                                                           LIN: P=0.297; STR: P=0.085; WOB: P=0.148) 
Normozoospermic ANOVA P-value (VAP: P=0.941; VCL: P=0.850; VSL: P=0.954; ALH: P=0.662; hyperactivation: P=0.441; BCF: P=0.937;  
                                                             LIN: P=0.928; STR: P=0.921; WOB=0.990) 
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Different concentrations of M. whitei did not cause any effect on velocity average path (VAP) for 
spermatozoa in both groups: (repeated measure ANOVA: oligozoospermic; P=0.289 and 
normozoospermic; P=0.972) (Figure 40); with one-way ANOVA P=0.053 in the oligozoospermic group 
and P=0.975 in the normozoospermic group. However, the velocity curvilinear (VCL) of spermatozoa 
significantly (P=0.0008) increased from the control to concentration at 185 µg/ml on the oligozoospermic 
group (Figure 41). Yet, further analysis of VCL using one-way ANOVA and repeated measure ANOVA 
showed no  changes nor a trend in both groups: one-way ANOVA (oligozoospermia P=0.058 and 
normozoospermia P=0.869) and repeated measure ANOVA (oligozoospermia P=0.412 and 
normozoospermia P=0.394). 
 
3.2.3. Effect of aqueous root extract of M. whitei on sperm vitality and mitochondrial membrane 
potential 
As expected, the sperm vitality values in normozoospermic group were significantly higher than those in 
the oligozoospermic group (Figure 42), with no dose-dependent effect in both groups: repeated measure 
ANOVA (oligozoospermia P=0.339, normozoospermia P=0.151), as well as, one-way ANOVA 
(oligozoospermia P=0.937, normozoospermia P=0.797).  
 
Treatment of washed spermatozoa with increasing concentration of M. whitei root extract resulted in a 
dose-dependent increase in the percentage of spermatozoa with intact mitochondrial membrane potential 
in both groups: One-way ANOVA  (oligozoospermia P=0.0001 and normozoospermia P=0.0007), as well 
as repeated measure ANOVA for a trend analysis (oligozoospermia P=0.0007 and normozoospermia 
P=0.0001) (Figure 43). In fact, a highly significant increase was seen at 185 µg/ml (oligozoospermia 
P=0.0027 and normozoospermia P=0.0001) when compared to the controls in both groups.  
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Figure 40: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
velocity average path (VAP) of washed spermatozoa in vitro. Yellow represents: oligozoospermic 
(concentration <15 million/ml) group (n = 19); Blue: normozoospermic (concentration >15 million/ml) 
group (n = 28). Values shown as mean±SEM. No effect nor trend is seen in both groups: one-way ANOVA 
(oligozoospermia P=0.053 and normozoospermia P=0.975) and repeated measure ANOVA 
(oligozoospermia P=0.289 and normozoospermia P=0.972). 
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Figure 41: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on 
velocity curvilinear (VCL) of washed spermatozoa in vitro. Yellow represents: oligozoospermic 
(concentration <15 million/ml) group (n = 19); Blue: normozoospermic (concentration >15 million/ml) 
group (n = 28).Values shown as mean±SEM. Significant (P=0.0008) increase in sperm VCL is seen from 
the control to concentrations at 185 µg/ml. One-way ANOVA and repeated measure ANOVA show no 
effect nor trend in both groups: one-way ANOVA (oligozoospermia P= 0.058 and normozoospermia 
P=0.869) and repeated measure ANOVA (oligozoospermia P=0.412 and normozoospermia P=0.349). 
 
 
3.2.4 Effect of aqueous root extract of M. whitei on the percentage of ROS-positive spermatozoa 
After incubation with different concentrations of M. whitei for 1 hour, repeated measure ANOVA showed 
a significant positive trend in the percentage of ROS-positive sperm in both groups (oligozoospermia 
P=0.0013 and normozoospemia P=0.0015) (Figure 44).  Yet, one-way ANOVA showed no changes in both 
groups: (oligozoospermia: P=0.096 and normozoospermia: P=0.178). In direct comparison, the percentage 
of ROS-positive spermatozoa in the control was significantly lower than in those incubated with 185 μg/ml 
in the oligozoospermic (P=0.0172) as well as normozoospermic subjects (P=0.0009).  
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Figure 42: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185μg/ml) on the 
percentage of vitality of washed spermatozoa in vitro. Yellow represents: oligozoospermic (concentration 
<15 million/ml) group (n=19); Blue: normozoospermic (concentration >15 million/ml) group (n=28).  
Values shown as mean±SEM. There is no dose-dependent effect in vitality in both groups: the repeated 
measure ANOVA (oligozoospermia P=0.339 and normozoospermia P=0.151) and one-way ANOVA 
(oligozoospermia P=0.937 and normozoospermia P=0.797). 
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Figure 43: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of intact mitochondrial membrane potential (MMP) of washed spermatozoa in vitro. Yellow 
represents: oligozoospermic (concentration <15 million/ml) group (n = 19); Blue: normozoospermic 
(concentration >15 million/ml) group (n = 28). Values shown as mean±SEM. A highly significant dose-
dependent increase (one-way ANOVA: oligozoospermia P=0.0001 and normozoospermia P=0.0007) and 
trend (repeated measure ANOVA: oligozoospermia P=0.0007 and normozoospermia P=0.0001) is seen in 
both groups. In fact, a highly significant increase is seen in the oligozoospermic (P=0.0027) and 
normozoospermic (P=0.0001) groups when their controls are compared to their highest concentrations (185 
µg/ml).  
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Figure 44: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of ROS positive washed spermatozoa in vitro. Yellow represents: oligozoospermic 
(concentration <15 million/ml) group (n=19); Blue: normozoospermic (concentration >15 million/ml) 
group (n=28). Values shown as mean±SEM. A significant trend is seen in both groups (repeated measure 
ANOVA: oligozoospermia P=0.0013 and normozoospermia P=0.0015). No significant change is seen 
(one-way ANOVA: oligozoospermia P=0.144 and normozoospermia). However, a significant increase is 
seen from the groups controls to concentrations at 185µg/ml (oligozoospermia P=0.0172 and 
normozoospermia P=0.0009). 
 
 
3.2.5 Effect of aqueous root extract of M. whitei in DNA fragmentation 
 
One-way ANOVA did not show any effect of M. whitei on DNA-fragmentation of washed spermatozoa 
from both groups (oligozoospermia P=0.144 and normozoospermia P=0.764) (Figure 45). However, the 
oligozoospermic group showed a significant negative trend (repeated measure ANOVA P=0.0048), while 
no trend could be established in the normozoospermic group (repeated measure ANOVA P=0.435). In 
direct comparison a significant (P=0.0245) decrease in the percentage of DNA-fragmented spermatozoa 
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from the control to the highest concentration (185 µg/ml) used was found in the oligozoospermic group. 
Thus, the extract only showed an effect on the sperm from the oligozoospermic group. 
 
 
Figure 45: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of DNA fragmentation of washed spermatozoa in vitro. Yellow represents: oligozoospermic 
(concentration <15 million/ml) group (n=19); Blue: normozoospermic (concentration >15 million/ml) 
group (n=28).  Values shown as mean±SEM. At 185 μg/ml, there is a significant (P=0.0245) decrease on 
the percentage of DNA-fragmented cells in comparison to the control in the oligozoospermic group. 
However, one-way ANOVA is not significant in both groups (oligozoospermia P=0.144 and 
normozoospermia P=0.764). While, the repeated measure ANOVA is significant (P=0.0048) in the 
oligozoospermic group but not significant (P=0.435) in the normozoospermic group. 
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3.2.6 Effect of aqueous root extract of M. whitei in sperm capacitation and acrosome reaction 
Despite the fact that the values for normozoospermic subjects were obviously higher than those for 
oligozoospermic subjects (Figure 46 and 47), the chlortetracycline fluorescence (CTC) assay (Table 9) 
revealed no effect of the extract on the percentage of capacitated and acrosome-reacted sperm in both 
groups (oligozoospermic and normozoospermic). In addition, trend analysis using repeated measure 
ANOVA was not significant for both the percentage of capacitated (oligozoospermia P=0.909 and 
normozoospermia P=0.370) and capacitated, acrosome-reacted sperm (oligozoospermia P=0.551 and 
normozoospermia P=0.731) from both groups. Similarly, the one-way ANOVA revealed no effect on 
capacitated (oligozoospermia P=0.6804 and normozoospermia P=0.806) and capacitated acrosome-reacted 
spermatozoa from both groups (oligozoospermia P=0.986 and normozoospermia P=0.856).  
 
Table 9: Summary statistics of the sperm capacitation and acrosome reaction on oligozoospermic 
(concentration <15 million/ml) and normozoospermic (concentration >15 million/ml) sperm samples as 
detected by CTC stain after 1 hour incubation with increasing concentrations of M. whitei root extract. 
Concentration 
(µg/ml) 
Capacitated sperm (%) Capacitated-acrosome reacted sperm 
(%) 
Oligozoospermia Normozoospermia Oligozoospermia Normozoospermia 
Control 46.95±17.81 63.87±21.55 16.47±9.06 20.30±10.16 
0.0185 49.42±16.10 65.78±19.28 16.10±6.76 22.68±11.36 
0.185 49.37±16.52 62.78±19.35 15.10±7.39 20.07±8.89 
1.85 53.58±17.42 65.63±20.02 15.32±5.86 19.66±10.10 
18.5 52.37±16.35 65.67±19.43 14.89±8.59 20.30±9.81 
185 55.37±20.94 68.20±21.34 14.47±8.59 20.34±9.50 
One-way 
ANOVA P-
value 
0.699 0.885 0.263 0.786 
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Figure 46: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of capacitated washed spermatozoa in vitro. Yellow represents: oligozoospermic (concentration 
<15 million/ml) group (n=19); Blue: normozoospermic (concentration >15 million/ml) group (n=28). 
Values shown as mean±SEM. There is no dose-dependent effect in the percentage of capacitated 
spermatozoa in both groups: repeated measure ANOVA (oligozoospermia; P=0.909 and 
normozoospermia; P=0.370) and one-way ANOVA (oligozoospermia; P=0.680 and normozoospermia; 
P=0.432).  
 
 
 
 
 
96 
 
Figure 47: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of capacitated acrosome-reacted washed spermatozoa in vitro. Yellow represents: 
oligozoospermic (concentration <15 million/ml) group (n=19); Blue: normozoospermic (concentration >15 
million/ml) group (n=28). Values shown as mean±SEM. There is no dose-dependent effect nor trend seen 
in the percentage of acrosome-reacted spermatozoa in both groups: repeated measure ANOVA 
(oligozoospermia P=0.551 and normozoospermia P=0.731), as well as, one-way ANOVA 
(oligozoospermia P=0.986 and normozoospermia P=0.856) 
 
 
3.2.7 Correlations of various sperm parameters within oligozoospermic and normozoospermic 
groups  
Correlations between the percentage of total motility and the sperm functional parameters hyperactivation, 
progressive motility, intact-MMP and capacitated, acrosome-reacted spermatozoa revealed that total 
motilility spermatozoa had a significant strong positive relationship with the percentage of hyperactivated 
spermatozoa in both groups: oligozoospermia (r=0.647, P<0.0001) and normozoospermia (r=0.592, 
P<0.0001) (Table 10). Similarly, the percentage of progressively motile spermatozoa strongly significantly 
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correlated with the percentage of total motile spermatozoa in both groups: oligozoospermia (r=0.768, 
P<0.0001) and normozoospermia (r=0.795, P<0.0001). The percentage of spermatozoa with intact-MMP 
showed a weak but positive and significant correlation with the percentage of total motile spermatozoa in 
the oligozoospermic (r=0.343, P=0.002) group, but with no significant relationship in the normozoospermic 
group. On the other hand, the percentage of capacitated, acrosome-reacted cells was significantly weakly 
positively correlated with the percentage of total motile spermatozoa in the oligozoospermic (r=0.378, 
P<0.0001) group with no relationship in the normozoospermic subjects. 
 
Table 10: Correlation of total motility with sperm functional parameters. 
 PARAMETERS Oligozoospermia Normozoospermia 
r P r P 
Hyperactivation (%) 0.647 <0.0001 0.592 <0.0001 
Progressive motility (%) 0.768 <0.0001 0.795 <0.0001 
Intact-MMP (%) 0.343 0.0002 0.117 0.0666 
Capacitated, acrosome- 
reacted (%) 
0.378 <0.0001 0.086 0.3657 
 
Table 11 shows the correlation between percentages of ROS-positive spermatozoa with the following 
sperm functional parameters: the percentages of spermatozoa with intact-MMP, DNA-fragmentation and 
capacitated, acrosome-reacted sperm. The percentage of ROS-positive spermatozoa had a significant weak 
negative association with percentage of spermatozoa with intact-MMP in the normozoospermic      (r=-
0.195, P=0.0022) but no relationship with the percentage of spermatozoa with intact-MMP in the 
oligozoospermic group. However, the percentage of ROS-positive spermatozoa had a significant weak 
negative relationship with the percentage of spermatozoa with DNA fragmentation in the oligozoospermic 
(r=0.243, P=0.0091), but no relationship with percentage of DNA-fragmented spermatozoa in the 
normozoospermic group.  The same applied for the percentage of capacitated, acrosome-reacted 
spermatozoa where both groups had no significant relationship with ROS.  
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Table 11: Correlation of the percentage of ROS-positive sperm with sperm functional parameters.  
PARAMETERS Oligozoospermia Normozoospermia 
r P r P 
Intact-MMP (%) 0.078 0.4068 -0.195 0.0022 
TUNEL (%) -0.243 0.0091 0.111 0.0834 
Capacitated, acrosome- 
reacted (%) 
0.027 0.7749 0.008 0.9014 
 
The relationship between the percentage of hyperactivated, ROS-positive and capacitated acrosome-
reacted spermatozoa as shown in Table 12 revealed a strong relationship of the percentage of 
hypearctivated spermatozoa with the percentage of ROS-positive spermatozoa in oligozoospermic 
(r=0.678, P<0.0001) subjects but not normozoospermic (r=0.626, P<0.0569) subjects (Table 13), whereas, 
the percentage of sperm with intact-MMP had a significant weak relationship with the percentage of 
hyperactivation spermatozoa in the oligozoospermic (r=0.321, P=0.0006) group, with no significant 
correlation in the normozoospermic group. 
 
Table 12: Correlation of the percentage of hyperactivated sperm with sperm functional parameters  
PARAMETERS Oligozoospermia Normozoospermia 
r P r P 
ROS-positive (%) 0.678 <0.0001 0.626 0.569 
Intact-MMP (%) 0.321 0.0006 0.056 0.3830 
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3.3.1 Effect of aqueous root extract of M. whitei on total and progressive motility in 
asthenozoospermic and normozoospermic samples 
Computer-assisted sperm analysis (CASA) revealed a dose-dependent increase and trend in total sperm 
motility after exposure to increasing concentrations of the extract in the asthenozoospermic group:          
(one-way ANOVA: P=0.024); (repeated measure ANOVA: P=0.0047). Essentially, total motility in 
asthenozoospermic samples significantly (P=0.0010) increased from the control to 185 μg/ml extract 
(Figure 48). In contrast, in the normozoospermic samples no change (one-way ANOVA P=0.197) was 
found despite the fact that, repeated measures ANOVA revealed a significant (P=0.0047) and positive trend 
between the control and the highest concentration (185 μg/ml) used. 
More so, there was a significant increase in the percentage of progressively motile sperm from the control 
in the asthenozoospermic (P=0.0149) as well as normozoospermic (P=0.0001) groups to the highest 
concentration (185 µg/ml) (Figure 49). On further analysis, one-way ANOVA depicted no changes in both 
groups (one-way ANOVA: asthenozoospermia P=0.203 and normozoospermic P=0.498). In addition, 
repeated measures ANOVA also revealed no trend between the control and 185 μg/ml in both groups 
(repeated measure ANOVA: asthenozoospermia P=0.576 and normozoospermia P=0.249).  
 
3.3.2 Effect of aqueous root extract of M. whitei on sperm kinematic parameters 
As anticipated, the mean values for the various parameters in the normozoospermic subjects were generally 
higher than those in asthenozoospermic subjects (Table 13). No change nor any trend could be established 
by one-way ANOVA and repeated measure ANOVA, respectively 
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Figure 48: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of total motility of washed spermatozoa in vitro. Yellow represents: asthenozoospermic 
(progressive motility <32% or total motility <40%) group (n=20); Blue: normozoospermic (progressive 
motility >32% or total motility >40%) group (n=28). Values shown as mean±SEM. A significant 
(P=0.0010) dose-dependent increase in progressive motility is seen in asthenozoospermic (one-way 
ANOVA P=0.024). In addition, repeated measure ANOVA show significant trend in both groups 
(asthenozoospermia P=0.004 and normozoospermia P=0.023). However, one-way ANOVA show no 
changes in normozoospermia (one-way ANOVA P=0.197). 
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Figure 49: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of progressive motility of washed spermatozoa in vitro. Yellow represents: asthenozoospermic 
(progressive motility <32% or total motility <40%) group (n=20); Blue: normozoospermic (progressive 
motility >32% or total motility >40%) group (n=28). Values shown as mean±SEM. A significant increase 
in the percentage of progressive motile sperm is seen between the control and 185 μg/ml is both 
(asthenozoospermic P=0.0302 and normozoospermic P=0.082) groups. However, there is no changes (one-
way ANOVA: asthenozoospermia P=0.203 and normozoospermia P=0.498) and trend (repeated measure 
ANOVA: asthenozoospermia P=0.576 and normozoospermia P=0.249) seen in both group.  
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Table 13: Summary statistics of sperm kinematic motility parameters, following incubation with increasing concentration of M. whitei for 1hour.  
Data comprises of asthenozoospermic group (n=20) and normozoospermic group (n=28) and is expressed as mean±SD. BCF; beat across frequency, 
LIN; linearity, STR; straightness, ALH; average lateral head displacement, BCF; beat across frequency, LIN; linearity, STR; straightness, wobble 
(WOB), SD; standard deviation. 
Asthenozoospermic ANOVA P-value (VAP: P=0.743; VCL: P=0.205; VSL: P=0.619; ALH: P=0.270; hyperactivation: P=0.335; LIN: P=0.343; STR:  
                                                               P=0.503; WOB: P=0.651; BCF: P=0.920).                                     
Normozoospermic ANOVA P-value (VAP: P=0.941, VCL: P=0.850, VSL: P=0.954; ALH: P=0.662; hyperactivation: P=0.441, LIN: P=0.928, STR: 
                                                             =0.921; WOB: P=0.990, BCF=0.937).   
Kinematic Parameters Group Control 0.0185 µg /ml 0.185 µg /ml 1.85 µg /ml 18.5 µg /ml 185 µg  /ml 
VAP (µm s-1) Asthenozoospermic 27.80±11.423 30.37±10.56 26.88±7.38 27.29±11.99 29.37±8.18 31.32±11.22 
Normozoospermic 36.57±10.79 37.47±11.16 37.59±11.34 37.44±10.28 37.06±11.23 36.16±9.11 
VCL (µm s-1) Asthenozoospermic 53.17±11.89 58.9±11.25 52.91±9.03 55.03±13.58 70.25±13.34 61.61±11.37 
Normozoospermic 66.09±15.96 71.31±13.11 70.08±15.10 70.25±13.34 70.26±14.79 68.87±12.05 
VSL (µm s-1) Asthenozoospermic 22.04±11.29 20.86±10.97 17.45±6.95 18.83±10.73 20.9±7.73 24.16±11.18 
Normozoospermic 27.24±10.95 30.38±12.65 29.26±14.30 28.39±10.84 28.30±12.29 28.0±12.29 
ALH (µm) Asthenozoospermic 1.68±0.65 2.06±0.68 1.89±0.72 1.88±0.67 1.99±0.44 2.01±0.61 
 Normozoospermic 2.26±0.46 2.3±0.29 2.38±0.32 2.072±0.37 2.40±0.39 2.20±0.43 
Hyperactivation  
(%) 
Asthenozoospermic 1.54±1.42 1.69±0.83 1.97±1.75 1.67±1.74 1.3±1.52 2.4±2.6 
Normozoospermic 4.01±2.92 4.67±2.98 4.10±3.26 4.23±2.57 4.41±3.29 4.60±3.52 
LIN (%) Asthenozoospermic 34.79±12.30 35.90±11.18 33.25±7.76 35.52±13.43 35.59±11.7 36.5±13.99 
Normozoospermic 38.18±11.35 37.63±10.555 36.10±11.96 37.29±11.74 36.28±11.14 35.55±10.28 
STR (%) Asthenozoospermic 65.42±10.43 71.62±11.32 67.42±10.63 66.36±10.89 71.36±8.05 69.4±12.88 
Normozoospermic 69.21±12.43 70.1±12.41 70.90±12.97 68.10±13.39 67.32±12.89 66.49±12.70 
WOB (%) Asthenozoospermic 47.82±8.7 51.83±9.7 48.47±6.18 48.15±10.62 51.60±9.02 50.62±10.27 
Normozoospermic 51.67±9.80 51.23±10.01 50.54±10.50 50.81±9.49 50.14±910.94 50.09±9.54 
BCF (HZ) Asthenozoospermic 11.00±4.65 11.12±5.77 10.46±3.47 14.57±3.10 10.81±4.93 11.78±3.67 
Normozoospermic 13.74±2.75 13.66±2.43 13.44±2.75 14.42±3.13 13.60±92.96 13.42±5.59 
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3.3.3 Effect of aqueous root extract of M. whitei on vitality and mitochondrial membrane potential 
(MMP) 
Exposure to the extract revealed no effect on sperm vitality in both groups (one-way ANOVA: 
asthenozoospermic P=0.983 and normozoospermic: P=0.596) (Figure 50). Similarly, no trend was 
observed in both groups (repeated measure ANOVA: asthenozoospermic P=0.601 and normozoospermic 
P=0.076).  
With regard to the mitochondrial membrane potential, there was a highly significant (one-way ANOVA: 
asthenozoospermic: P=0.0004 and normozoospermic: P=0.031) dose-dependent increase in the percentage 
of sperm with intact MMP seen in the both groups (Figure 51). Virtually, there was a significant increase 
in asthenozoospermic: P=0.0008 and normozoospermic: P=0.0016 group when their controls were 
compared to the highest (185 µg/ml) concentrations. When analysed further, repeated measure ANOVA 
showed a significant trend from the control to 185 µg/ml (repeated measure ANOVA: asthenozoospermic 
P=0.0002 and normozoospermic P=0.002). 
 
3.3.4 Effect of aqueous root extract of M. whitei on the percentage of ROS-positive sperm 
 
Treatment of sperm with increasing concentrations of M. whitei showed a significant positive trend towards 
higher values by means of repeated measure ANOVA (asthenozoospermic: P=0.011 and 
normozoospermic: P=0.015) for the percentage of ROS-positive sperm in both groups (Figure 52), but with 
one-way ANOVA no change could be observed (asthenozoospermic: P=0.091 and normozoospermic: 
P=0.1784). More so, there was a dose-dependent increase in the percentage of ROS-positive sperm from 
the control to the highest concentrations (185 µg/ml) in the asthenozoospermic (P=0.0050) as well as the 
normozoospermic group (P=0.0251). 
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Figure 50: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of vitality of washed spermatozoa in vitro. Yellow represents: asthenozoospermic (progressive 
motility<32% or total motility<40%) group (n=20); Blue: normozoospermic (progressive motility>32% or 
total motility>40%) group (n=28). No dose-dependent effect (one-way ANOVA: asthenozoospermic 
P=0.983 and normozoospermic: P=0.596) nor trend (repeated measure ANOVA: asthenozoospermic 
P=0.601 and normozoospermic P=0.076) is seen in both groups.  
 
 
3.3.5 Effect of aqueous root extract of M. whitei in the percentage of DNA-fragmentation 
There was no effect of the extract on the percentage of DNA-fragmented sperm in both groups (one-way 
ANOVA: asthenozoospermic P=0.725 and normozoospermic P=0.764; repeated measure ANOVA: 
asthenozoospermic: P=0.297 and normozoospermic: P=0.435) (Figure 53).   
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Figure 51: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of washed spermatozoa with intact-MMP in vitro. Yellow represents: asthenozoospermic 
(progressive motility<32% or total motility<40%) group (n=20); Blue: normozoospermic (progressive 
motility>32% or total motility>40%) group (n=28). Values shown as mean±SEM. A highly significant 
dose-dependent increase (one-way ANOVA: asthenozoospermia P=0.0004 and normozoospermia 
P=0.031) and trend (repeated measure ANOVA: asthenozoospermia P=0.0002 and normozoospermia 
P=0.002) is seen in both groups. 
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Figure 52: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of ROS-positive washed spermatozoa in vitro. Yellow represents: asthenozoospermic 
(progressive motility<32% or total motility<40%) group (n=20); Blue: normozoospermic (progressive 
motility>32% or total motility>40%) group (n=28). Values shown as mean±SEM. A significant trend 
(repeated measure ANOVA: asthenozoospermic P=0.011 and normozoospermic P=0.015), but no change 
(one-way ANOVA: asthenozoospermic: P=0.091 and normozoospermic: P=0.1784) in the percentage of 
ROS-positive sperm is seen in both groups (Figure 38).  More so, there is an increase in the percentage of 
ROS-positive sperm from the control to the highest concentrations (185 µg/ml) in the asthenozoospermic 
(P=0.0050) group as well as the normozoospermic (P=0.0251). 
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Figure 53: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of DNA fragmentation of washed spermatozoa in vitro. Yellow represents: asthenozoospermic 
(progressive motility<32% or total motility<40%) group (n=20); Blue: normozoospermic (progressive 
motility>32% or total motility>40%) group (n=28).  Values shown as mean±SEM. There is no dose-
dependent effect in the percentage of DNA fragmented sperm in both groups (one-way ANOVA: 
asthenozoospermic P=0.725 and normozoospermic P=0.764) nor trend (repeated measure ANOVA: 
asthenozoospermic: P=0.297 and normozoospermic: P=0.435).   
 
 
3.3.6 Effect of M. whitei on sperm capacitation and acrosome reaction in asthenozoospermic and 
normozoospermic samples 
The chlortetracycline fluorescence (CTC) assay (Table 16) revealed no changes in the percentage of 
capacitated and capacitated, acrosome-reacted spermatozoa in both groups (asthenozoospermic and 
normozoospermic) after exposure to increasing concentrations of the M. whitei root extract; no trend could 
be determined on capacitation (repeated measure ANOVA: asthenozoospermia: P=0.129 and 
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normozoospermia: P=0.370) and the percentage of capacitated acrosome-reacted sperm (repeated measure 
ANOVA (asthenozoospermia: P=0.898 and normozoospermia: P=0.731) (Figure 54 and 55). Similarly, 
one-way ANOVA revealed no effect on capacitated (asthenozoospermia: P=0.757 and normozoospermia: 
P=0.806) and capacitated, acrosome-reacted sperm (asthenozoospermia: P=0.548 and normozoospermia: 
P=0.856) in both groups.  
 
Table 14: Summary statistics of the sperm capacitation and acrosome reaction in asthenozoospermic sperm 
samples as detected by CTC stain after 1 hour incubation with increasing concentrations of M. whitei root 
extract. 
 
 
 
 
 
 
Concentration 
(µg/ml) 
Capacitated (%) Capacitated acrosome reacted sperm 
(%) 
Asthenozoospermia Normozoospermia Asthenozoospermia Normozoospermia 
Control 47.69±18.97 63.87±21.55 15.93±9.12 20.30±10.16 
0.0185 50.19±18.47 65.78±19.28 16.38±11.09 22.68±11.36 
0.185 49.75±15.19 62.78±19.35 15.31±5.79 20.07±8.89 
1.85 53.50±18.49 65.63±20.02 15.81±10.44 19.66±10.10 
18.5 54.69±18.83 65.67±19.43 14.56±7.78 20.30±9.81 
185 56.25±23.57 68.20±21.34 15.81±11.06 20.34±9.50 
One-way 
ANOVA P-
value 
0.699 0.885 0.263 0.786 
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Figure 54: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of capacitated washed spermatozoa in vitro. Yellow represents: asthenozoospermic 
(progressive motility<32% or total motility<40%) group (n=20); Blue: normozoospermic (progressive 
motility>32% or total motility >40%) group (n=28). Values shown as mean±SEM. No trend (repeated 
measure ANOVA: asthenozoospermia P=0.129 and normozoospermia P=0.370) nor dose-dependent 
change (one-way ANOVA: asthenozoospermia P=0.757 and normozoospermia P=0.432) is seen in both 
groups.  
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Figure 55: Effect of different concentrations of M. whitei (0.0185, 0.185, 1.85, 18.5 and 185 μg/ml) on the 
percentage of capacitated acrosome-reacted spermatozoa in vitro. Yellow represents: oligozoospermic 
(progressive motility<32% or total motility<40%) group (n=20); Blue: normozoospermic (progressive 
motility>32% or total motility>40%) group (n=28).  Values shown as mean±SEM.  No dose-dependent 
effect (one-way analysis: asthenozoospermia: P=0.548 and normozoospermia: P=0.806) nor trend 
(repeated measure ANOVA: asthenozoospermia: P=0.898 and normozoospermia: P=0.731) is seen in both 
groups. 
 
 
 
 
3.3.7 Correlations of various sperm parameters within the asthenozoospermic and 
normozoospermic group 
As expected, total motility strongly and significantly positively correlated with hyperactivation (r=0.671; 
P<0.0001) and progressive motility (r=0.733; P<0.0001) in the asthenozoospermic group as well as 
normozoospermic group (hyperactivation: r=0.464; P<0.0001; progressive motility (r=0.685; P<0.0001) 
(Table 15). 
 
 
 
 
111 
  
 
Table 15: Correlation of total motility with sperm functional parameters.  
PARAMETERS Asthenozoospermia Normozoospermia 
r P r P 
Hyperactivation (%) 0.671 <0.0001 0.464 <0.0001 
Progressive motility (%) 0.733 <0.0001 0.685 <0.0001 
Intact-MMP (%) 0.018 0.0399 0.086 0.0666 
Capacitated, acrosome- 
reacted (%) 
0.146 0.3675 0.487 0.5372 
 
 
 
The percentage of ROS-positive sperm weakly but significantly positively correlated with the percentage 
of intact-MMP sperm (r=0.172, P=0.0260) in the asthenozoospermic subjects as well as normozoospermic 
(r=0.017, P=0.0460). Contrary, the percentage of ROS-positive spermatozoa weakly but significantly 
negatively correlated with the percentage of TUNEL-positive sperm (r=-0.034, P=0.0073) in the 
asthenozoospermic subjects (figure 16). However, there was no statistical significant relationship between 
the percentage of ROS-positive and capacitated, acrosome-reacted sperm in both groups. In addition, the 
percentage of spermatozoa with intact MMP had no relationship with percentage ROS-positive sperm in 
the normozoospermic subjects, neither did the percentage of TUNEL-positive sperm have a relationship 
with percentage ROS-positive sperm in the asthenozoospermic group. 
 
Table 16: Correlation of the percentage of ROS-positive sperm with sperm functional parameters  
PARAMETERS Asthenozoospermia Normozoospermia 
r P r P 
Intact-MMP (%) 0.172 0.0260 0.017 0.0460 
TUNEL (%) -0.034 0.0073 0.206 0.7431 
Capacitated, acrosome- 
reacted (%) 
0.001 0.9997 0.032 0.6861 
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Table 17 portrays the relationship between hyperactivated spermatozoa, the percentage of progressive 
motility of spermatozoa and the percentage of sperm with intact MMP. A strong significant positive 
relationship was observed between hyperactivated spermatozoa and progressive motility from both 
groups (asthenozoospermic: r=0.513; P<0.0001 and normozoospermic: r=0.502, P<0.0001). Also, 
there was a weak significant (r=0.321; P=0.0006) relationship between the percentage of 
hyperactivated spermatozoa and the percentage of intact-MMP sperm in the asthenozoospermic 
subjects. Yet, there was no relationship in the normozoospermic subjects. 
 
Table 17: Correlation of the percentage of hyperactivated sperm with sperm functional parameters  
PARAMETERS Asthenozoospermia Normozoospermia 
r P r P 
Progressive motility (%) 0.678 <0.0001 0.626 <0.0001 
Intact-MMP (%) 0.321 0.0006 0.056 0.3830 
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CHAPTER 4: DISCUSSION 
Reproductive health care has been regarded as one of the most prevalent problems on the African 
continent (Kamatenesi-Mugisha and Oryem-Origa, 2005). With increasing awareness of its detrimental 
effects, studies have recorded high prevalence rates of male infertility of up to 20-40% in certain 
regions of Africa labelled as `Infertility belt’, which is a stretch across sub-Saharan Africa (Cates et 
al., 1985; Leke et al., 1993; Larsen et al., 2000; Dyer et al., 2004). A multitude of causes (Walczak-
Jedrzejowska et al., 2013) render infertility difficult for a rational treatment plan.  In addition, poorly 
defined pathological processes complicate the diagnosis and treatment even further (Howards, 1995). 
Due to traditional beliefs and economic reasons, many South Africans have resorted to using traditional 
medicines for the treatment of a range of health problems, especially where Western Medicine has 
fallen short (Digby, 2014). 
Traditional Medicine is termed as the oldest and possibly the most popular therapeutic system 
(Mahomoodally, 2013), and has been regarded as a growing industry in South Africa. Herbal medicines 
contribute an estimated R 29 billion to the South African national economy with an equivalent of 27 
million consumers, with the traditional healers being a driving force in this market (Mander et al., 
2007; Moeng and Potgieter, 2011). In order to ensure the safety, efficacy and quality of the treatment 
rendered, the Traditional Health Care Service in South Africa is regulated by the Traditional Health 
Practitioner Act No. 22 of 2007 (Pefile, 2005).   
As a result of growing interest in traditional medicine, there has been a number of local and 
international initiatives which undertake to explore the botanical resources of South Africa with the 
aim of screening indigenous plants for pharmacologically active compounds (Rybicki et al., 2012).  
For example, the South African Department of Health through the National Reference Centre of Health 
for African Traditional Medicine, in conjunction with Council for Scientific Research and Medicine 
Control Council are involved in various research programs aimed at developing new medicines by 
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analysing medicinal plants (Ngcobo et al., 2012). Furthermore, studies are centred on new plausible 
biologic technologies like phytochemical analysis, microarray methodology, metabolomic assessment 
and pharmacogenesis of these plants (Firenzuoli and Gori, 2007). In a previous study, Gericke (2011) 
agreed that significant research and development opportunities exist to discover novel and useful 
biological activities for South African medicinal plants. For that reason, South African research 
institutions focus more on phyto-pharmacological studies using indigenous plants with the aim to 
discovery a novel phyto-products for new markets (Hughes and Mbamalu, 2015). 
According to De Smet (1997), approximately 25% of modern medicines or their active ingredients are 
derived from higher plants. Farnsworth and Soejarto (1985) indicated that 95 plants species have been 
listed as the source of 121 clinically useful prescriptions derived from medicinal plants. 
Phytochemicals found in these indigenous medicinal plants act individually, catalytically as well as 
synergistically; providing stability from the combined effect that is more beneficial than individual 
constituents in terms of improving health (Mahomoodally, 2013). Moreover, in conventional medicine, 
these active phytochemicals from medicinal plants are extremely purified and the standardized forms 
are used directly as drugs or therapeutic agents, as starting material for synthesis of new drugs or as a 
tool for drug development and testing (Calixto, 2000). 
As a result of the renaissance in scientific exploration of medicinal plants with therapeutic actions 
(Vaidya, 2014), there has been an increasing  trend  in validating  traditional  medicine  claims  from  
scientific studies  especially  for  plants  which have been used to treat diseases (Brookes and Katsoulis, 
2006). A good example is M. whitei, a plant of the Apocynaceae family, which is indigenous to South, 
Central, East and West Africa. Its roots are used in the treatment of male infertility (Aremu et al., 
2011). 
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4.1 Previous studies on M. whitei 
4.1.1 Previous in vivo and in vitro studies on M. whitei root extract 
The primary medicinal use of M. whitei is based on the aphrodisiac properties of the extract and its use 
as a treatment for male infertility (Lampiao et al., 2008; Martey and He, 2010).  Besides, studies by 
Watcho et al. (2001) initially suggested that the aqueous root extract of M. whitei has contraceptive 
properties. This claim was based on the observed inhibition of spermatogenesis and reduced fertility 
in vivo. This research group further evaluated the in vivo androgenic activity of the same extract and 
found an increase in serum and intra-testicular testosterone levels after chronic exposure to M. whitei 
aqueous root extract (Watcho et al., 2004).  In 2006, Watcho et al. decided to use hexane, methylene 
chloride and methanol as solvent for the extraction of M. whitei roots and investigated the in vivo and 
in vitro androgenic activity and found that the methanolic extract had reversible androgenic effects and 
potentiated the actions of norepinephrine on the vas deferens in rats, while the hexane fraction had 
significant inhibitory effects against KCl-and adrenaline-induced contractions in isolated deferent 
ducts in vitro. Moreover, in 2007, Watcho et al. found that the extracts caused an increase in the number 
of intromissions and erectile frequencies of inexperienced male rats. From the above mentioned 
studies, it was deduced that the extract displays both contraceptive properties as well as properties 
associated with enhancing male fertility. 
In Ghana, the in vivo aphrodisiac activities of the ethanoic root extract of M. whitei was investigated 
(Quasie et al., 2010). The study showed not only an increase in cyclic guanosine monophosphate 
(cGMP), but also improved and sustained erection which was associated with the activation or 
stimulation of nitric oxide synthase (NOS) activity (Quasie et al., 2010).  These authors linked the 
mechanism of action to the phytochemicals found in the root extract which was presumed to either 
stimulate or activate NOS, which would result in the elevation of nitric oxide (NO) and cGMP and the 
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subsequent relaxation of vas the deferens and corpus cavernosum causing vasodilation which increased 
blood inflow into penile tissue resulting to erection (Quasie et al., 2010).  
The aphrodisiac effects of M. whitei have also been investigated in combination with Ekerbegia 
capensis (cape ash), Aloe exelsa (noble aloe) and Cucurbita pepo (pumpkin seed) (Gundidza et al., 
2009). Results showed a dose-dependent increase in sexual arousability (decreased mounting latency), 
copulatory efficiency (decreased intercoupulatory interval) and improved sexual sensation (increased 
in neuromotor activity) for the rats treated with M. whitei, E. capensis, Aloe exelsa and C. pepo seeds. 
The study displayed significant aphrodisiac properties with regards to sexual behaviour.  
In spite of Mondia whitei root extract being used in traditional medicine for the treatment of male 
infertility, there appears to be a lack of research/information on its effect on human spermatozoa. Only 
one in vitro study (Lampiao et al., 2008) investigated the effects of an aqueous extract of M. whitei on 
human sperm total and progressive motility as the only parameter. Therefore, this is the first study to 
shed light on the in vitro effects of aqueous root extract of Mondia on different aspects of human sperm 
functionality by the use of traditional-based therapeutic concentrations, hence, assisting in the 
validation of the safety and efficacy of the traditional use of Mondia. Since, scientific studies into the 
biological properties of the extract and its phytochemical analysis have shed light on the plant 
traditional usage to treat male infertility, yet various observable ambiguities exist.  
4.1.2 Phytochemical studies on M.  whitei root extract 
Mondia whitei belongs to the botanical family Apocynaceae, a plant family which generally contains 
a high loads of alkaloids (Bunel et al., 2014). Therefore, Bunel and colleagues hypothesized a 
possibility of presence of alkaloid in Mondia. These alkaloids were presumed to be responsible for the 
reported biological properties. Further investigation by these authors confirmed the presence of 
alkaloids known as 2-hydroxy-4-methoxybenzaldehyde (2H4MBZA) from Mondia root extract, which 
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was found to react with neurotransmitters to form adducts of dopamine γ-aminobutyric acid (GABA), 
norepinephrine and serotonin. These findings might give an explanation for the alleged aphrodisiac, 
tonic and anti-depression activities of the Mondia root extract (Bunel et al., 2014). An additional study 
indicated the 2H4MBZA alkaloid as a potent tyrosinase inhibitor (tyrosinase enzyme is responsible for 
melanin formation) (Batubara et al., 2010). The benzaldehyde group in 2H4MBZA was found to be a 
mixed type inhibitor for the oxidation of L-3-4-dihydroxyphenylalanine (L-DOPA) by forming Schiff 
base with primary amino group in the enzyme (Kubo and Kinst-Hori, 1999a). This could infer possible 
antioxidant properties from 2H4MBZA compound found in Mondia extract. 
Furthermore, Foreman and Wernicke (1990) found dopamine and norepinephrine to have been 
implicated in regulation of sexual function. Additionally, Shishkina et al. (2001) stated that 
norepinephrine transmission seem to have a positive effect on sexual function, and it has been generally 
accepted as the principle neurotransmitter to control penile flaccidity and detumescence (Foreman and 
Wernicke, 1990). However, serotonin (5-HT) receptors have been found to possess both facilitatory 
and inhibitory effects on sexual function depending on the receptor sub-type and location (Fernández-
Guasti et al., 1992; de Castilhos et al., 2006). On the other hand, dopaminergic neurons activation is 
secondary to nitric oxide synthase activation, which leads to the production of nitric oxide. In turn, 
nitric oxide activates oxytocinergic neurons in the paraventricular area which lead to the release of 
oxytocin in the extra-hypothalamic brain area and the spinal cord to induce erection (Melis and 
Argiolas, 1995).  
In contrast, GABA receptor stimulation may produce different outcomes (Argiolas and Melis, 2002). 
Depending on the brain areas in which they act, GABAA and GABAB stimulation may either cause 
excitatory or inhibitory effects on penile erection and yawning (Argiolas and Melis, 2002). To facilitate 
penile erection dopamine, acts on D1 or D2 receptors on GABA neurons within the central nervous 
system, whereby activation of D1 receptors initiates penile erection but decreases the number of 
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seminal emission while activation of D2 inhibits sexual activity by suppressing erection but then 
favouring seminal emission (Steers, 2002; Nutsch et al., 2016).  
In their previous study Watcho et al. (2012) found that two compounds (β-sitosterol and a mixture α- 
and β-amyrin acetate) in the hexane extract of Mondia significantly increased the mounting frequency, 
penile erection and ejaculatory latency of sexually naïve albino male rats. α-and β-amyrin acetate are 
triterpenes whereas β-sitosterol is a steroid compound. These compounds are thought to induce changes 
at the level of neurotransmission by modulating  neuro-transmitters on the target cells (Sertoli and 
Leydig cells) or by increasing androgen levels (Kumar et al., 2000) via binding to hormone receptors 
or enzymes that metabolize hormones in the intermediary steroidal pathway (Baker, 1995). Therefore, 
increasing testosterone, dihydrotestosterone and dehydroepiandrosterone (Gauthaman and Ganesan, 
2008).  Mondia root extract has been found to contain phenolic and flavonoid compounds (Bouba et 
al., 2010; Gakunga et al., 2013), as well as vitamin E (Sharma and Agarwal, 1996; Van Wyk, 2011), 
all of which possess radical scavenging activities (Moyo et al., 2010), hence, generally protecting 
spermatozoa from oxidative stress caused by free radicals which may lead to protein oxidation, DNA 
damage, and lipid peroxidation (Halliwell, 1996). 
4.2 Traditionally used concentration of root extract of M. whitei  
Generally, traditional healers will prescribe a handful of dried roots of M. whitei to prepare a 
concoction for treatment of patients. This study focused on the principle of traditional healers’ 
preparation to obtain an effective therapeutic concentrations of concoctions. Based on the assumption 
that an average man weights about 80kg, an average (14.80g) of three handful of M. whitei roots was 
obtained to establish the amount of aqueous root extract a patient would ingest per day. Thereafter, an 
effective therapeutic concentration of 1.85 µg/ml M. whitei aqueous root extract was calculated, and a 
stock solution containing 2000 µg/ml M. whitei in HTF-BSA was prepared. To account for both supra 
and hypo-physiological effects of the M. whitei root extract, a scale ranging from 0.0185-185 µg/ml 
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was used. Therefore, the concentrations used for the functional parameters of spermatozoa were 
considered to be in a tolerable range. Nonetheless, none of the previous studies attempted to take the 
prescribed therapeutic concentration used by the traditional healers into account, which could be a 
possible reason for conflicting results.  
4.3 Effect of aqueous root extract of M. whitei on sperm vitality 
Vitality is a reflection of the proportion of live, immotile, membrane-intact spermatozoa determined 
by the evaluation of cellular and membrane integrity (Björndahl et al., 2003; Klimowicz-Bodys et al., 
2012; Moskovtsev and Librach, 2013). In the present study, the valuation of sperm viability was used 
as factor to investigate possible cytotoxic effects of the aqueous root extract of M. whitei on human 
spermatozoa.  
Results from this study show that the extract had no significant direct toxic effect on sperm in all groups 
analysed (donor, patient, oligozoospermia, asthenozoospermia, and normozoospermia). Therefore, M. 
whitei extract does not show acute sperm cell cytotoxicity on human spermatozoa in vitro. Currently, 
there are no published studies that have investigated the effect of M. whitei on sperm cell vitality.  
However, other studies have indicated that plant extracts might either increase, have no effect or 
decrease cell viability depending on the plant’s chemical composition. For instance, plants containing 
antioxidants such as flavonoids and vitamins for example Vernonia amygdalina (Bitter leaf) have been 
found to possess modulating function therefore, they act to maintain sperm viability (Iwalewa et al., 
2005). On the other hand, certain alkaloids found in some plant extract have been implicated in reduced 
sperm viability. The postulated mechanism of action of such alkaloids involves releasing metabolites 
which bind to cell molecules and cross link DNA causing cytotoxicity (Saalu et al., 2010). 
Furthermore, analysis of in vitro effects of aqueous root extract of Astragulus membranaceus (Huảng 
qỉ) and Eleutherococcocus senticosus (Siberian ginseng) on human sperm were found to exhibit 
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significantly increased viability (Liu et al., 2004).  The hypothesized mechanism of action of 
Astragalus membranaceus could be attributed to the chemical composition which consists of 
isoflavonoids, saponins, triterpene glycosides, polysaccharides, amino acids and trace elements (Ma et 
al., 2002). Additionally,  the in vivo effect of these phytochemicals on type 1 and 2 diabetic rats have 
exhibited protection of pancreatic beta cells from autoimmune cell death, by immunomodulation of 
several inflammation and apoptotic cytokines, enzymes and proteins (Agyemang et al., 2013). 
Furthermore, the in vivo effects of flavonoids found in Astragalus have also been shown to poses 
antioxidant and cellular protection properties by exerting cellular antioxidant effects, scavenging free 
radicals, protection against lipid peroxidation hence protecting the cell against hypoxic challenges. 
Furthermore, the polysaccharides were linked to increase the protein synthesis and RNA activity in 
other tissues, equally, increase enzyme activities responsible for specific regulation of cellular 
metabolic activities (Agyemang et al., 2013). Therefore, it could be concluded that the combination of 
secondary metabolites found in Astragalus were not cytotoxic to spermatozoa but, might have acted 
synergistically to maintain sperm viability.  
Conversely, in vitro effect of aqueous root extract of Aconitum carmichaelli (Monkshood), Polyporus 
squamosus (Zhu ling) (Liu et al., 2004) and Cissampelos capensis (Dawidjies) (Shalaweh et al., 2015) 
were found to have no effect on sperm viability; whereas, in vitro effect of aqueous extract of Aegles 
mermelos (Bael) and Allium sativum (garlic) have been exhibited to decrease the vitality of ejaculated 
human spermatozoa (Remya et al., 2009). The proposed active ingredient in Allium is allitridum which 
might act by causing sperm membrane disintegration on human ejaculated spermatozoa (Ogbuewu et 
al., 2011). 
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4.4 Effect of aqueous root extract of M. whitei on sperm motility 
Sperm motility has been found to significantly correlate with fertilization (Kasai et al., 2002). 
Generally, it gives a measure of the integrity of the sperm axone and tail structure not forgetting the 
metabolic machinery of the mitochondria; rendering it as the best criterion to demonstrate the male 
fertilization capacity (Karpuz et al., 2007).  
An in vitro study performed by Lampiao et al. (2008) on the effects of aqueous root extract of M. whitei 
on human sperm total and progressive motility reported that Mondia signiﬁcantly enhanced total 
motility as well as progressive motility in a time-dependent manner. Hence, these authors concluded 
that the results from their study may open the way for the use of Mondia whitei especially in men 
affected with asthenozoospermia. However, the study design had some discrepancy making the 
conclusion questionable. Since, limited sperm functional parameters were investigated precisely total 
motility and progressive motility. In addition, the number of sperm donors used in this study was not 
stated and the rationale behind the usage of concentration ranges of 5, 10, 20 and 50 µL/mL was not 
substantiated, clearly the traditional therapeutic concentration was not taken into consideration. Taking 
everything into account, the results exhibited an increase in sperm motility after two hours incubation 
when the controls were compared to some of the concentration, there was no significant differences in 
total motility as well as progressive motility among the Mondia whitei treated groups at all time points.  
In the recent study, treatment of sperm with aqueous root extract of M. whitei significantly increased 
total (P<0.0001) and progressive motility (P=0.0002) in patients’ spermatozoa with a positive trend 
towards higher percentages of total motile spermatozoa (ANOVA trend analysis: P=0.0001) and 
progressive motile spermatozoa (ANOVA trend analysis: P=0.0068) at higher concentrations of 
Mondia.  The donor (normozoospermic) group showed a slight increase in total motility (ANOVA 
trend analysis: P=0.144) as well as progressive motility (ANOVA trend analysis: P=0.3618). However, 
this did not reach statistical significance. Moreover, it can be deduced that aqueous root extract of 
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Mondia showed physiological effects on total and progressive motility especially in the patient group. 
However, the question arises whether these physiological effects can have a biological impact since 
there is an increase of about 25 % of the total motile sperm from the control to the highest concentration 
(185 µg/ml) in patients. The same question applies to the results obtained from the study conducted by 
Lampiao et al. (2008), which renders the conclusion obtained from their study stating that Mondia 
whitei significantly enhanced total motility as well as progressive motility in a time-dependent manner 
questionable.  
Furthermore, various study on plant extracts have shown different outcome on sperm motility which 
is said to be predominately dependent on energy produced from the mitochondrial compartment of the 
sperm mid-piece (Ruiz-Pesini et al., 1998). For instance, different concentration of aqueous root extract 
of Cissampelos capensis (dawidjies) exhibited no effect on the sperm total and progressive motility. 
However, hyperactivation and beat across frequency increased with increase in concentration 
(Shalaweh et al., 2015). In a similar study, treatment of sperm with aqueous extract of Erycoma 
longifolia (Tongkat ali) showed a significant dose-dependent trend in total motility (Erasmus et al., 
2012) a property which has been attributed to its phytochemical which includes; alkaloids, quassinoids, 
quassinoid diterpenoids, eurycomoside, eurycolactone and laurycolactone. Additionally, a different 
study also revealed that polyphenol-rich grape pomace extract maintained the percentage of total and 
progressive motility of spermatozoa compared to the control after 2 hours of sperm incubation. The 
proposed mechanism of action was attributed to the polyphenol-rich grape pomace extract free radicals 
scavenging capacity, rendering protection to spermatozoa from lipid peroxidation which leads to loss 
of motility (Harat et al., 2008).  
Other investigations have revealed spermicidal properties of plant extract since they led to reduced 
human sperm motility like Azadirachta indica (Neem) (Khillare and Shrivastav, 2003), Carica papaya 
(Paw paw) (Lohiya et al., 2000), Ruta gravoelens (Rue) (Harat et al., 2008). In addition, a study by 
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Nath and colleagues (2013) revealed that highest (300mg/mL) concentration of Ricinus communis 
(Castor oil) extract led to 100% reduction in rapid progressive motility within 60 seconds and 100% 
immotility within 30 minutes of incubation. The spermicidal capacity of castor oil is attributed to 
ricinoleic acid which has been revealed as major compound in this plant (Raji et al., 2006). 
Nonetheless, former studies have stated that as much as sperm motility provides useful information for 
diagnosing male infertility, it cannot be used in isolation as diagnostic parameter of infertility (Guzick 
et al., 2001) since numerous additional characteristics of spermatozoa are required to ensure successful 
fertilization with an oocyte (Aitken and Baker, 2006). These parameters include oxidation-antioxidant 
balance (Henkel, 2005), capacitation and acrosome reaction (Aitken, 2006), normal sperm 
mitochondrial membrane function (Marchetti et al., 2002) and DNA integrity of the sperm (Henkel et 
al., 2010).  
4.5 Effect of aqueous root extract of M. whitei on intact-mitochondrial membrane potential of 
the sperm 
Mitochondrial membrane potential is the parameter that best indicates mitochondrial function and is a 
reflection of mitochondrial energy production in form of adenosine triphosphate (ATP) (Donnelly et 
al., 2000). ATP can either be produced through oxidative phosphorylation which takes place in the 
mitochondria’s intermediate tract or through glycolysis which occurs in the main tract (Piomboni et 
al., 2012). However, ATP production is termed to be more efficient in mitochondrial respiration than 
in glycolysis (Turner, 2003). The chemical energy (ATP) produced through both aerobic and anaerobic 
respiration can be used for sustaining sperm motility (Turner, 2003). Espinoza et al. (2009) termed 
mitochondrial membrane integrity to be a reflection of sperm quality, thus, rendering its evaluation 
highly recommendable to complement routine sperm analysis.  
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Besides, Paoli et al. (2011) suggested that sperm motility is dependent on the functional integrity of 
the mitochondria. This was well reflected in their study whereby the sperm total motility was positively 
correlated to intact sperm mitochondrial membrane potential. Furthermore, this relationship was 
confirmed in the current study, in which there was a significant positive association (r=0.2452; 
P<0.0009) between total motile and spermatozoa with intact MMP in the patient group. Further 
analysis of the patients sub-group that is oligozoospermic (r=0.343; P<0.0002) and asthenozoospermic 
(r=0.018; P<0.0399), also showed significant positive association. These findings support early results 
where there was improved sperm motility, and the MMP findings which revealed maintained MMP in 
the patient group and the subsequent sub-groups (oligozoospermic and asthenozoospermic). The 
improved percentage of sperm motility in relation to the percentage of intact MMP could be attributed 
to the maintained mitochondrial membrane potential, thus, enabling the breaking down of the reducing 
sugars (Quasie et al., 2010) found in M. whitei root extract through oxidative phosphorylation and 
glycolysis, hence, providing ATP energy fundamental in rendering the sperm motile since it assists in 
flagella movement (Troiano et al., 1998). 
Most importantly, mitochondrial membrane potential has been termed as the most sensitive test of 
determining sperm quality (Marchetti et al., 2002) not forgetting its alteration has been associated with 
male infertility (Bourgeron, 2000). In the present study, further observation on the effect of M. whitei 
root extract on MMP showed that there was maintained mitochondrial membrane potential state of 
spermatozoa across all groups: one-way ANOVA analysis: donor (P=0.0007), patient (P<0.0001), 
oligozoospermic (P=0.0001), asthenozoospemic (P=0.0004) and normozoospermic (P=0.0007) in a 
dose-dependent manner. Therefore, the extract did not have a negative effect on the mitochondria 
hence, the mitochondrial membrane permeability and function was not altered. These observations 
may imply that Mondia does not contain cytotoxic compounds that may impair the mitochondrial 
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membrane nor cause any disruption to the mitochondria and supports the observation that the extract 
has no effect on viability. 
Additionally, a study by Rossato et al. (2005) which evaluated the effect of cannabinoids and 
endocannabinoids components of Cannabis sativa (Marijuana) on mitochondrial function in human 
sperm, revealed that these compounds inhibited sperm mitochondrial activities in a dose-dependent 
manner. Hypothetically, cannabinoids are thought to interfere with mitochondrial electron transport 
which could be via depletion of NADH as well as interference with mitochondrial permeability 
transition pore complex. Similarly, in vitro effect of extract of Typha capensis (bulrush) was found to 
decrease mitochondrial membrane potential of spermatozoa (Henkel et al., 2009). On the other hand, 
aqueous extract of medicinal plants like Ruta graveolus (Rue) have been found to immobilize sperm 
motility without impairing sperm  mitochondrial membrane potential and viability (Harat et al., 2008). 
Furthermore, Propolis (different plant products collected by bees) which can be described as bee glue 
containing complex chemical composition mainly flavonoids, was found to enhance the activity of 
mitochondrial respiratory complexes II and IV. However, the mechanism of action did not affect the 
coupling of the electron transport to ATP synthesis and mitochondrial membrane potential in 
permeabilized human spermatozoa in vitro (Cedikova et al., 2014). Whereas Ginsenoside plant-derived 
glycoside from Panax ginseng, has been shown to maintain mitochondrial membrane potential by 
preventing lipopolysaccharide stimulated cytokine production, sepsis and inflammation (Shen et al., 
2007). Also, it has been reported to have anti-apoptotic and antioxidant properties (Hwang and Kim, 
2013). 
4.6 Effect of aqueous root extract of M. whitei on sperm DNA-fragmentation 
Precise transmission of the paternal genomic information has been credited to sperm DNA integrity 
which has been identified to play a major role in male fertility as elevated sperm DNA fragmentation 
has been linked to reduced fertility levels (Hamamah et al., 1997; Agarwal and Said, 2003; Henkel et 
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al., 2004; Shamsi et al., 2011; Robinson et al., 2012). Additionally, spermatozoa from fertile men have 
been found to have less DNA fragmentation than those from infertile men (Zini and Libman, 2006).  
The present study has no prior outcomes on DNA fragmentation on Mondia extract treated 
spermatozoa. On the whole, the results showed a trend (ANOVA trend analysis: P=0.004) towards a 
lower percentage of DNA-fragmented spermatozoa with increasing M. whitei extract concentration, 
especially in the patient, oligozoospermic and asthenozoospermic group (ANOVA trend analysis: 
patient, P=0.004; oligozoospermic, P=0.005, asthenozoospermic, P=0.0295). However, no significant 
effect was seen in the donor (normozoosermic) group. It may be hypothesized that washing of 
spermatozoa leads to the removal of seminal plasma which in turn gets rid of enzymes such as catalase 
and superoxide dismutases which scavenge for ROS (Shekarriz et al., 1995). Besides centrifugation 
increasing ROS generation in the already compromised patients’ sperm. However, introduction of 
antioxidants from Mondia (phenols, flavonoids, Zinc and vitamin E) might have scavenged free 
radicals (Rahman, 2007) resulting in maintained DNA status of the spermatozoa. 
Further analysis of the results in this study showed an inverse relationship between the percentage of 
sperm with DNA-fragmentation and percentage of ROS-positive spermatozoa in the patient (r=-
0.3096; P<0.0001), oligozoospermic (r=-0.243; P=0.0091) and asthenozoospermic group (r=-0.034; 
P=0.0073). These results led to the hypothesis that the antioxidants (phenols, flavonoids, 2-hydroxy-
4-methoxybenzaldehyde, vitamin E and zinc) found in Mondia extract could have acted by regulating 
the production of reactive oxygen species (ROS) hence, preventing oxidative stress (OS) since, 
antioxidants have previously been shown to decrease oxidative stress by directly scavenging ROS or 
by inhibiting cell proliferation secondary to the protein synthesis (Lobo et al., 2010).  
Nevertheless, the imbalance of free radicals from excessive production of ROS and limited antioxidant 
defense results in OS (Doshi et al., 2012), which leads to sperm membrane and DNA damage (Agarwal 
 
 
 
 
127 
 
et al., 2006). Ordinarily, both enzymatic and non-enzymatic antioxidants scavenge free radical species 
and protect the body from over-exposure to oxidative stress (Doshi et al., 2012). In this case, Mondia 
roots have been found to contain non-enzymatic antioxidant such as phenols, flavonoids and vitamin 
E (Gopalakrishnan and Starlin, 2013). According to Moyo et al. (2010) secondary metabolites of 
phenolic and flavonoid compounds have been attributed for their antioxidant activities.  
In addition, Bouba et al. (2010) reported anti-oxidant activity by assessing the high hydroxyl radical 
scavenging activity as a result of in vivo detection of phenolics, flavonoids and tannins. The roots also 
contain vitamins A, D, K, E and trace elements such as zinc, iron and calcium (Van Wyk, 2011). 
Vitamin E refers to a set of eight related tocopherols and tocotrienols fat soluble vitamins possessing 
antioxidant properties (Herrera and Barbas, 2001). This set of vitamins especially α-tocopherols, which 
is the most bioavailable vitamin E, protects membranes from oxidation by reacting with lipid radicals 
in a lipid chain peroxidation reaction hence, removing free radicals intermediates bringing the 
propagated reaction to an end (Brigelius-Flohe and Traber, 1999). Likewise, Lector (1996) found that 
vitamin E acts by protecting the spermatozoa against endogenous oxidative DNA and membrane 
damage, though, this vitamin is said to have minimal effects in improving the post-thaw sperm 
parameters (Lector, 1996). However, addition of vitamin E to cryoprotectants benefited post-thaw 
measurements such as motility and improved membrane integrity of bovine spermatozoa (Uysal et al., 
2007). Besides, numerous studies have suggested that vitamin E supplementation can provide 
protection against sperm DNA damage (Lopes et al., 1998a; Russo, 2006). On the other hand, zinc and 
2-hydroxy-4-methoxybenzaldehyde are an antioxidant that may regulate ROS production (Wang et al., 
2003; Balasundaram et al., 2014).  
Erasmus et al. (2012) showed that the extract of Eurycoma longifolia (Tongkat ali) containing 
alkaloids, quassinoids, quassinoid diterpenoids, eurycomoside, eurycolactone and laurycolactone did 
not have deleterious effect on sperm DNA integrity. Whereas, extract of Cissampelos capensis 
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(dawidjie) consisting of alkaloids such as bisbenzyltetrahydroisoquino group were reported to have led 
to DNA fragmentation of spermatozoa (Shalaweh et al., 2015). Additionally, other antioxidants may 
act by reducing lipid derived free-radicals with detrimental effects on sperm lipid peroxidation (Sharma 
and Agarwal, 1996). Therefore, it can be hypothesized that antioxidants found in the root extract of 
Mondia might have helped in the maintenance of DNA integrity of spermatozoa in the present study. 
4.7 Effect of aqueous root extract of M. whitei on intrinsic reactive oxygen species production 
As much as elevated amounts of reactive oxygen species (ROS) play an important role in the 
pathophysiology of sperm dysfunction (Aitken et al., 1998; Agarwal and Said, 2003), including 
impairment to the normal spermatozoa by inducing lipid peroxidation and DNA damage. Decreased 
(physiological) level have been found to be beneficial to spermatozoa (Agarwal and Said, 2003; 
Henkel, 2005; Aitken and Baker, 2006).   For instance, preceding studies have shown that low levels 
of ROS production are essential and beneficial to normal sperm function like stimulation of sperm 
capacitation (O'Flaherty et al., 2006), enhancement zona pellucida binding (Aitken et al., 1989b; de 
Lamirande and Cagnon, 1993) and promotion of acrosome reaction and hyperactivation (de Lamirande 
and O’Flaherty, 2008).  
Nevertheless, ROS can be produced either by intrinsic factors such as spermatozoa themselves or 
extrinsic sources such as leukocytes (Agarwal and Said, 2003; Henkel, 2005). Whereas spermatozoa 
have been shown to produce minor sources of ROS, leukocytes almost present in every ejaculate are 
the predominant derivatives of ROS. In the present study, dihydroethidium (DHE), which reacts with 
intracellular superoxide was used in the detection of ROS (de Lamirande et al., 1997a; Loft et al., 2003; 
Henkel, 2005; Aitken and Baker, 2006; Mupfiga et al., 2013; Shalaweh et al., 2015).  
When investigating the effect of M. whitei extract on ROS production, the patient and combined group 
showed a higher tendency towards percentage of ROS-positive spermatozoa at higher concentrations 
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(repeated measure ANOVA: patients: P=0.005; combined: P=0.0015). Further analysis of the patient 
group revealed a significant trend in both groups (repeated measure ANOVA: oligozoospermic: 
P=0.001; asthenozoospermic: P=0.001). However, there was no change in the normozoospermic group 
(repeated measure ANOVA: P=0.661). Previous studies have demonstrated that ROS production by 
spermatozoa of oligozoospermic and asthenozoopermic patients is greater than that generated by 
spermatozoa of fertile donors (Aitken et al., 1998; Venkatesh et al., 2009), as sperm from patients 
exhibit defective sperm function which was associated with generating increased level of ROS (Aitken 
and Baker, 2013). 
Currently, there are no studies that investigated the effect of M. whitei on intrinsic ROS production. 
The percentage of ROS-positive spermatozoa significantly and negatively correlated with the 
percentage of DNA-fragmented spermatozoa in the patient (r=-0.3096; P<0.0001), oligozoospermic 
(r=-0.243; P=0.0091) and asthenozoospermic (r=-0.034; P=0.0073) group as opposed to the donors 
(r=0.2023; P=0.0063). These results show that Mondia extract might have prevented the production of 
intrinsic ROS which have been found to positively correlate with DNA fragmentation (Henkel, 2005). 
According to Wang et al. (2003), excessive ROS production is a possible inducer of apoptosis in human 
sperm; a process characterised by DNA fragmentation. Additionally, increased free radicals cause 
oxidative stress which leads to activation of apoptosis that results from induced cytochrome c and 
caspaces 9 and 3. Hence, reducing the high frequency of single- and double stranded DNA break in 
spermatozoa (Aitken and Koppers, 2011). 
Excessive ROS disrupt both, the inner and outer mitochondrial membrane, which results in release of 
cytochrome c, a protein which activates caspases and induces apoptosis. Basically, the exposure of 
ROS to mitochondrial releases apoptosis-inducing factor, interacts with DNA directly and leads to 
DNA fragmentation (Zeitoun and Al-Damegh, 2014). Non-enzymatic antioxidants found in Mondia 
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whitei (phenolic, flavonoids, vitamin E, 2-hydroxy-4-methoxybenzaldehyde alkaloid and zinc) might 
have prevented oxidative stress by scavenging free radicals, thus, maintenance of DNA integrity. 
According to Degảspari and Waszczynskyj (2004), phenolic and flavonoid compounds exert 
antioxidants role due to their oxidoreduction properties, hence, neutralize ROS. Other studies have 
demonstrated that flavonoids scavenge free radicals such as 1,1-diphenyl-2-picrylhydrazyl (.DPPH), 
2,2’-Azino-bis (3-ethyl-benzthiazoline-sulphonic acid) (ABTS·), superoxide (.O2
-), (.OH) and peroxyl 
(LOO.) radicals (Siddhuraju and Becker, 2003; Stagos et al., 2007). 
Previous studied have reported vitamin E as a primary membrane protector in spermatozoa (Yousef et 
al., 2003) and is believed to be the initial defence mechanism against the peroxidation of 
polyunsaturated fatty acids (Liebler, 1993). Furthermore, studies have reported the ability of enzymatic 
antioxidants like vitamin E, to reduce ROS production (Foote, 1967; Bascetta et al., 1983; O'Flaherty 
et al., 1997). Hence, leading to the hypothesis that phytochemicals found in the root extract M. whitei 
inhibit the action of sperm intrinsic superoxide production that leads to DNA fragmentation and does 
not increase ROS by causing oxidative stress at therapeutic concentration (1.85µg/ml).  
The scavenging ability of antioxidants helps neutralize the deleterious effects of free radical production 
(Askari et al., 1994; Dalvit et al., 1998; Bansal and Bilaspuri, 2010) due to their ability of eliminating 
oxidative stress (Miller et al., 1993; Kumar and Mahmood, 2001). In addition, enzymatic antioxidants 
such as superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and the glutathione 
peroxidase/ reductase system maintain the scavenging activities in the gonads and seminal fluid 
(Alvarez et al., 1987; Aprioku, 2013).  
In order to create a healthy environment for fertilization, a proper balance referred to as oxidative stress 
status (OSS) between ROS generation and scavenging activities as well as the right timing for ROS 
production has to be maintained (Maneesh and Jayalekshmi, 2006; Cocuzza et al., 2007). Furthermore, 
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maintaining the balance between physiological generation of ROS in the spermatozoa and scavenging 
activities, as well as, their surrounding environment is of utmost importance (de Lamirande et al., 
1997a).  Physiological amounts of ROS are necessary for initiating capacitation (O'Flaherty et al., 
1999), acrosome reaction (Villegas et al., 2003), hyperactivation of sperm motility (de Lamirande and 
Cagnon, 1993) and binding to zona pellucida and fusion with the oocyte (Sicherle et al., 2011). 
Contrary, excessive amounts of ROS have pathological effects on spermatozoa ranging from declined 
motility (Iwasaki and Gagnon, 1992), reduced sperm concentration (Aitken et al., 1991), sperm nuclear 
DNA damage (Twigg et al., 1998b) and apoptosis, hence, reduced fertilization (Sakkas et al., 1999). 
As part of their physiological function mature spermatozoa are frequently exposed to ROS (either 
produced by the spermatozoa themselves or by seminal leukocytes) which causes oxidation. On the 
other hand, these sperm are also exposed to reductive status as a protection mechanism from 
antioxidants. Therefore, an equilibrium in oxidative status is paramount for normal physiological 
function of the spermatozoa (Henkel, 2011). Excess ROS production leads to oxidative stress (OS) 
which is an imbalance between oxidation and reduction. Therefore, limiting the proper functioning of 
mammalian spermatozoa by causing lipid peroxidation, formation of protein adducts and induction of 
oxidative DNA damage (Aitken et al., 2012). Though, a certain concentration of ROS is needed to 
trigger vital physiological reaction necessary in regulating hyperactivation and the ability of a 
spermatozoa to undergo acrosome reaction (Aitken et al., 2012). Then again, excessive antioxidants in 
the reproductive system results to reductive status which is not physiological and may induce cancer, 
rendering the treatment of patient with antioxidant debatable. Furthermore, there are no precise values 
of amount of oxidants or antioxidants to state when the redox equilibrium is reached. This dilemma is 
known as the oxidative paradox. For this reason, patients’ semen should be analysed for ROS level and 
antioxidants capacity to ensure the fine balance between oxidants and antioxidants is maintained 
(Henkel, 2011). 
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4.8 Effect of aqueous root extract of M. whitei extract on capacitation, hyperactivation and 
acrosome reaction 
Capacitation refers to the physiological changes spermatozoa must undergo in order to be able to 
penetrate and fertilize an egg (Overstreet and Bedford, 1974). Therefore, capacitation is the 
prerequisite for normal acrosome reaction (Yanagimachi, 1994) for sperm to penetrate the zona 
pellucida (Koehler et al., 1982). Acrosome reaction has been directly related to the fertility rates in 
males since only acrosome-reacted spermatozoa can penetrate the zona pellucida (Koehler et al., 1982).  
Presently, there are no studies that investigated the effect of M. whitei on sperm capacitation and 
acrosome reaction. Though, in the current study, treatment of the sperm with the aqueous root extract 
of M. whitei did not result in any significant change nor trend in the percentage of capacitated 
spermatozoa and capacitated, acrosome-reacted cells across all groups as determined by the CTC stain. 
Since, the aqueous root extract of M. whitei does not trigger intrinsic superoxide production, 
capacitation is not triggered.  Physiological ROS production is beneficial and essential to normal sperm 
function like stimulation of sperm capacitation, promote acrosome reaction and hyperactivation and 
enhances zona pellucida binding (Aitken et al., 1989a; de Lamirande and Cagnon, 1993; O'Flaherty et 
al., 2006; de Lamirande and O’Flaherty, 2008).  
Nevertheless, sperm acquisition of fertilization ability depends on low and controlled concentration of 
ROS (de Lamirande and Gagnon, 1995). de Lamirande et al. (1997a) demonstrated that exogenous 
addition of superoxide anion induced human spermatozoa hyperactivation, capacitation and acrosome 
reaction. However, the mechanism of action of ROS mediated hyperactivation, capacitation and 
acrosome reaction are not fully understood (de Lamirande and Gagnon, 1995; Du Plessis et al., 2015). 
Though, the two processes that are believed to be responsible for physiological activation of adenyl 
cyclase, which is thought to play a role in human sperm capacitation are generation of ROS and calcium 
influx (de Lamirande et al., 1997a). On the other hand, physiological amounts of ROS production are 
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thought to be responsible in hyperactivation through a probable complex multiple influence and 
interaction (de Lamirande et al., 1997a). Yet, induction of acrosome reaction collectively depends on 
ROS generation, calcium influx, increase in adenyl cyclase activity and protein phosphorylation 
(Yanagimachi, 1994; Aitken et al., 1995; Leclerc and Kopf, 1995). Contrary, studies have indicated 
that ROS scavenges for superoxide anion and catalase prevented the effect of ROS (de Lamirande and 
Cagnon, 1993). Leading to the hypothesis that antioxidants (phenols, flavonoids, vitamin E, 2-
hydroxy-4-methoxybenzaldehyde alkaloid and zinc) found in Mondia extract might have scavenged 
intrinsic superoxide anions hence, preventing hyperactivation, capacitation and acrosome reaction. 
Furthermore, seminal plasma has been found to contain a high concentration of zinc as a membrane 
stabilizing compound, and is therefore considered a decapacitating factor (Andrews et al., 1994). A 
preliminary study by de Lamirande and Cagnon (1997) indicated that 50 µM of zinc decreased 
hyperactivation and capacitation on human spermatozoa. Yet, the percentage of sperm motility and 
vitality was not affected. Additionally, Riffo et al. (1992) observed that an addition of 100 µM of zinc 
to the incubation medium prevented human sperm capacitation and acrosome reaction. Hence, the 
assumption that the zinc content in Mondia might have led to the reduction of sperm hyperactivated 
motility and capacitation. Additionally, Mondia extract contains 2-hydroxy-4-methoxybenzaldehyde 
alkaloids, which have been found to possess free radical scavenging activities (Martey and He, 2010). 
Similarly, it may act through the same mechanism as the other mentioned antioxidant in Mondia thus, 
preventing hyperactivation, capacitation and acrosome reaction. Nonetheless, more studies need to be 
done on physiological effect of 2-hydroxy-4-methoxybenzaldehyde alkaloids on human sperm cells. 
4.9 Conclusion 
Previous studies have shown that Mondia root extract contains several phytochemical which are 
presumed to be responsible for the biological activities. These phytochemicals include antioxidants 
(phenols, flavonoids, vitamin E, 2-hydroxy-4-methoxybenzaldehyde alkaloids, and zinc) (Moyo et al., 
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2010) of which free radical scavenging activities might have prevented oxidative stress by protecting 
the sperm from lipid peroxidation and consequently, maintained essential sperm characteristics such 
as motility, intact mitochondrial membrane potential and DNA damage (Halliwell, 1989). This was 
confirmed in the present study where sperm motility, intact MMP and DNA integrity were maintained. 
The presence of reducing sugars (Quasie et al., 2010) might have also influenced motility by providing 
energy in form of ATP through oxidative phosphorylation that takes place in a proper functioning 
mitochondria. In contrast, antioxidants scavenging activities might have compromised positive role of 
ROS on initiating hyperactivated motility, acrosome reaction and capacitation. According to (de 
Lamirande et al., 1997b) mild oxidative stress promote the fertilizing potential by enhancing 
hyperactivation, acrosome reaction and capacitation, through increased tyrosine phosphorylation. 
However, there is a thin line between physiological amount of ROS needed to facilitate the process of 
fertilization and pathological amount of ROS that is detrimental to the spermatozoa. Therefore, for 
proper functioning of the spermatozoa the threshold should be maintained. Having this in mind, it can 
be hypothesized increased deoxidation from antioxidant found in Mondia extract (phenolic, flavonoic, 
vitamin E, 2-hydroxy-4-methoxybenzaldehyde alkaloids, and zinc) inhibited sperm hyperactivated 
motility, capacitation and acrosome reaction. 
The investigation of the effect of the aqueous root extract of Mondia whitei comprehensively sheds 
lights on the potential action on human male spermatozoa in vitro. Therefore, it can safely be assumed 
that the extract has no direct toxic effects on functional sperm parameters and does not trigger intrinsic 
ROS production at therapeutically used concentrations (<1.85 µg/ml). Since, phytochemicals found in 
Mondia do not increase ROS by causing oxidative stress the total motility, progressive motility, MMP 
and DNA integrity is maintained. In addition, results from the in vitro investigation suggest that the 
extract from Mondia may be beneficial especially to male patients (oligozoospermic and 
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asthenozoospermic) in terms of modulating sperm function but not as a possible treatment, since, it 
does not directly improve male fertility/sperm functions in vitro.  
Moreover, previous in vivo studies have shown Mondia whitei extract to act via different mechanism 
as well to influence fertility. Therefore, in the quest to find solutions surrounding the issues of male 
infertility, many factors must be considered including a proper understanding of the hypothalamus-
pituitary-gonadal axis and how it influences the Sertoli, Leydig and germ cells not forgetting the 
influence on FSH and LH. Additionally, basic knowledge about physiological and biochemical process 
involved in spermiogenesis will enable proper understanding of mechanism involved in abnormal 
sperm function. Besides, Mondia extract could have effect at any of the above point to influence 
fertility.   
Therefore, continuous research on novel medicinal plants frequently used for treatments but lacking 
scientific validation should be encouraged, and more specific investigation should be done on Mondia 
root extract for a clear understanding on its mechanism of action. Furthermore, the traditional aspect 
of the mode of administration and preparation of the plant material must not be ignored.  
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